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Abstract 
  Fire blight, caused by bacterium Erwinia amylovora, is a very 
serious disease affecting apple, pear and other fruit plants. The development of 
phage-based biopesticides is currently in progress in our lab. Emergence of 
phage-resistant bacteria is a valid concern. Two attributes of the bacterial host 
that may contribute to the development of resistance were studied, the 
Clustered Regularly Interspaced Short Palindromic Repeats/ CRISPR-
associated (CRISPR/Cas) system and exopolysaccharide (EPS) interaction with 
phages.  
The structure of E. amylovora CRISPR/Cas system was determined in 8 
E. amylovora isolates from different geographical regions. Three CRISPR-array 
sets named CR1, CR2 and CR3 were detected in 4 isolates, and only 2 arrays 
were determined in the rest of the isolates. No significant similarity was found 
between spacers in any of these systems to phage DNA sequenced in this study 
or from GenBank. Also the Cas level of expression was not stimulated during 
phage infection. Introduction of extra copies of Cas genes to enhance 
expression did not result in phage resistance. Nevertheless, E. amylovora 
CRISPR/Cas system was found to be efficient in blocking the transformation of 
plasmids carrying protospacers matched spacers in CRR1 and CRR2.  
Among phages that have been sequenced in this study are ΦEa9 -2 and 
ΦEa35-70. ΦEa9-2 (Podoviridae) genome is 75,568 bp, and found to be related 
to coliphage N4. ΦEa35-70 (Myoviridae) genome is 271,084 bp, and found to 
carry a potential EPS depolymerase gene. Activity of ΦEa35-70 EPS 
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depolymerase was only detected when cloned and expressed in E. coli, but His-
tagged purified protein did not exhibit any EPS-depolymerase activities. 
This study offers critical information for the design of novel and effective 
phage-based biopesticides for the control of E. amylovora. It provides a new 
knowledge on the molecular structure and function of CRISPR/Cas system and 
EPS-phage interaction.   
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Chapter 1 
General Literature Review 
 Erwinia amylovora (Burrill) Winslow et al. is a pathogen that can infect a 
wide range of species in the Rosaceae including Pyrus spp., Malus spp., Rubus 
spp., Sorbus spp., and Cydonia spp. (Bonn and van der Zwet, 2000; Johnson 
and Stockwell, 1998; van der Zwet and Keil, 1979). The infected tissues  
generally appear  black and collapsed,  as if they were scorched by fire (Bonn 
and van der Zwet, 2000; Coxe, 1817). The common name for the disease is fire 
blight and the symptoms are generally described by the specific location of the 
blight on the tree such as blossom, shoot, fruit, leaf, trunk and root (Thomson et 
al., 1992; van der Zwet and Beer, 1995).  . 
 Fire blight was first observed in New York State in the Hudson River 
highlands in 1780 (Stapp, 1961). Despite the early discovery of the disease 
symptoms in the US, the first observation of fire blight in Canada took place in 
British Columbia in 1865  (Bonn and van der Zwet, 2000),  and in England in the 
1950s (Crosse et al., 1960). In the next 20 years, the pathogen was reported in 
Belgium, Denmark, Poland and Netherlands (Borecki and Lyskanowska, 1968; 
Hockenhull, 1979; Kleijburg, 1979; Meijneke, 1972; van der Zwet and Sugar, 
1994; Verhoyen, 1983).  
 E. amylovora is a Gram negative, motile, rod shaped bacterium that 
belongs to the family Enterobacteriaceae. It is closely related to important 
human and animal pathogens such as Escherichia coli and Salmonella enterica 
(Holt et al., 1994). E. amylovora strains are relatively homogeneous in their 
biochemical and protein electrophoretic characteristics despite their different 
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geographical origins (Paulin, 2000; Vantomme et al., 1982). To date, there are 
two published complete genome sequences for E. amylovora: the European 
strain CFBP 1430, accession number of FN434113 (Smits et al., 2010), and the 
American strain Ea273, accession number of FN666575 (Sebaihia et al., 2010). 
E. amylovora CFBP 1430 strain was isolated in 1972 from a Crataegus sp., and 
Ea273 was isolated from a Malus sp. Even though these strains are from two 
different parts of the world, they have similar genome size of 3.8 Mb and show 
99.99% sequence similarity (Sebaihia et al., 2010; Smits et al., 2010). The high 
similarity between the genomes of these strains indicates minimal evolutionary 
changes of both strains (Jock et al., 2002; Smits et al., 2010; Zhang and 
Geider, 1997).  
 During cell growth E. amylovora produces exopolysaccharides (EPS) that 
are the main components of the bacterial capsule which is loosely attached to 
the bacterial surface and/or secreted into its surroundings (Bellemann et al., 
1994; Cerning, 1990; Durlu-Ozkaya et al., 2007; Kim et al., 2002). The 
production of the highly hydrated EPS is advantageous for growth and survival 
of the bacterium because it provides protection against environmental stress 
and avoidance of recognition by plant defense mechanisms (Leigh and Coplin, 
1992). EPS plays a major role in E. amylovora pathogenicity and is the main 
component of the bacterial ooze. Ooze is a yellow to orange-colored substance 
that is present on the surface of infected host tissues (Bellemann and Geider, 
1992; Bennett, 1980; Bennett and Billing, 1978; Koczan et al., 2011; Koczan et 
al., 2009; Ordax et al., 2010; Vrancken et al., 2013). In addition, EPS production 
may enhance the ability of the bacteria to resist antibiotic treatments since it 
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acts as a protection shield (Gander and Gilbert, 1997; Palmer et al., 2007; 
Ramey et al., 2004).  
 E. amylovora EPS is composed of levan (Du and Geider, 2002; Geider et 
al., 1993; Gross et al., 1992; Vrancken et al., 2013) and amylovoran (Bellemann 
et al., 1994; Bereswill and Geider, 1997). Koczan et al. (2011) showed that both 
amylovoran and levan are involved in the formation of the bacterial biofilm 
(Koczan et al., 2011; Ramey et al., 2004). Levan (Figure 1) is a polyfructan 
synthesized in the presence of sucrose by levansucrase (Geider et al., 1993; 
Geier and Geider, 1993), an enzyme encoded by lsc gene (Rairakhwada et al., 
2010). Levansucrase cleaves sucrose into glucose and fructose, and then 
polymerizes fructose to levan (Du and Geider, 2002; Geier and Geider, 1993; 
Gross et al., 1992; Zhang and Geider, 1997). Amylovoran, the most abundant 
component of the EPS, is a polymer, composed of pentasaccharide repeating 
units that are generally made of four galactose molecules and one glucuronic 
acid (Figure 1) (Jumel et al., 1997; Maes et al., 2001; Nimtz et al., 1996). The 
backbone of the repeating unit of amylovoran consists of three differently linked 
galactose residues. The major side chain consists of glucuronic acid and a 
terminal galactose decorated with pyruvyl and acetyl groups. A second side 
chain is formed when glucose is attached to the branched galactose residue in 
10 to 50% of the repeating units (Bellemann et al., 1994). Amylovoran is 
synthesized by the ams operon, a 16 kb region (Bugert and Geider, 1995; 
Eastgate, 2000; Langlotz et al., 2011). It consists of 12 genes (amsA to amsL) 
organized in a large gene cluster and all transcribed in the same direction. The 
products of ams genes seem be involved in individual steps of amylovoran 
synthesis (Bugert et al., 1996; Bugert and Geider, 1995).  
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Figure 1: E. amylovora   levan synthesis and amylovoran structure. 
Left:  levan synthesis in E. amylovora. Sucrose is metabolized by levansucrase 
releasing glucose and fructose. Fructose polymerizes to form levan. Right: 
amylovoran repeating unit structure. Letter code of the monosaccharide 
residues is shown: Gal, galactose; GlcA, glucuronic acid; Pyr, pyruval residue; 
p: pyranoside; n, degree of polymerization. (*) An additional glucose residue 
found in only 10% of the repeating units. Graphics by (Nimtz et al., 1996). 
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 The sugar residues of the repeating unit are presumably attached 
sequentially before the unit is transported through two cell membranes and 
attached to an existing amylovoran molecule (Geider et al., 1996). The role of 
some individual ams genes in EPS synthesis was determined by 
characterization of mutants obtained by transposon mutagenesis or of a 
resistance of mutants obtained by transposon mutagenesis or of a resistance 
cassette insertion (Aldridge et al., 1998; Bernhard et al., 1990; Bugert et al., 
1996; Bugert and Geider, 1995). EPS synthesis of E. amylovora is regulated by 
the activator proteins RcsA and RcsB and by RcsC as a sensor in a two-
component system (TCR) (Bereswill and Geider, 1997; Bernhard et al., 1990; 
Coleman et al., 1990; Poetter and Coplin, 1991). TCR plays critical roles in 
sensing and responding to environmental conditions and in bacterial 
pathogenesis. In this system, RcsC acts as a sensor to transfer environmental 
signals by attaching a phosphate group to RcsB an activator protein. RcsA, in 
turn, binds to RcsB, converting it to an efficient activator (Bereswill and Geider, 
1997; Bernhard et al., 1990; Coleman et al., 1990; Poetter and Coplin, 1991). 
 Amylovoran is a major pathogenicity factor (Mann et al., 2013; Roach et 
al., 2013) and the main constituent of the bacterial EPS (Ayers et al., 1979; 
Billing, 1960; Cerning, 1990; Geier and Geider, 1993; Koczan et al., 2011; 
Koczan et al., 2009; Ramey et al., 2004). The pathogenicity associated with 
amylovoran could be due to its role in bypassing the plant defence system and 
in disturbing and obstructing the vascular system of the plant (Bernhard et al., 
1996; Denny, 1995; Koczan et al., 2011; Ordax et al., 2010; Vrancken et al., 
2013). E. amylovora strains that do not produce amylovoran are non-pathogenic 
and are unable to spread in plant vessels (Bellemann and Geider, 1992; Geider 
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et al., 1993; Lee et al., 2010; Oh and Beer, 2005; Roach et al., 2011; Roach et 
al., 2013; Sjaarda, 2012; Steinberger and Beer, 1988; Vrancken et al., 2013). A 
mutation in ams gene cluster that involved in the biosynthesis of amylovoran 
resulted in the lack of bacterial pathogenicity (Geider et al., 1993; Roach et al., 
2011; Roach et al., 2013). Moreover the magnitude of amylovoran produced is 
associated with the degree of E. amylovora virulence (Maes et al., 2001; 
Vrancken et al., 2013). E. amylovora isolates that lack levan synthesis exhibit 
delayed symptom development in the host (Geider et al., 1993; Koczan et al., 
2011; Sjaarda, 2012; Vrancken et al., 2013). Levan is also considered a 
virulence factor in E. amylovora, since levan deficient mutants show a decrease 
in fire blight symptoms (Geider et al., 1993; Koczan and Sundin, 2011; Piqué et 
al., 2015). Two additional factors are directly involved in the pathogenicity of E. 
amylovora. These include the hrp genes involved in hypersensitivity response in 
non-host plants and dsp genes, disease specific genes involved in disease 
development (Oh et al., 2005; Piqué et al., 2015; Steinberger and Beer, 1988; 
Zhao et al., 2009). 
 
Disease cycle 
 E. amylovora from the infection events in the previous season survive and 
overwinter in bacterial cankers which are situated on the woody portions of the 
plant tissues. In early spring, under optimal temperatures of 24-28°C, E. 
amylovora multiply rapidly and the margins of the cankers discharge ooze.  
Ooze is a mixture of E. amylovora cells and EPS (Biggs, 1994; van der Zwet 
and Beer, 1995). The bacterial cells in the ooze, serve as the primary inoculum 
source.  The ooze is spread to open blossoms via insects, birds, rain and wind 
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(Miller, 1929; Thomson, 2000; van der Zwet and Beer, 1995; Van Laere et al., 
1980). Primary infection of the host occurs during open bloom when the 
bacterial cells reach the nutrient rich stigmal surface. Spring conditions at 
temperatures of 20-28°C and in the presence of nectar result in the 
multiplication of the pathogen (Johnson and Stockwell, 1998; Thomson, 2000; 
Vanneste, 2000). The infected blossom looks water-soaked then discoloured 
(van der Zwet and Keil, 1979).  In the presence of high humidity and/or free 
water the bacterial cells washes down into the hypanthium.  The bacterial cells 
continue to multiply and achieve high population numbers within the nectarthode 
(Johnson and Stockwell, 1998; Thomson, 2000).  The bacteria continue to 
multiply when invading the peduncle and the spur reaching the stem. EPS 
produced by the pathogen is accumulated leading to disruption of water flow in 
the xylem leading to the formation of bacterial aggregates (Sjulin and Beer, 
1978). These aggregates cause the xylem vessels to leak forcing the EPS to 
appear on the plant surface forming ooze, a characteristic of fire blight. 
 Bacteria can spread from blossom to blossom by pollinating insects 
initiating more blossom blight (Johnson et al., 1993; Thomson et al., 1998; 
Thomson et al., 1992). As long as favorable temperatures persist with high 
humidity, E. amylovora secondary infections may continue throughout all spring 
and early summer (Bonn and van der Zwet, 2000; Thomson, 2000). The 
secondary infection includes shoot, fruit, and rootstock blight. Shoot blight is a 
result of the spread of inoculum from infected blossoms to the healthy shoot 
tissue. Injuries caused by winds and hail can create wounds in host plant 
tissues creating an entrance for the pathogen, reducing their natural defense 
mechanisms and facilitating the spread of the infection (Steiner, 2000). 
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Rootstock blight occurs as a result of the movement of E. amylovora 
systemically from infected shoots and cankers into the rootstock (Roberts et al., 
1998; Steiner, 2000; van der Zwet and Beer, 1995). 
 
Fire blight control 
 Good agricultures practises such as proper pruning methods, suitable 
irrigation timing and type and timing to apply pesticides are good practises to 
prevent and manage the disease. To prevent the spread of the disease, 
previously infected tissue such as branches, cankers, or even whole trees 
should be removed during winter dormancy. 
 The difficulty to eradicate E. amylovora once it exists in an orchard and 
the complexity of the disease cycle makes controlling fire blight with a single 
method very difficult. In addition to good agricultural practises to  prevent and 
manage the disease, there are two main approaches for the control E. 
amylovora in the orchard. In chemical control, bactericides such as antibiotics 
and copper are used to reduce E. amylovora inoculum and prevent the 
proliferation of the bacterium.  In biological control, antagonistic non-pathogenic 
bacteria compete with the pathogen for nutrients on the stigma surface.  The E. 
amylovora populations are suppressed and infection of the flower is avoided 
(Johnson and Stockwell, 2000; Stockwell et al., 2011).  
 Despite the relatively low cost, the use of copper as a pesticide comes 
with drawbacks. The efficacy of copper in preventing fire blight disease is still 
controversial due to the lack of conclusive results from efficacy studies (Dimova 
Aziz, 1990; El Nasr et al., 1990; Tsiantos and Psallidas, 1993; Tsiantos et al., 
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2003).  Copper is bactericidal to E. amylovora but it may be phytotoxic to 
vegetative and reproductive plant tissues. Most importantly, the appearance of 
copper-resistant plant pathogens has been documented in bacteria (Behlau et 
al., 2011; Cooksey, 1994).  
 Streptomycin and kasugamycin are registered antibiotics for fire blight 
control in Canada (Bonn and Leuty, 1993; Lightner and Steiner, 1993; McGhee 
and Sundin, 2011; Norelli et al., 2003; Russo et al., 2008; Schnabel and Jones, 
1999). While they have a high efficacy for the control E. amylovora and other 
plant pathogenic bacteria, the use of antibiotics as bactericides comes with 
serious problems. The appearance of antibiotic resistance in E. amylovora and 
the regulatory movement away from antibiotics in certain jur isdictions has 
resulted in the re-evaluation of control options for fire blight (Breth et al., 2014; 
Loper et al., 1991; McManus and Jones, 1994; Russo et al., 2008; Schroth et 
al., 1979; Sholberg et al., 2001; Stockwell, 2014; Walsh et al., 2014). 
Streptomycin-resistant E. amylovora isolates have been discovered in British 
Columbia (Sholberg et al., 2001), California (Förster et al., 2015), Michigan 
(Coyier and Covey, 1975), Utah (Nischwitz and Dhiman, 2013) New York state 
(Russo et al., 2008; Tancos et al., 2016) and New Zealand (Thomson et al., 
1993; Vanneste and Voyle, 1998). 
 Biopesticides are generally composed of antagonistic bacteria that 
suppress E. amylovora populations on susceptible blossoms by competing for 
nutrients and space (Johnson and Stockwell, 1998; Kabaluk, 2010; Pusey, 2002; 
Rezzonico et al., 2009; Wilson and Lindow, 1993). This competition reduces the 
ability of E. amylovora to cause disease (Wilson and Lindow, 1993).  
Biopesticides that have been licenced for use in Canada for the control of fire 
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blight include Bloomtime™, BlightBan® A506, BlightBan® C9-1 (Nufarm 
Agricultural Inc.) and Blossom Protect™ (Bio-Ferm). Bloomtime contains the 
epiphytic Pantoea agglomerans strain E325, BlightBan® A506 contains 
Pseudomonas fluorescens strain A506, and the active ingredient of BlightBan® 
C9-1 is Pantoea vagans C9-1 and Blossom protect™ contains Aureobasidium 
pullulans, an epiphytic yeast. 
 The ability of antagonistic bacteria to supress E. amylovora mainly 
depends upon their ability to colonize open blossoms. Timing of application and 
quantity applied are critical for successful colonization and high efficacy 
(Ishimaru et al., 1988; Pusey, 2002). Biologicals need to be applied during the 
bloom period usually at 30-50 and 70-100% open bloom. The populations of the 
biological need to be established on the pistil of every opened flower.  In this 
manner the pathogen is excluded from the same environmental niche since it 
competes for the same nutrients as the biological control agent. 
 
Bacteriophages and their use as biological control agents 
 Bacteriophages, or phages, were first discovered by Twort in 1915 and 
d’Herelle in 1917 (Summers, 2005). They are viruses that multiply and replicate 
inside the bacterial host by manipulating the host’s biosynthetic machinery. 
Phage particles are generally composed of three major components that include 
the genome, capsid and tail. The phage genome can be linear or circular and 
either double- or single-stranded DNA or RNA. The viral genome is enclosed in 
a protective coating or capsid composed of phage-encoded proteins. 
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E. amylovora phages are icosahedral, tailed double-stranded DNA viruses 
belong to the Caudovirale order  (Born et al., 2011; Gill et al., 2003; Lehman, 
2007; Lehman et al., 2009; Müller et al., 2011a; Schnabel and Jones, 2001; 
Weinbauer, 2004; Weinbauer et al., 2007; Yagubi et al., 2014) . Erwinia spp. 
phages can be classified into three families: Myoviridae, Siphoviridae, and 
Podoviridae (Figure 2) (Gill et al., 2003). The Myoviridae phages have 
contractile tails; Siphoviridae phages, which constitute about 61% of tailed 
phages (Ackermann, 2007; Ackermann and Prangishvili, 2012), have long non-
contractile tails and the Podoviridae have short tails. Erwinia spp. phages 
genome sizes vary and could range from 45 kbp up to 280 kbp (Born et al., 
2011; Lehman et al., 2009; Müller et al., 2011a; Yagubi et al., 2014) . The size of 
the viral capsid can be different from phage to phage and it depends of genome 
size. The function of phage tail is to correctly identify a host and deliver the 
phage genome into the host cell interior.  
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                                  (Gill et al., 2003) 
 
Figure 2 : Electron micrographs of E. amylovora phages. 
A-D phages belong to the Myoviridae family; A and B in uncontracted state; C 
and D in the contracted state. E phages from the Podoviridae family. The arrow 
points to the tail. Micron marker in each frame represents 100 nm.   
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Bacteriophage life cycle 
 Phages can exhibit lytic or temperate life cycles. Lytic phages infect, 
replicate, and release progeny; this life cycle eventually leads to bacterial cell 
death. Temperate phages, on the other hand, are phages capable of undergoing 
both a lytic and lysogenic cycle (Ptashne, 2004; St-Pierre and Endy, 2008; Zeng 
et al., 2010). In the lysogenic cycle, phage genome integrates into the host 
chromosome and exists as prophage (Campbell, 2006; Campbell, 2007). This 
dormant integration state may persist indefinitely without any production of new 
virions or it may convert to a lytic infection under specific environmental 
stresses  (Campbell, 1961; Stewart and Levin, 1984). 
 Phage lytic cycle (Figure 3)  may be divided into five timely coordinated 
stages: attachment and genome insertion, synthesis of early proteins, phage 
DNA replication, synthesis of late proteins, lysis of the host cell  and the release 
of mature viral particles (Abedon, 2008; Lindberg, 1977). Initially, the phage 
binds to a receptor on the bacterial cell surface. The phage genome is inserted 
into the bacterial host, and it must be protected from the bacterial nucleases. 
Once the viral genome enters the host cell, the phage life cycle may undertake 
either lysogenic or lytic cycle (Figure 3) (Abedon, 2008; Koch, 2007). During the 
lytic cycle, some viral genes are expressed as mRNAs then translated, using 
host cell ribosomes and tRNAs to produce early viral proteins. Early proteins 
mainly allow the phage to control the host biosynthesis machinery and support 
viral DNA replication. The newly-replicated viral-DNA molecules are used to 
synthesis late viral proteins. The late proteins are mostly structural proteins that 
make up the capsid and tail. Following DNA replication and the synthesis of late 
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Figure 3: Bacteriophage lytic and lysogenic life cycles. 
Phage attaches to a cell (1) and inserts its DNA. (2) Phage DNA circularizes; at 
this stage, phage can initiate either a lytic cycle or lysogenic cycle. In lytic cycle:  
(3) Phage DNA replicates and phage protein synthesis followed by phage 
particles assembly; (4) Cell lysis and release of new phages. In lysogenic cycle: 
(5) Phage DNA integration into host chromosome (prophage, in red); (6) Phage 
DNA replicates when host cell divides; (7) daughter cell with prophage. (8) At 
this stage, a prophage may exit the bacterial chromosome, initiating a lytic 
cycle. Graphics by A. Yagubi. 
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proteins, phage particle assembly takes place. Once the assembly is 
accomplished, the host cell is lysed allowing the release of mature phages. The 
newly synthesized phages in turn infect nearby host cells and start a new 
infection cycle (Weinbauer, 2004). 
In the lysogenic cycle (Figure 3), temperate phages keep their 
chromosome stable and silent by integrating their genome into the bacteria host 
chromosome (Campbell, 2006; Campbell, 2007). The phage genome can silently 
replicate along with bacterial chromosome during normal cell division (Campbell, 
2006; Campbell, 1961; Stewart and Levin, 1984; Zong et al., 2010) . Phage DNA 
integrated into host cells during lysogeny is called prophage.  Bacterial cells 
carrying the prophage are referred to as the lysogenized host (Campbell, 1961; 
Stewart and Levin, 1984). In the lysogenic state, genes that involved in the lytic 
cycle are repressed (Oppenheim and Adhya, 2007).  If the repressed genes are 
activated, phage genome can be released from the bacterial chromosome (Dodd 
et al., 2004; Ptashne, 2004). The excised phage genome then acts as a 
template for the synthesis of viral proteins involved in the production and 
assembly of new viral particles. The end point of the lytic cycle results in the 
lysis of the bacterial host and the release of new phage. 
 Prophages have been detected in many phytopathogens and plant-
associated bacteria. These includes: Rhizobium spp. (Malek, 1990; Uchiumi et 
al., 1998), rhizosphere pseudomonads (Shaburova et al., 2000), Ralstonia 
solanacearum (Yamada (Addy, 2012a; Addy, 2012b; Murugaiyan et al., 2011; 
Yamada et al., 2007), Erwinia carotovora subsp. carotovora (Faltus and Kishko, 
1980; Kishko et al., 1982; Ruban et al., 1981; Toth, 1993; Tovkach, 2002a; 
Tovkach, 2002b; Tovkach, 2002c),  Xanthomonas campestris pv. azadirachtae  
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(Borkar, 1997)  and P. agglomerans (Erskine, 1973; Harrison and Gibbins, 
1975).  The presence of prophage(s) in bacterial hosts may prevents the 
infection of bacteria by homologous phage through superinfection immunity 
(Abedon, 2008). Temperate phages may involve in  phage-mediated transfer of 
genes that can improve bacterial virulence (Addy, 2012a; Brüssow, 2009; 
Brüssow et al., 2004; Canchaya et al., 2004; Wagner et al., 2002) or decrease 
virulence (Addy, 2012b). Temperate phages may also contribute to toxin genes 
and antibiotic resistance genes transfer (Mauro and Koudelka, 2011; Muniesa et 
al., 2013). Many phages are known to carry lysogenic genes that are involved in 
establishing lysogeny (Brüssow et al., 2004). The genomes of all fully 
sequenced Erwinia spp. phages in this study and others were found to lack the 
necessary genes for prophage integration (Born et al., 2011; Lehman et al., 
2009; Nagy et al., 2012; Yagubi et al., 2014).  
 Roach et al. (2015) showed that while lysogeny is possible in E. 
amylovora, it is rare and/or absent in natural populations. Real-time PCR 
primers were developed that detected the presence of E. amylovora phages 
belonging to the Myoviridae and Podoviridae families in a collection of bacterial 
isolates belonging to global E. amylovora and local isolates of P. agglomerans.  
Prophage were not detected in 161 E. amylovora isolates from different 
geographical areas of the world and 82 P. agglomerans isolates from southern 
Ontario (Roach et al., 2015). The possibility still remains that temperate phage 
may exist that belong to the Siphoviridae and/or unique phage isolates that are 
not detected by current real-time PCR primers (Roach et al., 2015).  
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Phages as biological control agents in agriculture 
  In 1924, phages were proposed as agents for the control  of plant disease 
(Moore, 1926). Phage filtrate collected from decomposed cabbage infected with 
Xanthomonas campestris pv. campestris inhibited in vitro growth of the 
phytopathogen  (Mallmann and Hemstreet, 1924) . In 1930s, phages were used 
to reduce the severity of bacterial blight in cotton (Massey, 1934). Phages were 
used for effective control of Pantoea stewartii, the causal agent of Stewart’s wilt 
disease (Thomas, 1935).  The discovery of antibiotics in the 1940s and their 
resulting high efficacy against bacterial pathogens resulted in the abandonment 
of bacteriophage based research (Chanishvili, 2012; Summers, 2001). 
 The appearance of antibiotic resistance in E. amylovora (Coyier and 
Covey, 1975; Miller and Schroth, 1972; Russo et al., 2008; Sholberg et al., 
2001), the demand for environmentally friendly pesticides (Dunne et al., 1996; 
Emmert and Handelsman, 1999; Manso et al., 2010) and the legislated removal 
of antibiotics in certain jurisdictions contributed to increasing interest in finding 
alternative solutions for control of plant pathogens. The use of bacteriophages 
as potential replacements for antibiotics for the control of fire blight has been 
recently investigated by a number of research groups in Europe and North 
America (Erskine, 1973; Gill et al., 2003; Lehman, 2007; Schnabel et al., 1999; 
Svircev et al., 2010). Phages have been used for the control of: bacterial wilt 
caused by Ralstonia solanacearum  (Tanaka et al., 1990),  bacterial spot of 
tomato (Xanthomonas sp.) (Balogh et al., 2003; Flaherty et al., 2000),  bacterial 
blotch of mushrooms (Pseudomonas spp.) (Munsch et al., 1995), potato scab 
(Streptomyces scabies) (Mckenna et al., 2001), blight on onion (Xanthomonas 
sp.) (Lang et al., 2007), and citrus bacterial canker (Balogh, 2006)  
 
   18 
Challenges in using phages as biological control agents 
 Phages are highly sensitive to harsh environmental factors when applied 
to aerial plant tissues (Balogh, 2002; Balogh et al., 2003; Civerolo and Kiel, 
1969; Frampton et al., 2012; Iriarte et al., 2007; McNeil et al., 2001). Field and 
laboratory studies have demonstrated that phages can be degraded and 
inactivated by exposure to high temperature, extreme pH, and UV light (Ignoffo 
et al., 1989; Ignoffo and Garcia, 1992; Iriarte et al., 2007). Phage survival in the 
environment has to be ensured by incorporating protective materials such as 
charcoal, starch (Balogh, 2002; Balogh et al., 2003; Ignoffo et al., 1997; 
Obradovic et al., 2004) and/or the use of a protective non-pathogenic bacterial 
host (Erskine, 1973; Lehman, 2007; Svircev et al., 2010). Field trials with 
phages failed due to the declined of the phage populations in the blossoms due 
to sun light (Ritchie and Klos, 1979; Schnabel et al., 1999). Some research 
groups have proposed the use of avirulent E. amylovora mutants to improve 
phage persistence in the environment (Schnabel et al., 1999; Tharaud et al., 
1997). The possible revision of mutants to virulent bacteria prompted the 
requirement for use a safer alternative. Our research group developed a 
successful and novel strategy for phage delivery by using an epiphytic 
bacterium.  The epiphyte delivered and maintained a replicating phage 
population in the blossom during the primary stages of E. amylovora infection 
(Lehman, 2007; Svircev et al., 2010).   The epiphytic and non-pathogenic 
Pantoea agglomerans (formerly Erwinia herbicola) and the Erwinia spp. phages 
were  applied onto the blossoms (Lehman, 2007).  P. agglomerans  Pa21-5 
controlled E. amylovora in open blossoms by competing with the pathogen for 
nutrients, protecting phages from the environmental factors and supporting 
 
   19 
phage population replication (Lehman, 2007). The dual action biological system 
uses P. agglomerans as a biological control agent and phage carrier (Lehman, 
2007; Svircev et al., 2010).  
 The ability of bacteria to develop resistance to bacteriophages would 
deter the acceptance of phage therapy for the control of plant pathogens (Marks 
and Sharp, 2000; Okabe and Goto, 1963; Vidaver, 1976). To avoid the 
development of bacterial resistance phage cocktails or mixtures of 2-6 phages 
are commonly used.  Generally, the mixture is prepared with individual phages 
that have dissimilar receptors to the pathogenic bacterium (Abuladze et al., 
2008; Balogh et al., 2010; Flaherty et al., 2001; Jackson, 1989). To avoid phage 
resistance, Jackson (1989) developed a new strategy by preparing mixtures of 
wild-type and host range mutant phages (h-mutants). The h-mutants were 
capable of lysing bacterial strains resistant to the parent wild-type phages 
(Jackson, 1989). The phage mixtures retain a host range wider than the parent 
phage as such the occurrence of phage-resistant host can be to prevented 
(Jackson, 1989). The strategy of using h-mutants was evaluated in the control 
Xanthomonas campestris pv. vesicatoria, bacterial spot disease on tomato, and 
Xanthomonas campestris pv.  pelargonii, bacterial blight of geranium (Flaherty 
et al., 2001; Flaherty et al., 2000). The application of these phage mixtures 
provided an equivalent disease control of bacterial blight of geranium and 
bacterial spot disease on tomato comparing to plants treated with the chemical 
bactericide (Flaherty et al., 2001; Flaherty et al., 2000).  
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Bacterial host resistance to bacteriophages  
 The development of bacterial resistance to phages may involve a number 
of mechanisms such as: the blocking of phage attachment to bacterial cell wall 
receptors (Nordström and Forsgren, 1974), abortive infection (Allison and 
Klaenhammer, 1998; Durmaz and Klaenhammer, 2007; Fineran et al., 2009; 
Smith et al., 1969), CRISPR/Cas systems (Marraffini and Sontheimer, 2010a; 
Sorek et al., 2008; van der Oost et al., 2009), physical exclusion by the 
production of extracellular matrix (Andersson and Banfield, 2008; Bernheimer 
and Tiraby, 1976; Cerning, 1990; Deveau et al., 2002; Looijesteijn et al., 2001; 
Scholl et al., 2005; Valyasevi et al., 1990; Wilkinson and Holmes, 1979) , and 
restriction-modification of invading phage nucleic acid (Bujnicki, 2004; Pingoud 
et al., 2005).  
 
Blocking receptors and prevention of phage adsorption 
 Phage attachment and adsorption to bacterial cell receptors constitutes 
the initial step in infection.  In order to successfully infect a cell, phages need to 
recognise and attach to a receptor on the bacterial cell. In turn, bacteria have 
evolved a wide range of mechanisms to prevent phage adsorption (Allison and 
Klaenhammer, 1998; Bohannan and Lenski, 2000; Labrie et al., 2010; Lenski, 
1988). In E. amylovora, the most common mechanisms involve mutation in the 
phage receptors and the production of an extracellular matrix (Born et al., 2014; 
Hyman and Abedon, 2010; Roach et al., 2011; Roach et al., 2013). 
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EPS and phage infection 
 In addition to protecting the bacterial cell against the harsh environment, 
the bacterial EPS may act as a protective shield for the cells by providing a 
physical barrier between phage and the receptors on the cell membrane 
(Andersson and Banfield, 2008; Bernheimer and Tiraby, 1976; Cerning, 1990; 
Deveau et al., 2002; Looijesteijn et al., 2001; Scholl et al., 2005; Valyasevi et 
al., 1990; Wilkinson and Holmes, 1979). Bacteria produce different types of EPS 
depending on the genus. In Pseudomonas spp. and  Azotobacter spp., the EPS 
is composed of alginate, an anionic copolymer of mannuronic acid and 
glucuronic acid (Remminghorst and Rehm, 2006; Sutherland, 1995). Hyaluronan 
(hyaluronic acid) is a high-molecular-mass polysaccharide produced by 
pathogenic Streptococcus pyogenes as a part of their capsule structure (Van de 
Rijn, 1983). P. agglomerans produces a polysaccharide that is composed of 
arabinose, glucose, galactose and glucuronic acid (Wang et al., 2007).   
 E. amylovora isolates in the AAFC Vineland Bacterial Collection have 
been found to produce EPS in varying amounts when grown under similar 
condition (Roach et al., 2011; Roach et al., 2013).  The level of EPS production 
can be used to roughly classify them as being high-exopolysaccharide-
producing (HEP) and being low-exopolysaccharide-producing (LEP) (Roach et 
al., 2011; Roach et al., 2013).  
 To successfully infect a bacterial host, phages have to pass the EPS 
structure of the bacterial host.  Many of these phages such as phages belong to 
Podoviridae family have evolved to overcome the EPS by producing virion-
associated proteins with EPS-depolymerization activities (Born et al., 2014; 
Hughes et al., 1998a; Pelkonen et al., 1992). The depolymerases degrade the 
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EPS structure allowing the phage to attach to the bacterial cell membrane 
(Hughes et al., 1998a). The role of EPS in phage infection is not fully 
understood. EPS can act as a barrier which blocks phage infection and/or as a 
receptor that enhances phage adsorption to the cell . E. amylovora ability to 
produce an EPS layer may be directly involved in phage host interactions 
(Roach et al., 2011; Roach et al., 2013; Roach, 2011; Sjaarda, 2012).  
Podoviridae phages have an absolute requirement for amylovoran. Podoviridae 
phages cannot infect amylovoran-deficient bacterial mutants (Roach et al., 
2013). In contrast, the Myoviridae phages do not require the presence of 
amylovoran on the cell surface. However, Myoviridae phages could not infect  
levan-deficient E. amylovora mutants (Sjaarda, 2012).  
  
CRISPR/Cas system 
 The CRISPR (Clustered Regularly Interspaced Short Palindromic 
Repeats)/Cas (CRISPR-associated) system was first described in the genome of 
E. coli  (Ishino et al., 1987).  The term CRISPR was proposed by Jansen et al. 
(2002) to reflect the specific structure of these sequences (Jansen et al., 
2002a). Similar systems were reported in the genomes of other prokaryotes: 
Streptococcus (Hoe et al., 1999), Methanococcus jannaschii (Bult et al., 1996), 
Archaeoglobus fulgidus (Klenk et al., 1997), Thermotoga maritima (Nelson et al., 
1999), and Pyrococcus horikoshii (Kawarabayasi et al., 1998). The CRISPR/Cas 
system has been found in viral genomes and plasmids suggesting that this 
system can be horizontally transferred between microorganisms (Godde and 
Bickerton, 2006; Makarova et al., 2006; Seed et al., 2013). This was a novel 
discovery since bacteria were not anticipated to have immunological memory 
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that could be invested in the fighting of repetitive viral infection as is the case in 
vertebrates. The CRISPR/Cas system functions as an immune system for 
prokaryotes, as it defends prokaryotic cells against invading phages and other 
exogenous genetic elements such as conjugative plasmids and transposons 
(Barrangou and Marraffini, 2014; Bolotin et al., 2005; Godde and Bickerton, 
2006; Koonin and Makarova, 2009; Mojica et al., 2005; Pourcel et al., 2005; 
Sorek et al., 2008; Westra et al., 2012a). This system is a highly adaptive and 
heritable resistance mechanism.  In this defensive system some bacterial hosts 
may acquire resistance against invading phages after survival of a previous 
exposure to the same or very similar phage (Horvath et al., 2008; Sorek et al., 
2008). 
 CRISPRs are sites containing conserved short direct repeats that typically 
range in size from 24 to 48 bp (Figure 4) (Grissa et al., 2007). The repeats are 
separated by sequences termed spacers, which range from 17 to 80 bp and 
have an average length of 36 nucleotides (Grissa et al., 2007). The spacers are 
usually unique in a genome and match sequences in phage genomes and/or 
plasmids (Barrangou et al., 2007; Bolotin et al., 2005; Horvath et al., 2009; 
Mojica et al., 2009; Mojica et al., 2005; Pourcel et al., 2005). Spacers may be 
acquired during phage infection or plasmid transformation, and later act as a 
genetic memory that helps protecting the bacterial cell from subsequent phage 
infection or plasmid conjugation through recognizing and silencing exogenous 
genetic elements at the DNA or RNA level (Barrangou et al., 2007; Brouns et 
al., 2008; Marraffini and Sontheimer, 2008; Marraffini and Sontheimer, 2010a) .   
 The leader sequences and CRISPR-associated (Cas) genes are the 
additional important components of the CRISPR system (Figure 4) (Haft et al., 
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2005; Jansen et al., 2002b; Makarova et al., 2006). Leader sequences are AT-
rich regions (approximately 200 bp) located upstream from CRISPR loci 
(spacers and repeats). This region contains promoters and sequence elements 
that are essential for spacer acquisition (Barrangou et al., 2007; Díez-Villaseñor 
et al., 2013; Jansen et al., 2002a; Pourcel et al., 2005; Tyson and Banfield, 
2008). Cas are conserved group of genes usually located as a cluster in the 
vicinity of CRISPR loci (Jansen et al., 2002b). Cas genes play a central role in 
spacer acquisition and silencing of exogenous genetic elements  (Barrangou et 
al., 2007).  They are genetically and functionally diverse, exemplifying their 
different functions and roles in CRISPR/Cas system defensive mechanisms. To 
date, more than 40 Cas gene families have been identified (Haft et al., 2005; 
Makarova et al., 2006).   
 The molecular mechanism of the CRISPR defense system in prokaryotes 
is not fully understood (Manica and Schleper, 2013; Richter et al., 2013). The 
proposed mechanism by which the CRISPR/Cas system resists foreign DNA 
can be summarized in three distinct stages (Figure 5). In the acquisition stage: 
foreign nucleic acid is recognised and processed by proteins encoded by Cas 
genes into smaller fragments and inserted between the repeats in the CRISPR 
locus as spacers.  In the subsequent transcription stage: the CRISPR loci are 
expressed and processed by Cas proteins to small RNAs (crRNAs).  Each 
crRNA is made of an individual spacer with two flanking half repeats. In the final 
surveillance and interference stage: the crRNAs guide other Cas proteins to  
recognize invading phages at the DNA or RNA level through detecting specific  
sequences called protospacers that are complementary to spacer sequences of 
crRNA.  Upon recognition, crRNA hybridized with the protospacers in the target 
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DNA for degradation by the Cas nucleases or other nucleases (Figure 5) (Haft 
et al., 2005; Szczepankowska, 2012). 
 
 
 
 
 
     Modified from  (Karginov and Hannon, 2010) 
 
Figure 4: CRISPR/Cas system structure in bacteria. 
A CRISPR system includes Cas genes and the leader sequence followed by 
spacers and repeats. The leader sequence is an AT rich region harbouring 
promoters.  Spacer numbers vary depending on bacterial host. 
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Figure 5: The proposed mechanism of CRISPR/Cas system.  
The CRISPR mechanism may be summarized in three stages: (1) Acquisition: 
upon the invasion of foreign DNA, Cas3 digests foreign DNA and inserts it into a 
CRISPR locus as a spacer with the help of Cas1 and Cas2. (2) Transcription: a 
CRISPR array (spacers and repeats) is transcribed into a single long transcript 
under the control of a promoter in the leader. Repeats form loops where the 
large transcript is cleaved into to smaller RNA molecules (crRNA).  The crRNA 
contains one spacer flanked with half of a repeat on each side. (3) Surveillance 
and interference: crRNA guides a Cas protein complex (labelled cascade 
complex) to recognize invading DNA and digest it with the help of Cas3. 
Graphics by A. Yagubi.  
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Study Objectives 
 The aims of this study are to explore the potential roles of two phage 
resistance mechanisms in E. amylovora, the CRISPR/Cas system and the 
production of the EPS.   
 A) In order to investigate the role of CRISPR/Cas system, the following will be 
carried out: 
1) Investigate the existence and structure of CRISPR/Cas system in E. 
amylovora isolates. 
2)  Study the responses of CRISPR/Cas system to phage infection.  
3) Explore the ability of CRISPR/Cas system in prevention of invasion of 
exogenous elements such as phages and plasmids. 
4) Study the ability of CRISPR/Cas system to gain new spacers upon phage 
infection.  
B) To investigate the mechanisms by which E. amylovora phages interact with 
the bacterial EPS, ΦEa35-70 and ΦEa31-3 EPS depolymerase proteins will be 
characterized. 
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Chapter 2 
Investigating the structure and function of CRISPR/Cas system in E. 
amylovora 
Abstract 
 The CRISPR/Cas system is present in E. amylovora, but the functionality and 
role of this system in phage resistance is still unknown. In this study, the genome of E. 
amylovora isolates Ea6-4, EaD7, Ea110R and E17-1-1 were found to harbour three 
CRISPR arrays (CRR1, CRR2 and CRR3). A set of Cas genes were determined in the 
vicinity of CRR1 and CRR2 of EaD7 and Ea6-4; no Cas genes were located near 
CRR3. Only two CRISPR arrays (CRR2 and CRR3) were detected in the genomes of 
EaG5, BC29, BC1280 and Ea4-96 isolates. BLAST analysis of spacers detected in all 
CRISPR arrays in these isolates showed no matches to any existing Erwinia spp. phage 
genomes in GenBank. Monitoring expression level of Cas genes during phage infection 
revealed that CRISPR/Cas system is not stimulated by phage invasion. The 
enhancement of E. amylovora CRISPR/Cas system by introducing plasmids that carried 
an artificial set of Cas genes and spacers that target existing Erwinia sp. phages did not 
improve CRISPR/Cas system ability in blocking phages. E. amylovora CRISPR/Cas 
system was tested for its efficiency in blocking plasmid DNA transformation. When 
CRISPR/Cas system was challenged by transforming E. amylovora with plasmids 
carrying protospacers matching existing spacers,  90% of the plasmids carrying 
protospacers matching spacers in CRR1 and CRR2 were blocked in comparison to 
plasmid without protospacers and plasmid carrying protospacers against CRR3.  
Research data from this study indicate that the CRISPR/Cas system of E. amylovora is 
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not effective and efficient host resistance mechanism. Preliminary data indicate that 
the system can partially block plasmid DNA transformation. 
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Introduction 
 The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) /Cas 
system has been characterized as an adaptive immune system in bacteria; it provides a 
specific and acquired immunization against repeated phage infection (Barrangou et al., 
2007; Jansen et al., 2002b; Rath et al., 2015). Certain bacterial hosts can insert pieces 
of phage DNA as spacers into a CRISPR array, which later allows these hosts to exhibit 
immunity against phages that carry homologous sequences to the inserted spacers. 
The first direct evidence that CRISPR/Cas system could protect bacteria from phages 
was reported in Streptococcus thermophilus (Barrangou et al., 2007). S. thermophilus 
phage resistant mutants were isolated subsequent to phage infection.  Phage resistant 
isolates had incorporated new spacers in the CRISPR system that matched sequences 
in the phage genome. Elimination of these new spacers restored host sensitivity to 
phage infection (Barrangou et al., 2007). In addition,  CRISPR/Cas systems can prevent 
plasmid transformation in Staphylococcus epidermidis (Marraffini and Sontheimer, 
2008).  Bacterial CRISPR/Cas systems are highly diverse perhaps reflecting the 
selective pressures that are enforced by mobile genetic elements.  The CRISPR/Cas 
system significantly contributes to the continuous co-evolution of phages and their hosts 
(Bondy-Denomy et al., 2013).   
 
Types of CRISPR/Cas systems 
 Currently, CRISPR/Cas systems have been classified into three major types and 
more than 12 different subtypes (Makarova et al., 2011). The classification of 
CRISPR/Cas systems is mainly based on differences in crRNA maturation, interference 
mechanism and architecture of the CRISPR/Cas loci (Jansen et al., 2002a; Kunin et al., 
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2007; Makarova et al., 2011). The key feature for type I, II and III CRISPR/Cas system 
is the presence of a signature Cas protein such as Cas3, Cas9, or Cas10.  In general, 
six Cas gene families (Cas1–Cas6) are found in a wide range of CRISPR/Cas types 
with Cas1 and Cas2 in particular present in almost all CRISPR types. Cas3 protein is a 
nuclease/helicase essential in the interference step and in spacer acquisition 
(Beloglazova et al., 2011; Jackson et al., 2014; Mulepati and Bailey, 2011; Richter et 
al., 2012b; Sinkunas et al., 2011). Type I and type III systems are slightly related and 
are found in many bacteria and archaea, however, type II systems are genetically 
different and found only in bacteria (Fonfara et al., 2014; Haft et al., 2005; Heidrich and 
Vogel, 2013). 
 
Mature crRNA production and target surveillance and interference 
  Highly effective CRISPR/Cas systems need to be able to express and process 
CRISPR array (spacers and repeats) transcripts and use them to assist in the 
recognition and interference of invaders.  CRISPR array transcription initiates at the 
upstream of the leader sequences at the end of the locus sequence to generate a long 
single precursor transcript (known as a pre-crRNA) (Figure 6). Transcription is 
controlled by promoters located in the leader region that possibly serve as binding sites 
for regulatory proteins (Hale et al., 2012; Lillestøl et al., 2009). The long pre-crRNA is 
eventually processed into small crRNAs that enable the CRISPR system to recognise 
and interfere with invaders (Figure 6). This process occurs in dissimilar organisms such 
as Archaeoglobus fulgidus (Tang et al., 2002), Sulpholobus solfataricus (Tang et al., 
2005),  Escherichia coli (Brouns et al., 2008), Pyrococcus furiosus  (Hale et al., 2008), 
Sulpholobus acidocaldarius (Lillestøl et al., 2009) and Xanthomonas oyrzae (Semenova 
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et al., 2009).   In type I and III systems, the pre-crRNA transcript is processed and 
cleaved by the endoribonucleases Cas6 to generate mature crRNA (Carte et al., 2008; 
Jore et al., 2011; Sinkunas et al., 2013; Wiedenheft et al., 2011b). The resultant mature 
crRNA has a complete spacer flanking with a short 5' repeat handle and a repeat 
sequence that forms a stem-loop at the other end (Haurwitz et al., 2010; Judith et al., 
2013b; Nam et al., 2012b; Sashital et al., 2011; Wiedenheft et al., 2012).  Processing of 
pre-crRNA in the type II system is entirely different from type I and type III. In addition to 
Cas proteins, CRISPR/Cas system type II encodes a trans-activating crRNA 
(tracrRNA), a 25 bp stretch that is complementary to the to the repeats within the pre-
crRNA (Deltcheva et al., 2011). In addition to the tracrRNA, Cas9 and host RNase III 
are needed for the processing of pre-crRNA into mature crRNA (Deltcheva et al., 2011; 
Jinek et al., 2012). 
  
CRISPR surveillance complexes  
 To facilitate targeting and cleavage of invading nucleic acid, mature crRNAs and 
some Cas proteins form multi-subunit ribonucleoprotein targeting complexes generally 
known as crRNA and Cas proteins (crRNP) complexes. These complexes act as a 
surveillance and interference tool that recognises and binds to invading DNA for 
elimination. Different types of CRISPR/Cas systems form different crRNP complexes 
and their structure dictates the terminology used to describe these complexes 
(Makarova et al., 2011).     
 In CRISPR/Cas system type I, the targeting and surveillance crRNP complexes 
are known as Cascade (CRISPR-associated complex for antiviral defence) (Brouns et 
al., 2008; Judith et al., 2013a; Westra et al., 2012a).  In CRISPR/Cas type I-E of E. coli, 
 
   33 
the Cascade complex has a size of 405 KDa, and is composed a hexameric backbone 
formed by Cas7 bound to Cas5, Cas6e, Cse1 and Cse2 proteins in addition to a single 
61-nucleotide crRNA; Cse proteins are also CRISPR-associated proteins found In 
CRISPR/Cas system type I. in  The 5’ end of crRNA in this system, which forms the 
stem-loop, is bound by Cas6e and the 3' end is bound by Cse1 (Brouns et al., 2008; 
Jore et al., 2011; Wiedenheft et al., 2011b). The Cascade complexes of the rest of type 
I systems share the same feature as type I-E; however, they contain different and fewer 
Cas proteins (Makarova et al., 2011). In CRISPR system type II, crRNPs are known as 
Cas9 complexes which are structurally different from crRNP complex of CRISPR/Cas 
system type I (Gasiunas et al., 2012; Jinek et al., 2012; Jinek et al., 2014; Nishimasu et 
al., 2014). Cas9 complexes of type II contain only Cas9 associated with a single-guide 
RNA (Jinek et al., 2012; Jinek et al., 2014; Nishimasu et al., 2014; Sapranauskas et al., 
2011).  
 
The role of protospacer adjacent motif and seed sequences  
 In order for CRISPR/Cas systems to interfere with invading DNA, crRNP 
complexes have to find and recognize a sequence that is complementary to the 
sequence of the scanning crRNA. These sequences in invading DNAs are known as 
protospacers. It has been suggested that crRNA forms a loop structure in Cse1 that 
facilitates recognition and interaction with a specific short sequence that has been 
named protospacer adjacent motif (PAM) (Figure 6) (Jore et al., 2011; Sashital et al., 
2012; Westra et al., 2012a). PAMs are highly conserved sequence motifs of 3 to 6 
nucleotides that are immediately located at either side of the protospacer (3’ or 5’ end) 
in the target and help to discriminate between self- and non-self- targeting by the  
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Figure 6: Surveillance and interference by crRNP complexes of type I 
CRISPR/Cas system. 
Steps 1, 2 and 3 show the production of pre-crRNA, crRNA maturation and 
interference, respectively.  In the interference step, Cascade and crRNA form a 
complex that interferes with invading DNA. The PAM motif promotes the identification 
of the foreign DNA which is followed by hybridization between the seed sequence of 
the crRNA and the target DNA. Subsequently, the nuclease Cas3, is recruited and it 
degrades the target DNA. Graphics by A. Yagubi. 
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CRISPR system (Deveau et al., 2008; Jore et al., 2011; Mojica et al., 2009; Mulepati et 
al., 2012; Sashital et al., 2012; Semenova et al., 2009; Shah et al., 2009; van der 
Ploeg, 2009; Westra et al., 2012a). PAM sequences are replaced by repeats in 
CRISPR arrays in bacterial genome. The absence of PAM within the CRISPR locus in 
bacterial genome might explain why the CRISPR locus itself is not recognized by 
crRNA of CRISPR/Cas system (Marraffini and Sontheimer, 2010b). The recognition of 
the CRISPR/Cas system to its arrays could lead to the degradation of bacterial genetic 
material and eventually cell death.  
 The recognition of PAM motif by crRNP complex through Cse1 seems to 
denature the invader DNA duplex allowing a secondary alignment between a short 
sequence termed seed region (first 6 to 10 nucleotides) of the spacer and the 
complementary sequence in the target protospacer (Sashital et al., 2012; Sorek et al., 
2013; Westra et al., 2012a). The seed sequence within the crRNA spacer is critical for 
binding to target DNA (Semenova et al., 2011; Wiedenheft et al., 2011a; Wiedenheft et 
al., 2011b). Single nucleotide mutation in the seed sequence results in failure to bind to 
target DNA. In contrast, mutations in the crRNA spacer sequence outside of the seed 
sequence do not affect binding efficiency (Semenova et al., 2011). The complementary 
base pairing of crRNA and target strand leads to the formation of an R‑loop structure 
within crRNA (Spilman et al., 2013; Wiedenheft et al., 2011a). The formation of the R‑
loop structure may also function as a signal to stimulate nucleases such as Cas3 to 
target the invading DNA (Hochstrasser et al., 2014; Westra et al., 2012b). The helicase 
and nuclease activity activities of Cas3 facilitate the degradation of the target DNA. 
After initial cleavage, degradation of the target strand proceeds in the 3ʹ to 5ʹ direction 
(Beloglazova et al., 2011; Sinkunas et al., 2013; Westra et al., 2012b). 
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 In type II systems, the interference tools for the invading DNA are completely 
different from that of type I and type III systems, and require minimum Cas proteins for 
immunity. The interference in type II systems is carried out by Cas9–RNP complex 
which simply consists of Cas9 and a mature crRNA-tracrRNA hybrid (Deltcheva et al., 
2011; Garneau et al., 2010; Gasiunas et al., 2012; Jinek et al., 2012).  
 
Selection and acquisition of spacers and protospacer targeting 
 The first evidence of spacer acquisition from phages was reported in the type II-A 
system of S. thermophilus (Barrangou et al., 2007; Garneau et al., 2010). Spacer 
acquisition  was also reported in CRISPR systems of E. coli type I-E (Datsenko et al., 
2012; Swarts et al., 2012; Yosef et al., 2012), P. aeruginosa type I-F (Cady et al., 2012), 
Streptococcus agalactiae type II-A (Lopez‐Sanchez et al., 2012) and Sulfolobus 
solfataricus type I and III-B  systems (Erdmann and Garrett, 2012). The details of the 
spacer acquisition mechanism are only partially understood. Spacer acquisition starts 
with the recognition and fragmentation of invading DNA. The selection of protospacers, 
from invading DNA, which will be inserted as spacers in CRISPR arrays, is influenced 
by the recognition of PAM sequences. The existence of conserved PAM sequences that 
flank protospacers indicates that protospacers are not randomly selected for insertion in 
CRISPR loci. The conserved sequences provide a recognition signal for the selection of 
sequences which will be added as new spacers (Deveau et al., 2008; Mojica et al., 
2009; Shah et al., 2013). Upon the selection of the proper sequences for spacer 
insertion, the CRISPR system processes target DNA sequences into spacer precursors, 
small fragments with a defined size (Swarts et al., 2012). These small fragments are 
then inserted at the end of a CRISPR locus in a polarized fashion next to the leader 
sequence (Figure 5, Chapter 2) (Barrangou et al., 2007; Díez-Villaseñor et al., 2013; 
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Pourcel et al., 2005; Tyson and Banfield, 2008). Spacer-repeat units can be added to 
CRISPR loci as a single or as group of four units (Deveau et al., 2008). Upon the 
insertion of a new spacer, the repeat at the end of the leader sequence duplicates to 
flank the newly inserted spacer (Yosef et al., 2012). Once a spacer is established in a 
CRISPR locus, it provides specific immunity against phages or plasmids with matching 
protospacers. 
 Cas1 and Cas2 proteins are required for spacer acquisition (Babu et al., 2011; 
Datsenko et al., 2012; Díez-Villaseñor et al., 2013; Nuñez et al., 2014; Yosef et al., 
2012).  Cas1 and Cas2 are not important for other CRISPR-related processes such as 
crRNA biogenesis and targeting (Brouns et al., 2008; Deltcheva et al., 2011; Hatoum-
Aslan et al., 2014; Sapranauskas et al., 2011). Cas1 and Cas2 are conserved genes 
and exist in most CRISPR/Cas systems (Makarova et al., 2011). Cas1 and Cas2 seem 
to function together directly since they were found to form a complex (Plagens et al., 
2012; Yosef et al., 2012). To date, the exact mechanisms by which these proteins 
facilitate the acquisition of new spacers are not fully understood. Cas1 is a metal-
dependent endonuclease that binds to dsDNA in a sequence-independent manner at 
the cleavage site (Babu et al., 2011; Beloglazova et al., 2008; Nam et al., 2012a; 
Wiedenheft et al., 2009). Cas1 cleaves dsDNA into short fragments that might serve as 
precursors for new spacers (Han et al., 2009; Wiedenheft et al., 2009) Cas2 is also a 
metal-dependent nuclease that is known to have endonuclease activities against 
dsDNA, and sometimes is found fused to another Cas protein  (Beloglazova et al., 
2008; Nam et al., 2012a).  In addition to Cas1 and Cas2, other Cas proteins such as 
Cas3 and Cas4 may play a role in spacer acquisition (Makarova et al., 2006; Makarova 
et al., 2011; Plagens et al., 2012; van der Oost et al., 2009).  
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E. amylovora CRISPR/Cas system  
 Rezzonico et al. (2011) characterized the molecular structure of the CRISPR/Cas 
system of 37 E. amylovora isolates from worldwide, and a total of 18 CRISPR 
genotypes were defined. The genetic diversity of E. amylovora was explored using 
sequences analysis of CRISPR regions from 85 E. amylovora strains from different 
geographic locations, plant hosts, plasmid content and variable sensitivity to 
streptomycin (McGhee and Sundin, 2012). A total of 588 unique spacers were 
determined; however, only 16% of the spacers were found to match sequences in 
plasmids and 5% match sequences in phage genomes from GenBank (McGhee and 
Sundin, 2012). The role of CRISPR/Cas system of E. amylovora in phage resistance 
and plasmids transformation blocking has not been investigated.  
 The objective of the study in this chapter is to determine the existence then the 
structure of CRISPR/Cas system in the genome of selected E. amylovora isolates from 
different regions of Canada. Also, to study spacer sequences in CRISPR arrays and 
determined if they match sequence in plasmids and phages in GenBank. The response 
of E. amylovora CRISPR system to phage infection and plasmid transformation will be 
also investigated.  
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Materials and Methods 
Bacterial isolates and culture conditions 
 E. amylovora isolates (Table 1) used in this study were originally isolated from 
apple and pear orchards demonstrating fire blight symptoms.  E. amylovora was 
cultured on 2.3% nutrient agar (NA; Difco Laboratories, Sparks, MD, USA). Cultures 
were incubated at 27°C for 18 h. Bacterial liquid cultures were carried out in 0.8% 
nutrient broth (NB; Difco Laboratories, Sparks, MD, USA). Liquid cultures were 
incubated at 27°C on an orbital shaker at 200 rpm for 18 h using New Brunswick™ 
Innova® 44 incubator shaker (Eppendorf, Mississauga, ON, Canada).  
 E. coli (used for cloning) was cultured on Luria-Bertani agar (LB agar, plates (1% 
tryptone, 0.5% yeast extract, 0.5% sodium chloride and 1.5% agar, Difco Laboratories, 
Sparks, MD, USA) plates, and incubated at 37°C for 16 h. E. coli liquid cultures were 
grown in Luria-Bertani  broth (LB, 10 g/L tryptone, 5 g/L yeast extract and 10 g/L NaCl,  
Difco Laboratories, Sparks, MD, USA), pH 7.5 . Antibiotics were added to broth and 
agar media at the following concentrations: 50 μg/mL ampicillin and 34 µg/mL 
kanamycin. Liquid cultures were incubated at 37°C with shaking at 200 rpm for 16 h. 
 
PCR amplification and DNA sequencing of CRISPR arrays and Cas genes 
 All PCR products in this study were amplified using the Pfx50™ DNA polymerase 
(Invitrogen, Burlington, ON, Canada). PCRs for CRISPR arrays were performed using 
the following general PCR conditions: 2 min at 94°C, (30 sec at 95°C, 30 sec at 58°C 
and 3 min at 68°C) × 30 cycles, and final extension for 5 min at 68°C. The primers used 
for PCR amplification of CRISPR loci and Cas genes of all E. amylovora isolates were 
designed based on sequences of CRISPR regions of E. amylovora strain CFBP 1430 
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(GenBank accession number FN434113)  (Smits et al., 2010). Primers used for 
amplification can be found in Appendix, Tables 1A and 2A. All PCR products were 
tested for size on 1% agarose gel. All PCR products were purified using Norgen Biotek 
Corp. PCR purification kit (Norgen Biotek Corp., Thorold, ON Canada). PCR products 
were cloned in PCR-Blunt II-TOPO® vector (Invitrogen), and sent for sequencing 
(MOBIX Lab McMaster University, Hamilton, ON, Canada). When the whole CRISPR 
array or Cas genes could not be sequenced with a single sequence read, the complete 
sequences of CRISPR array was obtained using primer walking. Primers used for Cas 
genes sequencing can be found in Appendix, Tables 3A. Cas genes were identified 
using BLASTN against other Cas genes in GenBank data base. CRISPR spacers were 
determined using the CRISPR finder tool (available at http://crispr.u-psud.fr/). Spacer 
sequences were analysed by BLASTN for homology to phage or plasmid DNAs in the 
NCBI nucleotide database. To identify conserved sequences within spacers and 
repeats, alignments were done using WebLogo (Crooks et al., 2004). 
 
Plasmid and bacterial genomic DNA isolation 
 Plasmid DNA was isolated from 2 mL culture using Plasmid MiniPrep DNA Kit 
(Norgen Biotek Corp.). Bacterial genomic DNA was extracted from 1 mL culture using 
Norgen Bacterial Genomic DNA Isolation Kit.  
 
Plasmid DNA transformation into E. coli and E. amylovora 
Transformation using chemically competent E. coli cells 
 Approximately 5 to 10 µL (10 to 50 ng) of plasmid DNA or of ligation reaction was 
transformed into 100 µL E. coli DH5α competent cells (Invitrogen).  DNA and cells were 
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mixed very gently and incubated on ice for 15 to 30 min.  Cells were heat shocked for 
45 sec to 1 min at 42°C.  Subsequently, the tubes were placed immediately on ice for 2 
min, and 300 to 500 µL of super optimal broth (SOB) medium (2% tryptone, 0.5% yeast 
extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4) was added to each 
tube. The cells were incubated for 1 h at 37°C and shaken vigorously using 
Thermomixer (Eppendorf, Mississauga, ON, Canada). Cells were plated out on LB agar 
plates (Difco Laboratories). Appropriate antibiotic for selection was used as needed 
followed by incubation for overnight at 37°C.  
 
E. amylovora transformation using electroporation 
Preparing E. amylovora electrocompetent cells 
 Frozen glycerol stocks of E. amylovora isolates were first streaked on NA plates 
and incubated 18 h at 27°C. Two mL of NB was inoculated with a loop full of bacteria as 
a starter culture and shaken at 27°C at 200 rpm for 8 h. Next, a 100 mL of NB was 
inoculated with 0.5 mL of the starter culture and grown in 27°C shaker until OD600 
reading of  0.4 - 0.6 was reached. Once the culture reached the desired density, cells 
were placed on ice for 20 to 30 min and then pelleted by centrifugation at 3500 xg for 10 
min at 4°C. Cells were washed by resuspension in 50 mL of ice-cold double-distilled 
water (ddH2O). Cells were harvested again by centrifugation at 3500 xg for 10 min at 
4°C. The cell pellet was resuspended in 20 mL of ice-cold 10% glycerol in ddH2O. The 
cells were harvest by centrifugation at 3500 xg for 10 min at 4°C. The supernatant was 
carefully aspirated and the cell pellet resuspended gently in 1 mL of ice-cold 15% 
glycerol. Cells were aliquoted into sterile 1.5 mL microfuge tubes (100 µL each) and 
stored in the -80°C freezer.  
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Transformation using electroporation 
 BIO-RAD Gene-Pulser (Bio-Rad, Mississauga, ON, Canada) was used for 
transformation of E. amylovora isolates.  The Gene-Pulser was set to capacitance of 25 
µF, resistance of 200 Ω, and voltage of 2.5 kV.  Competent cells were placed on ice for 
15 min, then 5 to 10 µL (10 to 50 ng) of plasmid DNA was added and allowed to rest for 
a few minutes. The mixture was transferred to a pre-cooled cuvette (Fisher brand 2 mm 
gap).  The cuvette was quickly placed into the Gene-Pulser chamber and the pulse was 
delivered.  Cells were immediately recovered by adding 1 mL of SOC medium (2% 
tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 
and 20 mM glucose) and shaken for 2 to 4 h at 27°C. After the recovery period, cells 
were plated on NAS plates (2.3% nutrient agar, 2% sucrose and 1% sorbitol). 50 μg/mL 
ampicillin antibiotic for selection was used as needed followed by incubation for 24 to 48 
h at 27°C.  
 
Constructions of plasmids carrying Cas genes for enhancing E. amylovora 
CRISPR/Cas system 
 To investigate the efficiency of E. amylovora CRISPR/Cas system, four plasmids 
were constructed: pSp21-4, pSpCas123, pSpCasg and pSpdel (Figure 13, Results).  
pIDTBlue plasmid, encoding ampicillin resistance (Integrated DNA Technologies, Inc., 
Coralville, IA, USA), was used to construct these plasmids. pSp21-4 plasmid carried 
CRISPR leader sequences from isolate EaD7 followed by three spacers that were 
created to target sequences of structural proteins in phage ΦEa21-4, refer to Figure 1A 
in the Appendix for more details about the plasmid and target proteins in ΦEa21-4 . The 
spacers were separated by four repeats matching repeat sequences found in EaD7 
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CRISPR arrays (refer to Figure 13 for repeats and spacers sequences). The second 
plasmid, pSpCas123, carried the exact sequence as in pSp21-4 plus Cas1, Cas2 and 
Cas3 of EaD7. To construct pSpCas123, Cas1, 2 and 3 genes from EaD7 were 
amplified using PCR as described previously. Cas genes were amplified either 
individually or in groups using primers with overhangs harboring sequences of 
restriction enzymes needed for cloning. Amplified Cas genes were then cloned in a 
stepwise manner. For the third plasmid, pSpCasg, Cas4, 5 and Cse1, 2, 3, 4 from EaD7 
were cloned in pSp21-4. A fourth plasmid, pSpdel, carried no insert and was used as a 
control to test the effects of the plasmid backbone. All the leader sequences, spacers 
and repeats, and Cas genes in these plasmids were cloned downstream from the T7 
promoter to enhance the level of expression, refer to Figure13 in the Results for more 
details on the plasmids. All plasmids were introduced to electrocompetent E. amylovora 
Ea6-4 cells as described previously.  
 
Construction of plasmids for E. amylovora transformation studies 
 In order to investigate the ability of the E. amylovora CRISPR/Cas system in 
blocking plasmid transformation, three plasmids were constructed pProtoCR1, 
pProtoCR2 and pProtoCR3, using ampicillin resistant pIDTBlue plasmid (Integrated 
DNA Technologies, Inc.). Each carries three protospacers complementary to 
endogenous CRISPR spacers in CRISPR arrays 1, 2, or 3 of Ea6-4, respectively 
(Figure 18, in Results). pProtoCR1 carried protospacers complementary to target 
spacers 1, 6 and 21 in CRISPR region 1 arrays (CRR1) of Ea6-4, pProtoCR2 plasmid 
protospacers target spacers 1, 22 and 26 in CRISPR region 2 arrays (CRR2), and 
pProtoCR3 for spacers 1, 3 and 4 of CRISPR region 3 arrays (CRR3). Each 
protospacer cloned in these plasmids was flanked with a PAM sequence to enhance 
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plasmid targeting by CRISPR/Cas system of the host. PAM sequences used in this 
experiment were determined based on protospacers alignment results from this study 
(Figure 18). A fourth plasmid, pProtoN, carried a random sequence insert with similar 
size (126bp) as inserts in target plasmids, was used as a control. The sequences of the 
insert in the control plasmid do not complement sequences to any of CRISPR spacers 
in E. amylovora. Plasmids and inserted protospacers sequences are shown in Figure 
18. Protospacers cloned in these plasmids were chemically synthesized to carry EcoR1 
sequences at both ends. To generate these plasmids, the pIDTBlue plasmid was 
modified to carry EcoR1 site. The EcoR1 was then used to linearize the plasmid and 
insert protospacers just downstream of T7 promoter (Figure 18). All cloned plasmids 
were verified by restriction enzymes analysis and sequencing of the inserts. 
 For transformation, electrocompetent Ea6-4 cells were thawed on ice, and 5 µL 
of plasmid DNA (2 ng/µL) was added to the cells. Cells were transformed by 
electroporation using BIO-Rad Gene-Pulser as explained previously.  50 μL and 100 μL 
of transformed cells were plated on 90 mm NAS plates supplemented with 50 μg/mL 
ampicillin. Plates were incubated for 16 h at 27°C. Next day, the colonies were counted 
and transformation efficiency was calculated. All transformations were carried out in 
triplicate. Transformation efficiency of each test plasmid was expressed by calculating 
the number of CFU per 1 μg of plasmid DNA.  Plasmids that escaped the CRISPR/Cas 
system were isolated and sent for sequencing to check for possible deletions or 
mutation in protospacers. 
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Generation of E. amylovora bacteriophage-insensitive mutants (BIMs) and 
investigation of CRISPR region for spacer acquisition 
 A modified secondary culture method was used to generate E. amylovora BIMs 
(Guglielmotti, 2006). BIMs were generated using wild-type Ea6-4 and Ea6-4 
transformed with pSpCas123 or pSpCasg plasmids and phagesΦEa31-3, ΦEa9-2, 
ΦEa35-70 and ΦEa21-4. In this procedure, 3 mL of E. amylovora culture (OD600 = 0.6; 
approximately 108 cells per mL) in 0.8% NB was prepared. Phages were added to the 
culture at MOI of 1.0. Then, the culture was incubated at 27°C for 16 h at 150 rpm.  5 
mL of fresh NB was added to the culture and further incubated for 18 h to allow 
secondary growth of bacteria. The culture was then streaked onto NA plates and 
incubated for 18 h at 27°C. Single colonies were picked and resuspended in 3 mL of 
0.8% NB. The liquid bacterial culture was incubated until OD600 reached 0.6. The same 
culture was reinfected with the same phage at MOI of 1.0. The culture was incubated at 
150 rpm for 16 h at 27°C, and non-infected cells were plated as described previously. A 
third round of subculture and infection was carried out as described.  The bacteria 
which survived the continuous infection process with the same phage were termed 
BIMs. The resistance of the BIMs to phage infection was further confirmed by exposing 
to the original phage and plated using the double agar overlay plate method (Adams, 
1959).  
 To investigate if CRISPRs were responsible for BIM generation, BIM CRISPR 
arrays were PCR amplified, cloned and sent for sequencing (MOBIX Lab McMaster 
University, Hamilton, ON, Canada). The sequence results of BIM CRISPR arrays were 
analyzed and compared to parental hosts to see if any alteration or addition of new 
spacers within CRISPR arrays had occurred. An alternative PCR procedure was 
employed to screen for spacer acquisition. In this protocol, set of primers were designed 
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to amplify the regions starting from the leader sequences proximal end of the CRISPR 
array of CRR1, CRR2 and CRR3 and to include the first few spacers of these regions 
(Figure 7).  The forward primers targeting the end of the leader sequences: CR1AcqF 
(5’CGTGCGTGCTTTAAAGTGGAAA3’) is located 59nt upstream of the first repeat of 
CRR1; the reverse primer CR1AcqR (5’AACACAGTTCCCGAGATGCTCG3’) annealing 
in spacer 4 of this region. For CRR2, forward primer CR2AcqF 
(5’CGCGGCTTTTGACAGCAAA3’) annealing 60 bases upstream of the first repeat, 
reverse primer CR2AcqR (5’CGGGGAACACGCTGTTTTGT3’) located at the junction of 
spacer 3 and repeat 4 of this locus. To detect spacer acquisition in CRR3, forward 
primer CR3F (5'AGACTGGCGTTATAGGATGG3') and reverse primer CR3R 
(5'AGCCCGTGAAGCAAAGTATG3') were used to amplify the whole CRR3 to produce 
a PCR product of 555bp. All PCR product sizes were evaluated on agarose gels to 
detect any spacer acquisition. In case of spacer insertion, shift in the PCR product by at 
least 61 bp. Primers used to detect spacer acquisition in CRR1, CRR2 and CRR3 of E. 
amylovora are listed in Table 5A, Appendix. 
 
Figure 7: PCR strategy used to investigate integration of new spacers in CRR1. 
Leader sequences upstream of CRISPR arrays are shown by light blue line. Grey boxes 
represent repeats and dark blue boxes represent spacers. The expected PCR product 
size from wild type is 315 bp. It was expected that the PCR product to be larger in size 
by at least 61 bp in case of integration of one spacer and one repeat.  A similar strategy 
was used to explore spacer insertion in CRR2. In CRR3, however, the entire CRISPR 
arrays were amplified due to the small size.  
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Investigation of Cas genes and crRNA expression  
Total RNA extraction and crRNA enrichment  
 Total RNA from E. amylovora was extracted from 1 mL bacterial culture (108 
CFU) using the Norgen Total RNA Isolation Kit (Norgen Biotek Corp., Thorold, ON 
Canada). DNase treated RNA was analyzed using a 1% agarose gel electrophoresis to 
ascertain the quality and integrity of RNA and the absence of DNA contamination. 
crRNA enrichment was carried out using microRNA Purification Kit (Norgen Biotek 
Corp.). 
 
RT real-time PCR 
 One-step RT real-time PCR assay was performed with the final volume of 25 μL 
using the Roto-Gene Rrobe RT-PCR Kit (Qiagen, Toronto, ON, Canada) and TaqMan 
Probes (Integrated DNA Technologies, Inc., Coralville, IA, USA). Each reaction was 
carried out using 2 μL of total RNA. RT real-time PCR program was reverse 
transcription of RNA at 50°C for 10 min. The PCR performed with an initial activation 
step at 95°C for 5 min, then 40 cycles of: denaturation at 95°C for 20 sec, annealing at 
45°C for crRNA, 54°C for Cas1 or Cas3 for 20 sec, and amplification at 60°C 20 sec. 
The fluorescence data were collected at the end of every 60°C step. Real-time multiplex 
reaction mix was carried out in total reaction volume of 25 µL according to 
manufacturer’s recommendations with final concentration of 200 nM primers and 100 
nM of gene of interest probe, and 100 nM primers and 50 nM probes for each 
housekeeping gene.  
 Three biological replicates (RNA isolated from three independent cultures) were 
carried out. The RT real-time PCR was chosen to measure RNA level since it is very 
 
   48 
sensitive and more reliable than the commonly used Northern blot protocol. The 
comparative Ct method ΔΔCT (Livak and Schmittgen, 2001) was used for level of 
expression data analysis and genes of interest were normalized to two endogenous 
housekeeping genes (recA and groEL). Level of expression at T0 was considered as an 
initial value of one fold. Fold change at a given time is the ratio of the value at a given 
time to the initial value (T0). Changes in expression levels were considered significant 
when the relative expression between a given point and T0 was ≥ one fold change. 
Primers and probes used for RT real-time PCR are listed in Table 4A in Appendix.   
 
Phage titre  
Plaque assay 
 Phage titres were determined by the double agar overlay method as described 
by (Adams, 1959). Phage stock solutions were serially diluted by using 0.1ml phage 
and 10 tubes contained 0.9 mL sodium phosphate buffer, pH 6.8 to generate 10 fold 
serial dilutions.  0.1 mL of 10-4, 10-6 and 10-8 dilutions were mixed with 0.1 mL of 
bacterial dilution at 108 CFU/ml in a test tube. The phage/cell mixes were incubated at 
room temperature for 10 to 15 min. In the meantime, molten top agar (0.8% nutrient 
agar, 0.25% yeast extract and 0.5% sucrose) was held at 50°C in a water bath. 4 mL of 
the molten top agar was added to each phage/bacteria mix. Tubes were swirled gently 
and poured on to solidified nutrient agar to form a thin top layer. Plates were incubated 
at room temperature to allow the top agar to solidify. The plates were incubated at 27°C 
for 18 h and PFU/mL in each sample was determined. 
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Determining phage titer with quantitative PCR  
 In this method, the absolute phage titer was determined using the standard curve 
method. The unknown phage titer was extrapolated based on a standard curve 
generated using known quantities of plasmid DNA.  
Standard curve preparation using plasmid template and phage titer  
 The pTotalStdA plasmid (Appendix, Figure 2A), developed by Steven Gayder 
(PhD Candidate, Brock University), was used to create standard curves in order to 
quantify phages with quantitative PCR assay. pTotalStdA was constructed to contain 
the full-length PCR amplicon sequences targeted by primers and probes of phages 
used in this study: ΦEa31-3, ΦEa21-4, ΦEa9-2 and ΦEa35-70. pTotalStdA was 
propagated in E. coli and purified using the Plasmid MiniPrep DNA Kit (Norgen Biotek 
Corp., Thorold, ON  Canada). The concentration of plasmid DNA was measured by at 
OD260, and the plasmid copy number was calculated based on the concentration and 
molecular weight of the DNA. The purified plasmid DNA was linearized with XhoI and 
the standard curve was generated (Invitrogen). The standard curve was created using 
10 fold serial dilutions of the linearized pTotalStdA ranging from 101 to 1011 plasmid 
copy/mL. Standard curve was created using at least four points in duplicate. 
Additionally, the range of concentrations in the standard curve covered the entire range 
of unknown phage concentrations. The amplification efficiency of varying plasmid 
dilutions were determined by obtaining a linear standard curve and R2 ≥ 0.98.  After 
amplification of pTotalStdA dilution series, the Ct values generated for each dilution 
were plotted against the log10 of copy number of the plasmid. The Stratagene™ 
Mx3005P system analysis software (Agilent Technologies, Santa Clara, CA, USA) was 
used to determine the unknown phage concentration by comparing Ct values of the 
unknown samples to the standard curve.  
 
   50 
 To titer phage solutions, quantitative PCR was performed on the Stratagene™ 
Mx3005P system (Agilent Technologies) in 96-well plates covered with adhesive 
sealing (VWR, USA). The quantitative PCR reaction was carried out in a total volume of 
20 μL using EVOlution Probe qPCR mix kit (MBI Montreal Biotech Inc., Montreal, QC, 
Canada) with a final concentration of 200 nM primer and 100 nM probe. The PCR was 
performed with a two-step PCR protocol: activation of the Taq DNA polymerase at 95°C 
for 10 min, followed by 40 cycles of 95°C for 10 sec and 54°C for 45 sec.  All real-time 
PCRs were performed as triplicates. Primer and probes used to quantify different phage 
types are listed in Appendix, Table 6A. 
 
Challenging artificial Cas genes with phages 
 Three E. amylovora Ea6-4 mutants were generated to carry plasmids: pSpdel, 
pSpCas123, and pSpCasg (Figure 13).  The specifications for these plasmids were 
previously described in this chapter. To determine the effect of transformed plasmids on 
the efficiency of E. amylovora CRISPR/Cas system, transformed isolates were 
challenged with four different phages: Myoviridae phages ΦEa21-4 and ΦEa35-70 and 
Podoviridae phages ΦEa31-3 and ΦEa9-2. Transformed E. amylovora isolates were 
grown in liquid culture on a shaker at 27°C until OD600 reached 0.1. Bacterial cultures 
were infected with the previously listed phages at MOI of 0.1. Cultures were incubated 
for 8 h. Phages titers were determined every 2 h with quantitative PCR as described 
previously.  
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Results 
Bioinformatics analysis of CRISPR arrays and Cas genes 
CRISPR arrays sequences (spacer and repeats) 
 The sequences of CRISPR arrays of selected E. amylovora isolates from 
different areas in Canada were determined (Table 1). A total of three CRISPR arrays 
labelled CRR1, CRR2 and CRR3 were identified in E. amylovora isolates Ea6-4, EaD7, 
Ea17-1-1 and Ea110R. Only two CRISPR arrays, CRR2 and CRR3, were detected in 
E. amylovora isolates EaG5, BC29, BC1280 and Ea4-96 (Table 1). 
 E. amylovora isolates Ea6-4, EaD7, Ea17-1-1 and Ea110R carry 36 spacers in 
CRR1. CRR1 in these isolate is located upstream of the Cas gene cluster (Figure 8). 
The average length of the spacers in this region is 32bp and spacers were interspersed 
by 37 palindromic repeats. Spacer sequences from these three isolates were identical 
to CRR1 of E. amylovora CFBP1430 (Smits et al., 2010). The average length of the 
repeats in CRR1 of these isolates is 29 bp. The consensus sequence of the repeats is 
(5’GTGTTCCCCGCGTGAGCGGGGATAAACCG3’).  CRR2 of Ea6-4, EaD7 and Ea17-
1-1, on the other hand, were found just downstream of the Cas gene cassette (Figure 
8), and contained 26 spacers. Spacer sequences of CRR2 of Ea6-4, EaD7 and Ea17-1 
isolates were identical and separated by 27 repeats (average 29 bp in size) with a 
consensus  sequences (5’GTGTTCCCCGCGTATGCGGGGATAAACCG3’) which was 
slightly different from repeats in CRR1 ( refer to underlined sequences in both repeat 
sequences). CRR2 of Ea110R carries only 23 spacers interrupted by 24 palindromic 
repeats with consensus sequences matching Ea6-4, EaD7 and Ea17-1-1. The 23 
spacers of CRR2 of Ea110R match spacers in Ea6-4, EaD7 and Ea17-1-1; however, 
Ea110R lacks spacer 7 (5’ATCGGAACGACTTAGATTAGCGTCCTTGCACAT 3’), 
spacer  8 (5’TAACCGCAACCATCGCCGCGATAAATCCACTG3’) and spacer 9 
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(5’GTTGATACGGCTGATTACAATAAAATGTCACT3’) that exist in Ea6-4, EaD7 and 
Ea17-1-1 isolates. 
 Isolates EaG5, BC29, BC1280 and Ea4-96 have a larger CRR2 than isolates 
Ea6-4 and EaD7 from Essex County, Ontario. CRR2 of EaG5 has 57 spacers 
interspersed with 58 repeats, which makes this region as one of the largest CRISPR 
array as compared to any known CRISPR arrays found in E. amylovora isolates 
worldwide. CRR2 from BC29 and BC1280 were identical and carried 49 spacers. 
Isolate Ea4-96 has a shorter CRR2 with 30 spacers. Alignments of CRR2 of all isolates 
revealed that isolates Ea6-4, Ea17-1-1 and EaD7 from apple (Essex County, Ontario) 
shared the exact spacer sequences in all CRISPR regions. Interestingly, majority of 
spacers exist in BC29 isolates from pear (Kelowna, British Columbia) and Ea6-4 from 
apple (Essex County, Ontario) exhibited matches to spacers found in EaG5. Isolate 
Ea4-96 from raspberry (Kentville, Nova Scotia) carried unique spacers which were not 
found in any other isolate (Figure 9).  
 All bacterial isolates in this study contained only five spacers in CRR3 with 
exception to Ea4-96 which carried 6 spacers. Spacer 1 
(5’GGCTAAATGCCTGAATTCAACGTTCTACAAAA3’) of Ea4-96 was not found in other 
isolates. However, all spacers in CRR3 are identical among all isolates. The repeat in 
CRR3 of Ea4-96 is 24 bp in size (5’GTTCACCGCCGTACAGGCGGCTTA3’), and is 
shorter than the repeats of CRR3 of other isolates, which is 28 bp 
(5’GTTCACTGCCGTACAGGCAGCTTAGAAA3’). 
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Bacterial 
isolates 
Origin 
CRISPR1 CRISPR2 CRISPR3 
CRISPR 
length 
(bp) 
# Spacers 
CRISPR 
length 
(bp) 
# Spacers 
CRISPR 
length 
(bp) 
# Spacers 
Ea6-4 Apple (Essex County, ON) 2224 36 1616 26 328 5 
EaD-7 Apple (Essex County, ON) 2224 36 1616 26 328 5 
Ea17-1-1 Apple (Essex County, ON) 2224 36 1616 26 328 5 
Ea110R 
Rifampicin resistant-mutant 
Apple (MI, USA) 
2224 36 1432 23 328 5 
EaG5 Unknown Not detected 3508 57 328 5 
BC29 Pear (Kelowna, BC) Not detected 3020 49 328 5 
BC1280 Apple (Westbank, BC) Not detected 3020 49 328 5 
Ea4-96 Raspberry (Kentville, NS) Not detected 1858 30 383 6 
 
Table 1: List of E. amylovora isolates selected for CRISPR arrays sequencing.  
The origin of each isolate is shown, ON: Ontario, BC: British Columbia, NS: Nova 
Scotia, MI; Michigan.  The length of the CRISPR array in base pairs is shown. The 
number of spacers found in each CRISPR array and the average size of spacers (32 
bp) are also indicated. 
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Figure 8: Genetic map of the CRISPR locus of E. amylovora Ea6-4 and EaD7. 
The location of CRISPR-associated genes (Cas and Cse) and CRISPR arrays 1, 2 and 
3 (CRR1, CRR2, and CRR3) are shown. Cas genes occupy a region of 8.3 kbp. 
Sequences represented by thin gray lines contain genes unrelated to CRISPR function. 
Leader sequences of CRR1 and CRR2 are shown by letter (L). The distance between 
CRR2 and CRR3 is not known. 
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Figure 9: E. amylovora CRR2 spacer genotypes. 
Each CRISPR spacer is represented by a box and number that indicates the spacer 
position in the array of a specific isolate. The first spacers that lie next to the leader 
sequence are on the left side of the picture and the oldest spacer is on the right. . 
Identical spacers of different isolates are aligned in the same column and coloured grey. 
The white boxes with numbers indicate the absence of spacer match among isolates 
(e.g. spacer numbers 1 to 30 of Ea4-96). 
 
 
 
 
 
  
Isolate Spacer location 
Ea6-4, EaD7, Ea17-1-1 
                        
EaG5 1 2 3 4 5 6 7 8 9 10 11 
  
12 13 14 15 16 17 18 19 20 
 
21 
BC29, BC1280 
           
1 2 3 4 5 6 7 8 9 10 11 12 13 
Ea4-96 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
 Isolate Spacer location 
Ea6-4, EaD7, Ea17-1-1 
    
1 2 3 4 5 6 7 8 9 10 11 12 
 
13 
 
14 15 
   
EaG5 22 23 24 25 
     
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 
BC29, BC1280 14 15 16 17 
     
18 19 20 21 22 23 24 25 26 
 
27 28 29 30 31 
Ea4-96 25 26 27 28 29 30 
                  
 
Isolate Spacer location 
Ea6-4, EaD7, Ea17-1-1 
       
16 17 18 19 20 21 22 23 24 25 26 
EaG5 41 42 43 44 45 46 47 
 
48 49 50 51 52 53 54 55 56 57 
BC29, BC1280 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 
Ea4-96 
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 Alignments of spacers by WebLogo representation to determine conservation 
within spacer sequences from CRISPR arrays CRR1, CRR2, and CRR3 from all 
isolates showed more than one conserved sequences among each CRISPR arrays. 
The spacers of CRR1of all isolates showed conversed sequences at nt3-5, nt15-17 and 
nt24-26. In CRR2 Spacers, conserved sequences located at nt6-15; and in CRR3 
spacers at nt13-16. The existence of PAM conserved sequences flanking protospacers 
was also investigated in this study.  The alignment of PAM sequences from phage 
genomes revealed the presence of short conserved regions. At the 5’ end of 
protospacers, sequences (AAA, GAA, AAC, AAG and GTA) were detected.  No 
conserved PAM sequences were found at the 3’ end of protospacers (Figure 10). 
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Figure 10: WebLogo representation of the sequence conservation of 
protospacers. 
Sequence conservation of protospacers and PAM sequences from CRISPR arrays 
CRR1, and CRR2 of E. amylovora isolates used in this study.  In total, only 19 
protospacers were found in phages and plasmids to have exact match to spacers from 
this study. Protospacer sequences are present in positions 7 to 38, and PAM 
sequences are in positions 1 to 6 and 39 to 44. There is no continued conserved PAM 
sequence upstream of protospacers, an indication of insignificance of these sequences 
in CRISPR system function.   
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CRISPR spacers blast results  
 124 individual spacers were identified within the three CRISPR arrays of the 
seven bacterial isolates in this study. A spacer was considered unique if it contained 
10% or more nucleotide mismatch compared to other spacers. Sequences in phages 
homologous to spacers were identified using NCBI BLASTn analysis. Each spacer 
sequence was blasted against Erwinia spp. phages in NCBI database. The default 
values of NCBI BLASTn for short sequences were used: match/mismatch 2(-3), Expect 
value (10) and with modified word size (7).  A majority of spacers showed no significant 
similarity to sequences of phages in the NCBI database. No spacers exactly matched 
the sequences of any sequenced E. amylovora phages from Myoviridae and 
Podoviridae families. However, three spacers exactly matched Erwinia tasmaniensis 
phage Et88 genome sequence (Müller et al., 2011a). Few Erwinia spp. phages shared 
17 or less nucleotide match to some spacers, and the majority of these sequences are 
interrupted with a single nucleotide mismatch.  Table 2 shows spacers that have 13 or 
more nucleotide match to Erwinia phages ΦEa21-4 (Lehman et al., 2009), ΦEa35-70 
and ΦEa9-2 (this study).  For example, spacer 2 in EaG5 showed 15 nucleotides match 
out of 32 nucleotides (47% similarity)  to E. amylovora phage ΦEa21-4 (Lehman et al., 
2009). Eleven spacers showed from 14 to 15 nucleotides match out of 32 nucleotides, 
approximately 44 to 47% similarity, to sequences in phage ΦEa35-70 (Yagubi et al., 
2014) (Table 2). Of the all CRISPR spacers sequences determined, only 13 spacers 
showed similarity to sequences in plasmids and other bacterial genomes in the 
database, data not shown.   
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Spacer sequence  Host 
CRISPR 
region 
Spacer 
no. 
Phage 
Location on 
phage genome 
Target 
phage gene 
TTATTCATGAGCCTTTTTATCTTCGCGGCATG Ea6-4 1 1 φEa35-70 177033 to 177047 Hp 
AAGATGCTTTGACATTAATTATCTCCATAAAA Ea6-4 1 5 φEa35-70 38341 to 38355 Hp 
AAGATGCTTTGACATTAATTATCTCCATAAAA Ea6-4 1 5 φEa35-70 54602 to 54615 Hp 
AAGATGCTTTGACATTAATTATCTCCATAAAA Ea6-4 1 5 φEa35-70 73984 to 73997 Hp 
CCGCGAAAATCCGCAGTGAGCTGGCAATGAGC Ea6-4 1 29 φEa9-2 63339 to 63357 Hp 
TTTCTTCACACACAACGGTGAGGGCATTGTCT Ea6-4 1 35 φEa21-4 61435 to 61449 NA 
       
GCTCGGGGGGACATGAGCTTGTACAAAACAGC Ea6-4 2 3 φEa21-4 73508 to 73522 Hp 
GTTGATACGGCTGATTACAATAAAATGTCACT Ea6-4 2 9 φEa35-70 254734 to 254750 
Tail fiber 
protein 
AATGGACGAGATTTCACAGAAAATATCTGTTC Ea6-4 2 13 φEa21-4 41408 to 41423 NA 
GCTACTACGTGTACGCACAGCCGCTGGCCAGT Ea6-4 2 14 φEa35-70 100839 to 100855 Hp 
CGGGCGAGTTTTTCAGGATGCGTCTCATTGAA EaG5 2 2 φEa21-4 79202 to 79216 NA 
TACGTCAGCGGCATTATAAGGATTTACACGGA EaG5 2 6 φEa21-4 20967 to 20983 NA 
CAACTGAGCAACTCCGCTTTGCCCCATACCAA EaG5 2 15 φEa35-70 72650 to 72666 Hp 
CGACTATTCGGCGAACTGAAAGAGCCAACCGT EaG5 2 18 φEa35-70 104335 to 104351 Hp 
GAGAGCAACAACAAACTCCGACCGGAGAAACC EaG5 2 23 φEa35-70 3070 to 3084 Hp 
GTTTCGGCGAGCGCGTATATGGTCACGTTCAC EaG5 2 25 φEa21-4 73578 to 73594 Hp 
ACGGTCAGATGGTGGCGCTGGTTGCGCTGGCA EaG5 2 39 φEa35-70 22206 to 22222 Hp 
       
TTTACGTTTGCGTTAACAGTAAGCTCTGCAAC Ea6-4 3 1 φEa21-4 43706 to 43721 
Putative 
baseplate 
component 
ATCGCACCCCACTGATTGAAGAGCAGCACACT Ea6-4 3 2 φEa35-70 238369 to 238381 Hp 
 
Table 2: Summary of blast results blast of spacers against available E. 
amylovora phages in GenBank.  
Sequences in spacers that show similarity to sequences in phages are 
underlined. The mismatches are shown in bold and are not underlined.  The 
target phage genes by these spacers are shown in the most right column; Hp, 
hypothetical protein and NA, not available (genes with unknown function).  The 
location of the matching sequence in the phage genomes is shown.  
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Cas gene sequences analysis  
 The sequence analysis of CRISPR regions of bacterial isolates EaD7 and Ea6-4 
revealed the presence of eight Cas genes between CRR1 and CRR2 (Figure 8). Cas 
genes were found to span a region of 8.3 kbp. The start codon of Cas3, the first gene in 
the cluster, is located approximately at 2.5 kbp downstream of the last repeat of CRR1. 
On the other hand, the stop codon of Cas2, the last gene in the group, is located just 
upstream of the leader sequences of CRR2 (Figure 8). The location of CRR3 on the 
genome was not determined. It is expected to be thousands of base pairs downstream 
of CRR2 similar to CRR3 of E. amylovora strain ATCC 49946 (Sebaihia et al., 2010).  
Furthermore, no Cas genes were found associated with CRR3 of Ea6-4 and EaD7. 
Generally, the amino acid sequence and the orientation of Cas genes of EaD7 and 
Ea6-4 were found to match Cas genes found in E. amylovora strains ATCC 49946 and 
CFBP 1430 (Sebaihia et al., 2010; Smits et al., 2010). These strains carry CRISPR/Cas 
type I-E similar to CRISPR/Cas found in E. coli (Makarova et al., 2011; Touchon et al., 
2011). Cas gene sequences information and potential function are shown in Table 3.  
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Table 3: List of Cas proteins found in E. amylovora Ea6-4 and EaD7 and their 
potential function. 
The stage when these proteins are involved during different CRISPR system 
mechanisms is shown in the right column. Acquisition means involved in spacer 
acquisition step, processing RNA: involved in maturation of pre-crRNA to produce 
crRNA, and surveillance and interference: proteins are involved in finding invading 
phage DNA and degradation. Collected from (Richter et al., 2012a; Richter et al., 2013; 
van der Oost et al., 2014).  Cas and Cse proteins: are CRISPR-associated proteins 
found in CRISPR/Cas system type I. 
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Cas gene expression during phage infection  
 To obtain an understanding of CRISPR function in E. amylovora, the level of 
expression of three core genes involved in different stages in the CRISPR mechanism 
were monitored in Ea6-4 and EaD7 during phage infection. Cas1 is involved in the 
acquisition step, Cas3 in acquisition and interference and crRNA transcripts are 
involved in surveillance.  
 To investigate the response of E. amylovora CRISPR system to phage infection, 
Ea6-4 and EaD7 isolates were infected with phages ΦEa21-4, ΦEa9-2 and /or ΦEa35-
70. ΦEa9-2 has one sequence with 17 nucleotides match to one spacer (32 nt) in 
CRR1 of Ea6-4 and EaD7. ΦEa21-4 has four sequences with 14 to 16 nucleotides 
match to spacers in Ea6-4 and EaD7, one in CRR1, two in CRR2 and one in CRR3. 
ΦEa35-70 has four sequences with 14 to 15 nucleotides match to spacers in CRR1, 
two in CRR2 (each with16 nt match) and one in CRR3 of Ea6-4 and EaD7 (13 nt 
match). It was anticipated, based on the described  similarities, that the relative roles of 
the three CRISPR loci could be discerned by comparisons of the three phages during 
infection of Ea6-4 and EaD7, and the role of CRISPR/Cas systems in general by 
comparison of the results from challenge of the two bacterial hosts. The level of 
expression of Cas1, and Cas3 and crRNA were monitored for 2 h post infection.  To 
differentiate between the phage-induced changes in Cas gene expression from 
changes as a result of E. amylovora growth, in addition to phage-infected culture, a 
non-infected E. amylovora culture was used as a control.  
 Cas gene level of expression was measured during host infection by the 
Myoviridae phage ΦEa21-4 (Figure 11).  Results indicated that there were no major 
changes in the level of expression of Cas genes after 2 h of infection in comparison 
to non-infected cells. A minor increase in the level of expression in crRNA in Ea6-4 
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in the middle of the first phage replication cycle was observed, and then the level of 
expression declined to a level similar to the control (Figure 11). Each replication 
cycle of ΦEa21-4 in the host, takes approximately 60 min (data not shown). The 
duration of infection in the experiment allowed two complete cycles of phage 
replication.  In addition, the growth rate of the E. amylovora cells was not affected by 
phage infection during this experiment (data not shown). The level of expression of 
Cas genes were tested using phages, ΦEa9-2 (Podoviridae; accession no. 
NC_023579) and ΦEa35-70 (Myoviridae; accession no. KF806589) (Yagubi et al., 
2014). Expression of Cas genes and crRNA in EaD7 increased during the first 30 min of 
ΦEa9-2 infection (Figure12). After 30 min, expression declined to levels similar to non-
infected cells. Interestingly, no effect on Cas genes and crRNA expression was 
detected when Ea6-4 isolate was infected with the same phage with an exception of a 
minor increase in Cas3 expression in the first 30 min of infection (Figure12). A major 
drop in Cas1 was also observed late infection cycle (after 60 min) of ΦEa9-2 infection.  
On the other hand, ΦEa35-70 didn’t elicit any change in expression of Cas genes in 
both bacterial hosts (Figure 12). 
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Figure 11: Cas1 and Cas3 and crRNA level of expression in E. amylovora cells 
during ΦEa21-4 infection. 
Two bacterial host isolates were used: Ea6-4 and EaD7. Level of expression was 
measured every half hour for two hours. Negative control (-ve control) were cells with 
no phage infection. Steps in which these genes are involved in CRISPR function 
(acquisition, transcription and interference) are shown. The results were calculated 
using three biological replicate. 
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Figure 12: Cas1 and Cas3 and crRNA level of expression in E. amylovora cells 
during infection by phages ΦEa9-2 and ΦEa35-70. 
Two bacterial host isolates were used, Ea6-4 and EaD7. Level of expression was 
measured every half hour for two hours. Negative control (-ve control; blue line) is cells 
with no phage infection. Level of expression at T0 was considered as an initial value of 
one fold. Fold change at different times is the ratio of the value at a given time to the 
initial value (T0). ΦEa9-2 (brown line) and ΦEa35-70 (green line). Steps in which these 
genes are involved in CRISPR function (acquisition, transcription and interference) are 
shown. The results were calculated using three biological replicate. 
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Studying E. amylovora Cas gene function by introducing an artificial 
CRISPR/Cas system into Ea6-4 
 Despite the existence of a CRIPSR/Cas system in E. amylovora, to date the 
presence of phage resistant bacteria have not  been detected among in our collections 
of phages and E. amylovora hosts. The CRISPR/Cas system appears to be naturally 
inactive in E. coli K12 due to the low levels of Cas gene expression (Westra et al., 
2010). To test whether a low level of Cas gene expression is the reason for not 
detecting any phage resistance in E. amylovora, and to study the function of these 
genes, four plasmids were constructed to carry various sets of Cas genes: pSp21-4, 
pSpCas123, pSpCasg, and pSpdel (Figure 13). The plasmids are described in greater 
detail in the Materials and Methods.  These plasmids were introduced into Ea6-4. First, 
the level of Cas gene expression and crRNA production were investigated to test the 
effectiveness of the introduced genes.  The transformed Ea6-4 host cells were 
subsequently challenged with selected Erwinia spp. phages to determine if boosting 
Cas gene production has an effect on phage replication.  
 
Monitoring Cas gene expression  
 To test if the transformed plasmids would enhance the expression of Cas genes, 
and to ensure that T7 prompters would sustain a read-through transcription to Cas1 and 
Cas3 genes which are located distal to T7 promoter in pSpCas123 and pSpCasg 
plasmids, a quantitative reverse transcription PCR analysis of transcripts levels of Cas1 
and Cas3 was performed.  After introducing plasmids pSp21-4, pSpCas123, pSpCasg, 
and pSpdel into electrocompetent Ea6-4, transformants were incubated on a shaker for  
4 h, and total RNA was isolated every 2 h. Then, the level of expression of Cas1 and 
Cas3 was evaluated using RT real-time PCR (Figure 14). 
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 Results showed that after 2 h of incubation the transcript levels of Cas1 
increased seven fold in Ea6-4 with pSpcas123 and 15 fold in Ea6-4 carrying pSpCasg 
in comparison to wild type cells. The level of expression in Ea6-4 hosts carrying pSpdel 
or pSp21-4 plasmids didn’t increase since these plasmids do not carry an extra copy of 
Cas genes (Figure 14). After 4 h of incubation, the level of expression of Cas1 
increased to 32 fold in Ea6-4 harbouring pSpCas123 and pSpCasg compared to wild-
type Ea6-4. The level of expression of Cas1 in cells that carry only genomic copy of the 
gene (Ea6-4 harbouring pSpdel or pSp21-4 plasmids) did not change during the 4 h of 
incubation (Figure 14). On the other hand, the level of expression of Cas3 was relatively 
different from Cas1. The level of expression of Cas3 was increased by only one fold 
with pSpCasg and pSpCas123 in two hours incubation (Figure 14). However, in 4 h 
incubation the expression increase up to four fold in cells carry pSpCasg, and only two 
fold in cells with pSpCas123. Interestingly, the expression level of Cas3 was down 
regulated in cells with pSpdel or pSp21-4 compared to wild-type Ea6-4 (Figure 14). 
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Figure 13: Maps of pSpdel, pSp21-4, pSpCas123 and pSpCasg plasmids. 
pSp21-4 carries CRISPR leader sequences followed by three spacers that match 
protospacers existing in phage ΦEa21-4 (more information about the protospacers and 
target phage genes can be found in Figure 1A, Appendix). pSpCas123 carries the exact 
sequences as in pSp21-4 in addition to Cas1, Cas2 and Cas3. pSpCasg carries the 
exact sequences cloned in pSp21-4 in addition to all Cas genes found in EaD7 (Cas1, 
2, 3, 4, 5 and Cse1, 2, 3, 4). pSpdel does not carry any inserts and serves as a plasmid 
background control. T7 promoter location is shown in all plasmids.  
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Figure 14: Cas1 and Cas3 level of expression in Ea6-4 hosts transformed with 
plasmids carrying Cas genes. 
The level of expression of both genes was measured after 2 and 4 h of incubation. Fold 
changes were calculated in comparison to wild type; the level of expression in wild type 
host is considered as one fold. The results were calculated using three independent 
biological replicate. 
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Monitoring mature crRNA production  
 After determining that the levels of expression of Cas1 and 3 genes were 
enhanced in Ea6-4 hosts transformed with plasmids carrying these genes, it was 
important to assess the efficiency of the introduced Cas genes in processing and 
production of crRNA. If these genes are functional, an increase of crRNA production 
should be detected. For this purpose a RT real-time PCR was carried out to evaluate 
the production of pre-crRNA and mature crRNA.  
 RNA was isolated from wild type and transformed Ea6-4 after 2 and 4 h of 
incubation at 27°C. The RNA quality was verified on a Mini-PROTEAN® TBE-Urea 
Precast Gel (Bio-Rad). In order to separate pre-crRNA (>160 b) from crRNA (<160b), 
the microRNA Purification Kit (Norgen Biotek Corp.) was used; Figure 15 shows the 
separation of large RNA and crRNA.  Then RT real-time PCR was used to evaluate the 
level of production of total CRISPR RNA (pre-crRNA and mature crRNA) and crRNA 
only.    
 After 2 h of incubation the production of CRISPR RNA was not changed in any 
Ea6-4 transformant compared to the wild type host. However, after 4 h of incubation, 
the total CRISPR RNA production increased by at least 13 fold in cells harbouring 
pSpCasg and by 3 fold in cells with pSpCas123 (Figure 16). On the other hand, the 
accumulation of crRNA in these hosts was quite different. In 2 h of incubation, the 
production of crRNA was slightly increased in cells with pSpCas123 and pSpCasg 
plasmids. After 4 h of incubation, the level of accumulation of mature crRNA increased 
only 12 fold in Ea6-4 harbouring pSpCasg. No increase was observed in other hosts 
and particularly in Ea6-4 that harboured pSpCas123 plasmid, which carries Cas1, 2 and 
3 (Figure 16). 
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Figure 15: TBE-Urea gel of isolated RNA. 
Total RNA before crRNA separation is shown in the second lane from the left. Small 
RNA lane shows enriched RNA that is less than 160 bases, including crRNA.  Large 
RNA lane represents all RNA molecules larger than 160 bases including pre-crRNA. 
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Figure 16: Pre-crRNA and crRNA level of production in Ea6-4 hosts transformed 
with plasmids carrying Cas genes. 
Top Figure shows the level of production of total RNA (pre-crRNA and mature crRNA). 
Lower Figure shows the production level of only mature crRNA. The level of expression 
was measured after 2 and 4 h of incubation. Fold changes is calculated in comparison 
to wild type; the level of expression in wild type host is considered as one fold. The 
results were calculated using three independent biological replicate. 
 
   73 
Phage replication in Ea6-4 transformed with plasmids carrying artificial 
spacers and Cas genes 
 Ea6-4 with pSpdel, pSpCas123 or pSpCasg was challenged with Podoviridae 
phages ΦEa31-3 and ΦEa9-2 and Myoviridae phages ΦEa35-70 and ΦEa21-4 to 
determine the effect of the extra copies of Cas genes on phage replication. The Ea6-4 
host that transformed with pSpdel plasmid was used as a control since pSpdel carries 
no insert (no spacers and Cas genes).  Transformed Ea6-4 isolates were grown in liquid 
culture until OD600 of 0.1 was reached (approximately 4 h). The cultures were infected 
with the listed phage at MOI of 0.1 and incubated for an additional 8 h at 27°C. Phage 
titers were determined every 2 h using a standard curve and real-time PCR. In all hosts, 
there was no difference in phage titre. Transforming Ea6-4 with artificial Cas genes in 
addition to existing endogenous CRISPR system did not reduce the replication of 
phages from Myoviridae and Podoviridae families (Figure 17A, B, C and D). 
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Figure 17: Selected Myoviridae and Podoviridae phages replication in Ea6-4 
transformed with plasmids carry Cas genes. 
A: phage ΦEa21-4; B: ΦEa35-70; C: ΦEa31-3; ΦEa9-2. Blue lines represent phages 
titre in Ea6-4 transformed with the control plasmid pSpdel (no Cas genes).  The results 
were obtained using three independent biological replicate. 
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Generation of E. amylovora BIMs and spacer acquisition 
 In order to investigate the ability of E. amylovora to acquire new spacers in 
CRISPR arrays during phage infection, wild-type Ea6-4 and Ea6-4 transformed with 
pSpCas123 or pSpCasg were challenged with phages ΦEa31-3, ΦEa9-2, ΦEa35-70 
and ΦEa21-4. Following three rounds of E. amylovora phage infection, bacterial 
colonies of Ea6-4 that survived phage infection were investigated for spacer acquisition 
using PCR on formed colonies. 273 E. amylovora colonies formed by cells that survived 
three rounds of phages infection were screened for spacer acquisition.  Spacer 
acquisitions were not detected in any CRISPR array.  
 
E. amylovora CRISPR/Cas system and plasmid transformation 
 The efficacy of E. amylovora CRISPR/Cas system in blocking plasmid 
transformation was investigated. Plasmids pProtoCR1, pProtoCR2 and pProtoCR3 
were constructed to carry protospacers complementary to CRISPR spacers in CRR1, 2, 
or 3 of Ea6-4, respectively.  Plasmid pProtoN that did not carry protospacers was used 
as a control (Figure 18). 
 Transformation efficiency of all plasmids was calculated per 1µg of plasmid DNA 
(Figure 19).  If the plasmids carrying protospacers are blocked by the CRISPR system, 
low transformation efficiency should be expected comparing to control plasmid that 
carries random sequences that do not match spacers in Ea6-4. Transformation of 
plasmids carrying protospacers with similarity to CRR1 and CRR2 was blocked by one 
log compared to the control plasmid. The transformation efficiency of pProtoCR1 was 
approximately 4 times less than pProtoCR2 plasmid (Figure 19). The transformation 
efficiency of plasmid carrying protospacers with similarity to CRR3 was not considerably 
different from the control plasmid (Figure 19). Transformed plasmids that escaped 
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CRISPR system were investigated for mutations in protospacer sequences and site 
methylation. No mutations were detected in all plasmid, and plasmids were digestible 
with selected endonucleases that are known to be sensitive to methylation.  
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Figure 18: Plasmids used to challenge CRISPR/Cas system in Ea6-4.  
pProtoCR1 plasmid carries protospacers targeting CRR1; pProtoCR2 plasmid carries 
protospacers targeting CRR2; pProtoCR3 plasmid carries protospacers targeting 
CRR3. pProtoN: control plasmid.  PAM sequences are shown in red. Protospacers are 
underlined. 
PAM           Protospacer            
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Figure 19: Challenging E. amylovora Ea6-4 with plasmids carrying protospacers.  
Transformation efficiency is expressed in CFU/µg of plasmid DNA. The results were 
calculated using three biological replicate. 
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Discussion 
Sequences analysis of CRISPR/Cas system 
CRISPR arrays sequences  
 The CRISPR/Cas systems of eight different E. amylovora isolates were 
investigated in this study (Table 1). Earlier, three CRISPR arrays have been identified 
in the genomes of previously sequenced E. amylovora strains, European strain CFBP 
1430, isolated from a Crataegus sp. (Smits et al., 2010) and the American strain Ea273, 
isolated from a Malus sp. (Sebaihia et al., 2010). The existence of three CRISPR arrays 
was further confirmed in the genomes of many other E. amylovora strains from different 
geographical regions (McGhee and Sundin, 2012; Rezzonico et al., 2011). Even though 
the number of isolates included in this study was limited, similar results were obtained 
from the genomes of E. amylovora isolates from different locations in Canada and USA 
(Table 1).  
 E. amylovora CRISPR loci sequences showed that spacer content is mainly 
dictated by plant host and geographical location (McGhee and Sundin, 2012; Rezzonico 
et al., 2011).  In this study, it seems that the influence of the host plant on spacer 
sequences is more apparent than the geographical location. The spacers of Ea6-4, 
EaD7 and Ea17-1-1 isolates from infected apple in Essex County, Ontario were found 
to be identical, despite that these isolates are characterised to be profoundly different 
based on the criteria of pathogenicity, response to phage infection and EPS production 
level (Lehman, 2007; Roach et al., 2011; Sjaarda, 2012). Ea110R, rif R mutant, 
originating from EA110 isolated from infected apple in Michigan USA, also carried 
similar spacers as Essex County isolates. The observation that isolates from different 
host plants exhibit variation in spacer sequences was further confirmed from the spacer 
sequences of CRR2 of EaG5. EaG5 was significantly different from isolates from the 
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same geographical location, and more related to BC29 from infected pear in British 
Columbia.  Despite the genetic similarity between E. amylovora strains, the difference in 
spacer sequences was more evident between isolates from apple isolates and 
raspberry isolate Ea4-96. Previously, important differences in spacer sequences were 
detected between E. amylovora isolated from apple and from Rubus sp. (McGhee and 
Sundin, 2012; Powney et al., 2011; Rezzonico et al., 2011). Rubus strains are 
pathogenic on raspberry but not on apple and pear (Asselin et al., 2011; Triplett et al., 
2006). The variation in the sequences of in CRR2 of all isolates in study might also 
indicate that this region is active and allows spacer acquisition upon the bacterial host 
facing foreign DNA elements. In conclusion, the diversity of CRR2 arrays seems to be 
mainly based on the host plant rather than on geographical region. Bacterial isolates 
that inhibit different environmental niche usually encounter different environmental 
components which may have shaped their evolution independently (Bolotin et al., 2005; 
Touchon and Rocha, 2010).  
    
The origin of E. amylovora CRISPR spacers  
 Despite vast sequence variability of spacers detected in E. amylovora in this 
study, only a limited number of spacers was found to match phage genomes and 
plasmids. None of the detected spacers were found to exactly match the sequences of 
any E. amylovora phages in GenBank. Some spacers showed partial similarity to 
some E. amylovora phages from our collection, 13 to 17 nt match out of 32 nt spacer 
length (approximately 50% similarity), refer to Table 2. The lack of spacers that match 
phage sequences could be attributed to the small number of phage genomes that are 
available for comparison or more importantly to the inefficiency of E. amylovora 
CRISPR system.   
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 PAMs are sequences flanking protospacers, and are important elements for 
phage resistance in at least some of the bacterial CRISPR/Cas systems (Deveau et al., 
2008; Mojica et al., 2009). In CRISPR mediated immunity against phages of S. 
thermophilus,  mutations in PAM sequences abolished CRISPR-mediated immunity 
even in the presence of perfect matching between spacer and protospacer (Deveau et 
al., 2008).  Alignments of protospacers detected in this study revealed short conserved 
sequences at the ‘5 that could be PAMs (AAA, GAA, AAC, AAG and GTA) (Figure 10). 
These PAMs seem to be similar to those found in E. coli k12. E. coli K12, carries type I-
E CRISPR/Cas system, contained a PAM consensus sequence 5`-AWG  (Mojica et al., 
2009). The majority of anti-plasmid spacers acquired by the host were a complement to 
the protospacers flanked with an AAG PAM. Less spacers were gained with AAA, AGG 
, GAG, TAG, CGA, AAT, and ATG PAM (Swarts et al., 2012).  
 
E. amylovora CRISPR/Cas system and phage resistance  
  Earlier studies on E. amylovora CRISPR/Cas system have focused on the 
sequence analysis of  Cas genes and CRISPR arrays, origin of spacers, phylogenesis 
and diversity of E. amylovora (McGhee and Sundin, 2012; Rezzonico et al., 2011). This 
is the first study that addresses the expression and role of E. amylovora CRISPR/Cas 
system in phage resistance and blocking plasmid DNA transformation.  
 In order to examine the response of E. amylovora CRISPR/Cas system to phage 
infection, the expression profiles of crRNA and Cas1 and 3 genes of Ea6-4 and EaD7 
were explored during phage infection.  Cas1 plays an important role in spacer 
acquisition, and Cas3 is involved in spacers acquisition and interference step. 
Myoviridae phages ΦEa21-4 and ΦEa35-70  and Podoviridae phage ΦEa9-2 were 
used to investigates the response of CRISPR/Cas system since these phages showed 
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variability in host range studies (Steven Gayder, PhD unpublished data). The 
Myoviridae phages did not elicit E. amylovora CRISPR system, and did not affect the 
level of expression of Cas genes during two cycles of phage replication. It was expected 
that invasion of phages to induce expression of the transcriptional regulators that, in 
turn, activate the transcription of genes involved in phage resistance mechanisms such 
as Cas genes. The expressions of Cas proteins and crRNA are likely to respond to 
phage or plasmid invasion as they function as a defense system for bacteria. The level 
of expression of Cas1 and Cas2 in archaea increased after virus infection (Liu et al., 
2015; Quax et al., 2013).  Similar results were shown by S. thermophilus (Young et al., 
2012) and Thermus thermophilus (Agari et al., 2010). However,  the expression level of 
several Cas genes and CRISPR arrays in T. thermophilus were not up-regulated during 
the first 100 min of  phage infection (Agari et al., 2010). Even though the level of 
expression of Cas genes in E. amylovora in this study was monitored for 120 min, no 
up/down regulation was observed. It is important to note that phages used in this study 
were still in the eclipse phase up to 50 min post infection. Phage titer started to increase 
after 70 min post infection as an indication of the end of phages first replication cycle 
(data not shown). 
 In contrast to Myoviridae phages, an increase of Cas genes and crRNA level 
expression was observed with Podoviridae phages during the first 30 min in EaD7. 
However, the level of expression was down regulated 30 min post infection, an 
indication that the phage were taking over the host machinery. Infection of Ea6-4 with 
the same phage did not stimulate the level of expression of Cas genes. It is not clear 
whether the response of the CRISPR/Cas system to the Podoviridae ΦEa9-2 invasion 
is a result of challenging process of CRISPR/Cas system to phage infection, or 
reflecting an attempt of adaptation through spacer acquisition. EaD7 and Ea6-4 are 
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sensitive to phage ΦEa9-2 and other phages used in this study. No spacers were found 
in the CRISPR arrays of these isolates that perfectly match sequences in ΦEa9-2.  As a 
result, one might speculate that the increase in Cas gene level of expression in EaD7 
could be related to an attempt for a spacer acquisition process.   
 E. amylovora CRISPR/Cas system expression profile and response could be 
streamlined depending on the invading phage and infection mode of phages. The 
Podoviridae phages such as ΦEa9-2 are known to carry EPS depolymerase. The 
depolymerases facilitate phage entry by degrading the amylovoran, around the bacterial 
host allowing phages to reach their primary receptor on the cell membrane.  Dissolving 
the EPS capsule creates stress on the bacterial host stimulating the bacteria defence 
mechanisms including CRISPR/Cas system. The bacterial cell membrane contains  
signal transduction apparatuses that are responsible for sending signals that respond to 
environmental stress which leads to change in the bacterial gene expression (Beier and 
Gross, 2006; Mole et al., 2007). EaD7 isolates produce a higher amount of amylovoran 
than Ea6-4 (Roach et al., 2013).  Dissolving the EPS structure around EaD7 by the 
depolymerase of ΦEa9-2 might explain the difference in response of EaD7 and Ea6-4 
to Podoviridae phage infection.   
 The mechanism by which Myoviridae phages are able to escape from or down 
regulate E. amylovora CRISPR/Cas system is not understood and has to be further 
investigated. The CRISPR/Cas system in E. amylovora may be non-functional during 
phage infection  due to low level of Cas genes expression as the case in E. coli k12  
(Westra et al., 2010). Also, Erwinia phages may be equipped with the tools to escape 
CRISPR/Cas system by down regulating Cas gene expression.  Phage proteins with 
anti-CRISPR function against type I-F CRISPR/Cas and the type I-E CRISPR/Cas 
systems of P. aeruginosa have been identified  (Bondy-Denomy et al., 2013; Pawluk et 
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al., 2014). The finding of anti-CRISPR genes carried by P. aeruginosa phages raised 
the possibility that other phage genomes may harbour similar genes. In this study, 17 
Erwinia phages have been sequenced and analyzed (Chapter 4); no genes with similar 
sequences to anti-CRISPR genes of P. aeruginosa phages were detected in all known 
E. amylovora phage genomes.  Nevertheless, temperate phages entering the lysogenic 
cycle were able to down regulate the P. aeruginosa type I-F CRISPR/Cas system. 
These anti-CRISPR genes appear to function to permit and establish prophage 
existence (Bondy-Denomy et al., 2013). To date, no temperate E. amylovora phages 
have been found in E. amylovora (Roach et al., 2015).    
 Spacer acquisition by bacteria upon phage infection has been shown in several 
bacteria (Erdmann and Garrett, 2012; Erdmann et al., 2014).  During phage infection 
CRISPR loci of S. thermophilus acquired new spacers derived from the invaded phage 
DNA  (Barrangou et al., 2007). The acquisition of these spacers led to a high level of 
resistance to specific phages bearing homologous sequences in subsequent infection 
(Barrangou et al., 2007; Deveau et al., 2008). Streptococcus mutants, the principal 
aetiological agent of dental cavities, were challenged with phage M102 to study phage 
therapy for the prevention of tooth decay in rats. BIMs from Streptococcus were isolated 
that had added a new spacer that matched sequences in phage M102 (van der Ploeg, 
2009). New acquired spacers are usually inserted in the CRISPR arrays just upstream 
of the leader sequence and before the first repeat in the cluster (Barrangou et al., 2007; 
Deveau et al., 2008; Horvath et al., 2008).  
 In this study, three sets of BIMs were generated using E. amylovora isolates 
wild-type Ea6-4 and Ea6-4 transformed with pSpCas123 or pSpCasg plasmids. 
Bacterial cells were infected with phages from Myoviridae and Podoviridae families. 
CRISPR regions 1, 2 and 3 of all BIMs were investigated for spacer acquisition. No 
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insertions of new spacers were detected in all CRISPR arrays of the generated BIMs 
indicting that the gained phage-resistance feature of these BIMs was not due to spacer 
acquisition. The overall mechanism of spacer acquisition and the synthesis of new 
repeats are not well understood; however Cas1 and Cas2 play a role. The 
overexpression of both Cas1 and Cas2 in type I systems facilitate spacer acquisition 
indicating that both gene are required for this process  (Yosef et al., 2012).  The 
CRISPR/Cas system of E. coli K12 gained new phage-derived spacers in many cells at 
leader-proximal end of CRISPR following the increase of Cas level of expression 
(Datsenko et al., 2012). In this study, enhancing in E. amylovora Cas expression seem 
to have no effect on spacer acquisition. These results suggested that E. amylovora 
CRISPR/Cas system is not cable of spacer acquisition despite boosting it with extra 
copies of Cas genes. 
 
The effect of over expression of Cas genes on phage infection  
 To better understand the CRISPR/Cas system in E. amylovora, the function of 
CRISPR system was investigated in-depth by enhancing the level of expression of Cas 
genes by introducing an extra set of Cas genes cloned into plasmids. The E. coli   
CRISPR/Cas system is found to be transcriptionally repressed by the H-NS regulator 
protein that strongly inhibited Cas gene promoters (Pul et al., 2010; Westra et al., 
2010). Deletion in hns gene caused an increase in the expression of some of the Cas 
genes and increased abundance of small crRNA (Hommais et al., 2001; Pougach et al., 
2010). The approach of mutating hns gene to increase the level of expression of Cas 
genes was not the choice in this study. Instead, an artificial CRISPR/Cas system cloned 
into a plasmid next to T7 promoter was the chosen tactic.  When a plasmid carrying hns 
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gene was introduced into in E. amylovora, the capsular EPS production was reduced 
(Hildebrand et al., 2006). Also a mutation in chromosomal hns gene of E. amylovora 
increased amylovoran production (Hildebrand et al., 2006). Inducing EPS production in 
E. amylovora might affect phage adsorption while investigating CRSIPR/Cas system. 
Cas genes in E. coli K12 provided  resistance against λ phage when they co-
overexpressed from a plasmid but only when the cell harbors spacers matching the λ 
phage genome is transcribed by T7 RNA polymerase (Brouns et al., 2008). A similar 
strategy was carried out in this study; a pSpCasg plasmid was used to enhance 
CRISPR/Cas system this plasmid carried all Cas genes found in E. amylovora 
CRISPR/Cas system (Cas1, 2, 3, 4, 5 and Cse1, 2, 3, 4) in addition to three spaces 
targeting sequences in phage ΦEa21-4 (Figure13).  
 It was important to investigate the level of expression of Cas genes and crRNA in 
E. amylovora transformed with plasmids carried Cas genes prior to challenging with 
phages. The level of expression of Cas1 and Cas3 increased in all hosts that were 
transformed with a plasmid carrying a copy of Cas1 (Figure14). Interestingly, the level 
of expression of Cas3 in a host harbouring pSpCas123 was almost two fold less than 
pSpCasg (Figure 14). The apparent increase in the expression level of Cas3 in the 
isolate carrying pSpCasg could be a result in the presence of other Cas genes such as 
Cse1, 2, 3, and 4 in this plasmid.  Cas genes were found to regulate each other; the 
overexpression of Csa3a in type I-A of the archaeon Sulfolobus islandicus increased 
the transcriptional level of Cas1 and 2 genes (Liu et al., 2015). 
 In addition to Cas1 and Cas3, a high increase in total CRISPR RNA (pre-crRNA 
and crRNA) production in hosts harbouring pSpCasg was observed. The accumulation 
of total CRISPR RNA (pre-crRNA and crRNA) was less in cells carry pSpCas123 
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(Figure 16). Interestingly, the amount of processed mature transcript (crRNA) was also 
dramatically increased in cells harbouring pSpCasg comparing to other hosts. These 
results indicate that the noticeable increases in crRNA abundance only took place when 
all Cas genes were overexpressed. The increase of crRNA abundance was most likely 
due to the increase in intracellular concentration of all Cas genes which help in the 
expression or stabilizing the produced crRNA. Overexpression of only Cas1, 2 and 3, in 
hosts carrying pSpCas123, was not sufficient to increase pre-crRNA processing. 
However, the overexpression of CasE (Cse3) in E. coli was sufficient for the increase in 
the accumulation of crRNA (Pougach et al., 2010). The effect of absent of some Cas 
genes (Cse1, and Cse2, Cse4, Cas5 and Cse3) on the function of CRISPR region in E. 
coli K12 was investigated (Brouns et al., 2008). Only Cse3 protein is required for pre-
crRNA cleavage to produce mature crRNA (Brouns et al., 2008). In conclusion, the 
increase in processing mature crRNA in hosts carrying pSpCasg indicates that Cas 
genes of E. amylovora are functional. Also other genes rather than Cas1, 2, and 3 are 
needed for pre-RNA processing and may be stabilizing the produced crRNA.  
 Cas genes in E. coli K12 provided resistance against λ phage when they were 
co-overexpressed from a plasmid but only when the cell harbors spacers matching the λ 
phage genome (Brouns et al., 2008). Eliminating the Cas gene plasmid from the host 
permitted λ phage infection suggesting that the levels of expression of chromosomal 
Cas genes are not enough to deliver phage resistance (Brouns et al., 2008).  This was 
not the case in E. amylovora; this work shows that introducing plasmids which carry 
Cas genes and spacers matching ΦEa21-4 did not affect phage replication when 
compared to the control (Figure 17).  In addition, transformed Ea6-4 carrying extra Cas 
genes did not reduce the replication of Podoviridae phages ΦEa31-3 and ΦEa9-2 and 
Myoviridae phage and ΦEa35-70 (Figure 17). Phages can evade CRISPR immunity by 
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mutating residues in target sequence (protospacer) or around the target sequence in 
PAM (Deveau et al., 2008; Semenova et al., 2009).  Sequence analysis of 19 phages 
escaped CRISPR immunity in S. thermophilus were found  to contain a single or double 
mutation in the protospacer sequence (Deveau et al., 2008). Mutation in protospacers 
sequences should not be the reason for the absence of resistance in Ea6-4.  PSpCasg 
and pSpCas123 carry three spacers that target three different genes in ΦEa21-4 
genome; mutation in three protospacers at once is doubtful.   
In conclusion, the CRISPR/Cas system in E. amylovora is inefficient in 
preventing phage infection of the host. Overexpression of Cas genes and enhancing the 
production of crRNA, the surveillance and interfering tools, also did not enable 
CRISPR/Cas system in E. amylovora to block phage infection.   The CRISPR/Cas 
system appears to be inactive or partially ineffective in E. amylovora.  E. amylovora may 
have maintained the existence of an intact CRISPR/Cas system for some beneficial 
function to the host other than host phage resistance.  
 
CRISPR/Cas system efficiency in blocking plasmid transformation 
 To establish E. amylovora CRISPR/Cas system efficiency in blocking plasmid 
DNA transformation, four target plasmids were constructed to challenge CRISPR/Cas 
system of Ea6-4. The partial blocking of pProtoCR1 and pProtoCR2 plasmids, which 
target CRR1 and CRR2, respectively, might reflect the moderate efficacy of these 
regions in preventing DNA transformation. The transformation efficiency of pProtoCR3 
plasmid which targets CRR3 was not affected when compared to the control.  It could 
be concluded that CRR3 is inactive in comparison to CRR1 and CRR2.  
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 In conclusion, the detection of CRISPR/Cas system in almost 50% of bacteria 
indicates its significance as defense mechanism against phages and other exogenous 
elements. However, the E. amylovora CRISPR/Cas system seems to have no role in 
blocking phage infection. Improving the level of expression of Cas genes and inserting 
spacers to target certain phages also did not enable this system to function as a 
defences mechanism. Spacers that already exist in E. amylovora CRISPR loci might 
indicate that this system is involved in processing and acquisition of new spacers but 
not in defending the bacterial host against phages. In this study, it was shown that E. 
amylovora CRISPR/Cas system appears to be more effective in blocking plasmid DNA 
transformation than preventing phage infection. This might suggest that Erwinia phages 
are capable of escaping CRISPR/Cas system using unknown mechanism.    
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Chapter 3 
Sequences analysis of selected E. amylovora phages 
Abstract 
 Limited numbers of E. amylovora phage genomes are sequenced in GenBank. 
Sequencing of more phage genomes will improve our understanding on the relationship 
between Erwinia spp. phages and the CRISPPR/Cas system of their host. The 
complete genomes of seventeen E. amylovora phages from the Podoviridae and 
Myoviridae families were sequenced and analyzed in this study. The genome of E. 
amylovora phages is composed of double-stranded linear DNA with a length from 45 to 
280 kbp. Bioinformatics analysis shows that Erwinia spp. phages ΦEa10-1, ΦEa10-2, 
ΦEa10-4, ΦEa10-16, ΦEa21-2, ΦEa35-2, ΦEa45-1b, and ΦEa51-7 are 99.9% similar 
to the published Myoviridae phage ΦEa21-4. Phages ΦEa10-6, ΦEa10-7, ΦEa31-3, 
ΦEa35-3, ΦEa35-10 ΦEa46-1-A-1, and ΦEa46-1-A-2 were found to be very similar to 
the E. amylovora Podoviridae phage ΦEa1h that was previously published. In all 
sequenced phages, no protospacers were found to match spacers determined in all E. 
amylovora isolates CRISPR system from this study. Also no anti-CRISPR proteins 
similar to proteins found in P. aeruginosa were detected in the genome of all sequenced 
phages. The genomes of Podoviridae phage ΦEa9-2 and the Myoviridae phage 
ΦEa35-70 were found to be unique when compared to the known phage genomes in 
GenBank.  The genome of ΦEa35-70 is 271,084 bp and it encodes 318 putative 
proteins and one tRNA. Comparative analysis with other Myoviridae genomes suggests 
that ΦEa35-70 is peripherally related to the Phikzlikevirus genus within the Myoviridae 
family. Twenty six percent of the proteins are homologs with Pseudomonas phage ΦKZ. 
The genome of ΦEa9-2 is 75,568 bp in size. The sequence analysis shows that ΦEa9-2 
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is related to coliphage N4 in that their genomes are syntenic and they share 50 protein 
homologs (69% identity). Out of 94 CDSs encoded only 23 CDSs were annotated as 
functional genes encoding structural proteins and proteins involved in nucleic acid 
modification, an indication to distinctiveness characteristics of this phage. The data 
extracted from the sequence of these phages expands our knowledge of Erwinia spp. 
phages and their relation to their bacterial host. 
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Introduction 
 E. amylovora phages were first isolated in the 1960s (Billing, 1960; Hendry et al., 
1967). The characteristics and properties of E. amylovora phages were further 
described in the 1970s (Erskine, 1973; Ritchie, 1978; Ritchie and Klos, 1979). In recent 
years a number of  E. amylovora phages were isolated and sequenced (Born et al., 
2011; Boulé et al., 2011; Gill et al., 2003; Lagonenko et al., 2015; Lehman et al., 2009; 
Müller et al., 2011b; Schnabel and Jones, 2001; Yagubi et al., 2014).  E. amylovora 
phages are tailed, double-stranded DNA bacterial viruses that belong to the order 
Caudovirales (Gill et al., 2003; Lehman, 2007; Meczker et al., 2014; Schnabel and 
Jones, 2001; Yagubi et al., 2014). They are classified into three families: Myoviridae, 
Siphoviridae, and Podoviridae (Gill et al., 2003). Phages belonging to the 
Myoviridae have contractile tail, Siphoviridae have non-contractile tail, and 
the Podoviridae have short tail (Figure 2, Chapter 2). Gill et al. (2003) isolated 42 E. 
amylovora phages mainly from the soil underneath pear and apple trees exhibiting fire 
blight symptoms in southern Ontario, Canada. These phages were classified into 6 
groups based on molecular characterization using PCR, restriction fragment length 
polymorphisms (RFLPs)  and  morphology.   Group 1 phages belonged to the 
Myoviridae, Group 2 to the Siphoviridae and Groups 3 to 6 were members of 
Podoviridae family (Gill et al., 2003). E. amylovora phages have been further studied 
based on host range, RFLPs (Barionovi et al., 2006; Gill, 2000) and genomic sequence 
similarities (Born et al., 2011; Lagonenko et al., 2015; Lehman et al., 2009; Meczker et 
al., 2014; Yagubi et al., 2014).  
  Classification of phages based on plaque morphology, restriction map analysis, 
and transmission electron microscopy has limitations. Using restriction endonuclease 
analysis for phage classification comes with constraints especially in case of phages 
 
   93 
with large genomes and methylated restriction endonuclease sites. Classification of 
phages based on phage morphology does not discriminate phages belong to the same 
family, and plaques formed on E. amylovora LEP hosts are often faint and difficult to 
visualise.  
 Phage genome sequences play a critical role in phage taxonomy and 
classification. Genomic analysis of phages used as biological control agents needs be 
carried out in order to expand the knowledge about their evolution and genetic 
structure. Knowledge of phage genome structure is critical to our understanding of the 
biological relationship between phages and their bacterial hosts, and for phage 
detection in the field based biological control trials. Phage genome sequencing 
enhances our knowledge about the performance of these phages and identification of 
undesirable genes such as toxin encoding genes and lysogeny-associated genes 
and/or genes related to different phage resistance mechanism.   
 The objective of this study is to determine the genome sequence of 17 phages 
from the Myoviridae and the Podoviridae families. These phages were chosen from the 
AAFC Vineland Collection (Table 4), and were selected on the basis of phage family, 
host range and efficacy as biological control agents.  It was important to fully 
characterize all the phage isolates in the collection on the molecular level in order to be 
able to quantify and keep track of individual phages in bioassays and field based 
studies using qPCR protocols (Lehman, 2007). Availability of more information on the 
sequence of phage genomes will help in the detection of protospacers that might match 
spacer sequences in E. amylovora CRISPR arrays determined in this study. 
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Materials and Methods 
Phage isolation and purification 
To obtain a homogenous phage solution which originated from a single plaque, 
phage isolate were serially diluted and plated using the double agar overlay method 
(Adams, 1959). The dilution containing low numbers of similar plaques was used to pick 
off a single plaque using a sterile 1 mL micropipette tips.  The plaque was added to an 
Eppendorf tube that contained 1 mL of sterile NB. The sample was vortexed briefly to 
release phages from agar. To remove bacterial and agar residues, the phage 
suspension was filter-sterilised through a 0.45 µm filter. To ensure a single phage-strain 
population, second and third rounds of phage purification were carried out by repeating 
the above described protocol three times. Real-time PCR using primers and probes 
targeting a specific phage family were used to confirm the purity of the phage solution.   
 
Phage liquid culture  
 Bacterial starter cultures were prepared by inoculating 2 mL of 0.8% NB with a 
loop full of E. amylovora obtained from overnight streaked NA plates. The 2 mL 
inoculated cultures were shaken for 1 h at 150 rpm at 27°C.  Then 25 mL of 0.8% NB 
was inoculated with 0.5 mL of the starter culture and placed on an orbital shaker at 
27°C until the OD600 reached 0.5.  This resulted in a bacterial concentration of 
approximately 108 CFU/mL. The bacterial culture was infected with the desired phage to 
an MOI of 0.1 or 1.0. The culture was further incubated and shaken at 150 rpm for 16 h 
at 27°C. Cell debris were removed by centrifugation at 8000 xg for 25 min at 4°C, the 
supernatant was filtered through 0.2  µm syringe filter and collected into 50 mL dark 
glass tubes. Phage titre was determined by plaque assay and the phage stock was 
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stored at 4°C following the addition of a drop of chloroform to avoid bacterial 
contamination. 
 
Double agar overlay method 
 This method was fully described by Adams (1959). E. amylovora from overnight 
cultures was resuspended in 0.01 M PB; pH 6.8 to give 1 x 108 CFU/mL. Then 100 μL 
of resuspended host was mixed with phage in test tube at MOI of 0.1 or 1. The mixture 
was incubated at RT for 15 min; 4 mL of molten top agar at 55°C was added to the 
phage/host mixture.  Tubes were swirled, and the mixture was poured onto a previously 
prepared plate containing solidified NA. The top agar was allowed to solidify before 
placing the plate in a 27°C incubator for 18 h. Phage plaques were flooded with 5 to 10 
mL of 0.8% NB and the liquid was collected into a centrifuge tube. Bacterial debris and 
agar were removed by centrifugation for 25 min at 8000 xg. The supernatant was 
filtered through 0.45 µm filter and placed into 50 mL dark glass tubes. 
 
Phage concentration by PEG precipitation  
 One hundred milliliters of overnight E. amylovora infected with phage was 
centrifuged at 6000 xg for 20 min at 4°C to remove cell debris. The supernatant was 
filtered using 0.45 µm bottle top filter. To concentrate phage particles, 5.84 g of NaCl 
(Fisher Scientific, Fair Lawn, NJ, USA) was added to 100 mL of culture and swirled at 
RT until the salt was dissolved in order to make a final concentration of 1 M NaCl. 10 g 
PEG 8000 (Fisher Scientific) was added to make a 10% (w/v) final concentration. The 
PEG was dissolved by stirring slowly on a magnetic stir plate at RT. The mixture was 
incubated overnight at 4°C in order to precipitate the phage. To recover the precipitated 
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phage following overnight incubation, the mixture was centrifuged for 15 min at 11,000 
xg. The supernatant was removed and the phage pellet was slowly and gently 
resuspended in 10 mL of SM buffer (50 mM Tris-HCl, pH7.5; 0.1 M NaCl; 8 mM 
MgSO4, pH7.4).  The PEG and NaCl were removed by adding and mixing the phage 
suspension with 2 volumes of chloroform. The mixture was then centrifuged at 5,000 xg, 
for 10 min at 4°C. The upper aqueous layer (containing phage) was transferred to a 
fresh tube, and further extracted with 2 volumes of chloroform. 
 
Phage titre  
Phage titer using plaque assay and real-time PCR methods were described in materials 
and methods in Chapter 3. 
 
Phage DNA extraction  
 Two methods were used to extract phage DNA, extraction and purification using 
the Norgen Phage DNA Isolation Kit (Norgen Biotek Corp.) or using the 
phenol/chloroform. In the phenol/chloroform protocol, 2 mL of concentrated phage 
suspension was first subjected 1 µL of DNase I (Roche) (1mg/mL) and 1 µL of RNase A 
to remove any bacterial genomic DNA and RNA. SDS was then added (0.5% final 
concentration) and proteinase K (5 µg/mL final concentration), followed by incubation 
for 15 min at 65°C. Phage DNA was then extracted by adding an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) saturated with 10 mM Tris, pH 8.0. The 
aqueous layer containing phage DNA was collected after centrifugation at 6000 xg for 5 
min at room temperature. The phage DNA was precipitated by adding 2X volumes of 
95% ethanol and centrifugation for 15 min at 15,000 xg, 4°C. The DNA pellet was air 
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dried and resuspended into TE buffer. The DNA quality and concentration were tested 
on 0.9 % agarose gel, and by using spectrophotometer at OD260 before storing at -20°C. 
 
Phage DNA sequencing analysis and assembly  
 A DNA library was constructed using an Illumina Nextera XL kit with an average 
insert size of 800 bp, and this was sequenced by the McGill University and Genome 
Quebec Innovation Centre (Montreal, Canada) on an Illumina MiSeq. The phage 
genome was assembled using Seqman NGen 3 (DNASTAR, Madison, WI, USA). 
Contigs greater than 1kb were exported, reassembled into a single contig and 
proofread, using Seqman Pro (DNASTAR).  The average coverage for the phage was 
713X.  The final contig was oriented in the same manner as its nearest homolog 
(previously sequenced phages). The genome was autoannotated with MyRAST 
(Overbeek et al., 2014), with final visual analysis in Kodon (Applied Maths, Austin, TX, 
USA) where the annotation was checked for missed coding sequences (CDSs) and 
proper starts sites. tRNA genes were identified using tRNAscan-SE 1.21 (Schattner et 
al., 2005).  To determine the level of relatedness to other phages TBLASTX (e-value 
≤10-5) was used to compare the predicted protein sequences to the genome sequences 
of all other phages in NCBI. Phages sequenced in this study are listed in Table 4. 
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Phage Genome size in bp Family 
φEa10-1 84568 
Myoviridae  
φEa10-2 84575 
φEa10-4 84666 
φEa10-16 85534 
φEa21-2 84685 
φEa35-2 84581 
φEa45-1b 84651 
φEa51-7 84593 
φ Ea35-70 271085 
φEa10-6 45271 
Podoviridae  
φEa10-7 45177 
φEa31-3 45323 
φEa35-3 44739 
φEa35-10 45151 
φEa46-1-A-1 44923 
φEa46-1-A-2 45138 
φEa9-2 75588 
 
Table 4: List of phages sequenced in this study. 
The size of phage genome is shown in bp. Myoviridae phages (white box) are similar to 
E. amylovora phage ΦEa21-4 (Lehman et al., 2009). Podoviridae phages (gray box) are 
similar to E. amylovora phage ΦEa1h (Müller et al., 2011a; Ritchie, 1978; Ritchie and 
Klos, 1977). Phages ΦEa9-2 and ΦEa35-70 have no matches in GenBank. 
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Results and Discussion 
The genomic sequence of 17 phages in this study revealed that 15 of the phages 
have notable relatedness to previously sequenced phages. Phages ΦEa10-1, ΦEa10-2, 
ΦEa10-4, ΦEa10-16, ΦEa21-2, ΦEa35-2, ΦEa45-1b, and ΦEa51-7 belong to 
Myoviridae family, and are similar to ΦEa21-4 (Lehman et al., 2009). All these phages 
were included in Group 1 of Gill’s classification based on RFLPS and Transmission 
electron microscopy (TEM) morphology. On the other hand, Podoviridae phages 
belonging to Gill Group 3A:  ΦEa10-6, ΦEa10-7, ΦEa31-3, ΦEa35-3, ΦEa35-10 
ΦEa46-1-A-1, and ΦEa46-1-A-2 were found to be similar to E. amylovora phage ΦEa1h 
(Müller et al., 2011a; Ritchie, 1978; Ritchie and Klos, 1977). Two phages namely, 
ΦEa9-2 and ΦEa35-70, were shown to contain unique genome sequences and gene 
functions when comparing to sequenced phages in GenBank.  
  
Characteristics and morphological features of ΦEa35-70 and ΦEa9-2 
 Phages ΦEa9-2 and ΦEa35-70  were isolated from soil samples collected under 
infected pear trees in southern Ontario, Canada (Gill et al., 2003). ΦEa9-2 and ΦEa35-
70 are tailed phages with icosahedral heads. TEM revealed that ΦEa35-70 and ΦEa9-2 
to be members of the Myoviridae and Podoviridae families, respectively. ΦEa35-70 is a 
large phage with a head size of approximately 150 nm across; and a long contractile tail 
of approximately 200 nm in length (Figure 20).  
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Figure 20: Electron micrograph of ΦEa35-70 with an icosahedral head and 
extended tail.  
Phage was stained with uranyl acetate before visualizing under electron 
microscope at the integrated microscopy unit in the Biotron, Western University, 
London, Ontario. 
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 Protospacers in ΦEa35-70 and ΦEa9-2   
  One of the main purposes of sequencing this group of E. amylovora phages was 
to detect the presence of protospacers with similarity to spacers determined in the 
CRISPR system of E. amylovora isolates in this study (Chapter 3). Investigating ΦEa35-
70 and ΦEa9-2 genomes revealed that there were no protospacers in these two phages 
genomes that perfectly match spacers found in the CRISPR arrays of E. amylovora 
isolates.  Only 11 spacers from isolate EaG5 and Ea6-4 were found to have 14 to 15 
nucleotide matches (average 48% similarity) to sequences in ΦEa35-70 (Table 5). 
Among all determined spacers in this study, only spacer 29 in CRR1 of Ea6-4 was 
found to have 17 nucleotide match (53% similarity) to sequences in a gene that 
encodes for a hypothetical protein in ΦEa9-2 genome (Table 5).   
 It is not clear if 50% similarity (16 nt out of 32 nt spacer length) between spacers 
and their target in phage DNA is sufficient to cause interference by CRISPR system.  It 
has been shown that the seed sequence of the spacers (6 to 10 nucleotides) is the 
most important region in CRISPR interference (Semenova et al., 2011; Wiedenheft et 
al., 2011a; Wiedenheft et al., 2011b). Mutations in the spacer sequence out of the seed 
sequence didn’t affect crRNA binding to target; however, a single nucleotide mutation 
within seed sequence resulted in failure to bind to target DNA (Semenova et al., 2011). 
It is not confirmed if these sequences found in phage genomes that matched spacer 
sequences are located within seed sequences.  
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Spacer sequence  Host 
CRISPR 
region 
Spacer 
no. 
Phage 
Location on 
phage genome 
Target 
phage gene 
TTATTCATGAGCCTTTTTATCTTCGCGGCATG Ea6-4 1 1 φEa35-70 177033 to 177047 Hp 
AAGATGCTTTGACATTAATTATCTCCATAAAA Ea6-4 1 5 φEa35-70 38341 to 38355 Hp 
AAGATGCTTTGACATTAATTATCTCCATAAAA Ea6-4 1 5 φEa35-70 54602 to 54615 Hp 
AAGATGCTTTGACATTAATTATCTCCATAAAA Ea6-4 1 5 φEa35-70 73984 to 73997 Hp 
CCGCGAAAATCCGCAGTGAGCTGGCAATGAGC Ea6-4 1 29 φEa9-2 63339 to 63357 Hp 
       
GTTGATACGGCTGATTACAATAAAATGTCACT Ea6-4 2 9 φEa35-70 254734 to 254750 
Tail fiber 
protein 
GCTACTACGTGTACGCACAGCCGCTGGCCAGT Ea6-4 2 14 φEa35-70 100839 to 100855 Hp 
CAACTGAGCAACTCCGCTTTGCCCCATACCAA EaG5 2 15 φEa35-70 72650 to 72666 Hp 
CGACTATTCGGCGAACTGAAAGAGCCAACCGT EaG5 2 18 φEa35-70 104335 to 104351 Hp 
GAGAGCAACAACAAACTCCGACCGGAGAAACC EaG5 2 23 φEa35-70 3070 to 3084 Hp 
ACGGTCAGATGGTGGCGCTGGTTGCGCTGGCA EaG5 2 39 φEa35-70 22206 to 22222 Hp 
       
ATCGCACCCCACTGATTGAAGAGCAGCACACT Ea6-4 3 2 φEa35-70 238369 to 238381 Hp 
 
Table 5: Spacers from EaG5 and Ea6-4 with match to sequences in ΦEa35-70 
and ΦEa9-2. 
Sequences within each spacer with similarity to sequences in phages are underlined. 
Mismatches are in bold and not underlined.  CRSIPR regions where the listed spacers 
are located are shown.  The target phage genes by these spacers are shown in the 
most right column; Hp, hypothetical protein.  The location of protospacers on phage 
genomes is shown.  
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General features and annotation of the ΦEa35-70 genome 
The ΦEa35-70 genome is quite different from any other phage in GenBank. The 
complete genome sequence of ΦEa35-70 has been submitted to GenBank and 
assigned accession number KF806589.1. The genome of ΦEa35-70 is 271,084 bp long 
with a G+C content of 49.9%.  To determine the level of relatedness of ΦEa35-70 to 
other phages TBLASTX, with default settings, was used to compare the predicted 
protein sequences to the genome sequences of all other phages in NCBI. Comparative 
analysis with other phage genomes suggests that ΦEa35-70 is related to the 
Phikzlikevirus genus within the Myoviridae since 26% of ΦEa35-70 proteins share 
homology to proteins in Pseudomonas ΦKZ (Mesyanzhinov et al., 2002). 
Bacteriophage ΦKZ has a linear genome and 280,334 bp in size (Mesyanzhinov et al., 
2002). ΦEa35-70 is also peripherally related to Pseudomonas phage phiPA3 (Monson 
et al., 2011) and Erwinia phage PhiEaH1 (Meczker et al., 2014), refer to Tables 6 and 7 
for list of phages with similarity to ΦEa35-70. 
 The genome of ΦEa35-70 contains 318 CDSs of which 284 CDSs were 
annotated as encoding hypothetical proteins. 69% of the hypothetical proteins are 
unique to this phage and have no matches in GenBank. The orientation of genome 
annotation was chosen so that the majority of genes are encoded by plus strand; 302 
CDSs on plus strand and only 16 on minus strand. Only 34 open reading frames 
(ORFs) were annotated as functional genes encoding for proteins involved in nucleic 
acid modification and replication and phage DNA packaging. Most of identified genes in 
ΦEa35-70 were found to be involved in nucleotide metabolism, such as thymidylate 
kinase, dihydrofolate reductase, and diphosphate reductase ribonucleoside.  A putative 
HNH endonuclease which is involved in phage DNA packaging and common in double-
stranded DNA phages was also detected. Interestingly, an EPS-depolymerase gene, 
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involved in EPS degradation, and gene similar to Concanavalin A-like lectin was also 
identified.  The existence of EPS-depolymerase gene in ΦEa35-70 is interesting since 
E. amylovora Myoviridae phages usually lack this gene; the function of the EPS gene 
found in ΦEa35-70 was further investigated in this study in Chapter 4. Many important 
genes such those involved in DNA replication were not identified in ΦEa35-70 genome. 
This might suggest that ΦEa35-70 is evolutionarily distinctive phage and possibly 
sustain unique replication mechanism. Also a holin gene was not detected in the 
genome of ΦEa35-70. Among all genes involved in cells lysis only endolysin was 
identified.    
 There were 15 proteins identified as virion structural and tail proteins based on 
genome sequences, SDS-PAGE electrophoresis and liquid chromatography-tandem 
mass spectrometry (LC/MS/MS) analysis at Centre de Recherche du CHU de Quebec, 
Quebec, Canada. In contrast to ΦKZ genome which encodes six tRNAs, ΦEa35-70 is 
encoding one tRNA despite large genome size. The tRNA is located between ORF 199 
and ORF 200 which encode for proteins with unknown function. The existence of a 
single tRNA suggests that there may be similar codon usage patterns between ΦEa35-
70 and its bacterial hosts.  
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Phage Family 
Head 
dimension 
(nm) 
Tail 
dimension 
(nm) 
genome 
size (Kb) 
GC% Proteins tRNA 
ΦEa35-70 Myoviridae 150 200 27108 49.9 318 1 
Pseudomonas phage 
ΦKZ 
Myoviridae 145 200 280334 37 306 6 
Pseudomonas phage 
phiPA3 
Myoviridae 100 185 309208 47.7 375 5 
 
Table 6: General features of ΦEa35-70, Pseudomonas phage φKZ and 
Pseudomonas phage phiPA3. 
 
Phage 
number of 
shared 
homologs 
percentage 
related proteins 
Reference 
Sequence 
Reference 
Pseudomonas phage EL 76 homologs 23.9% NC_007623.1 (Hertveldt et al., 2005) 
Pseudomonas phage OBP 81 homologs 25.47% NC_016571.1 (Cornelissen et al., 2012b) 
Pseudomonas phage 201phi2-1 78 homologs 25.47% NC_010821.1 (Thomas et al., 2008) 
Pseudomonas phage ΦKZ 84 homologs 26.42% AF399011.1 (Mesyanzhinov et al., 2002) 
Pseudomonas phage phiPA3 84 homologs 26.42% NC_028999.1 (Monson et al., 2011) 
Erwinia phage PhiEaH1 89 homologs 27.99% NC_023610.1 (Meczker et al., 2014) 
 
Table 7: Number of shared homologs and the percentage related proteins to 
ΦEa35-70. 
Generated using CoreGenes 3.0. 
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General features and annotation of the ΦEa9-2 genome 
The genome of ΦEa9-2 is 75,568 bp long with a G+C content of 47% (Figure 
21). The complete genome sequence of E. amylovora phage ΦEa9-2 has been 
submitted to GenBank and assigned accession number KF806588. The ΦEa9-2 
genome contains 94 CDSs of which 71 (75.53%) were annotated as encoding 
hypothetical proteins. Based on gene predictions and annotation of the genome, only 23 
CDSs were annotated as functional genes encoding structural proteins and proteins 
involved in nucleic acid modification and replication. Seventy of the CDSs are located 
on (+) strand and the rest are encoded by (-) strand. Additionally, a single cluster of 
seven tRNA genes was detected in the genome.  Many genes in ΦEa9-2 such as RNA 
polymerase, DNA polymerase, DNA helicase and HNH endonuclease have been found 
to have similarity to ‘N4 like phages’.  Even though at the DNA level ΦEa9-2 and 
Escherichia coli phage N4 only share 19% overall sequence identity, bioinformatics 
analysis shows that ΦEa9-2 is related to Escherichia phage N4 in that their genomes 
are syntenic and they share 50 protein homologs with at least 69% identity. Escherichia 
phage N4, belongs to N4likevirus genus, has a double-stranded DNA genome, and is 
70,153 bp in length. Recently, based on protein homology, Wittmann et al. (2015), 
classified ΦEa9-2 to be a member of subfamily of N4-like phages which tentatively are 
called the ‘‘Enquartavirinae’’ (Wittmann et al., 2015), refer to Figure 22 for genome 
comparison of ΦEa9-2 and other N4-like phages . This subfamily also includes 
coliphage N4 (Ohmori et al., 1988; Schito et al., 1966; Willis et al., 2002), the E. coli 
vB_EcoP_G7C phage the member of ‘‘G7cvirus” (Kulikov et al., 2012) and 
Achromobacter phage JWAlpha (Wittmann et al., 2014). Genomic and morphological 
features of phages related to ΦEa9-2 are included in Table 8.  
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One of the early genes identified in ΦEa9-2 is a large virion-associated RNA 
polymerase (vRNA), 3523 amino acids, which is located on the (-) strand of phage 
genome between gene clusters of unknown function. The existence of large vRNA is a 
common characteristic of N4-like phages (Gan et al., 2013). Phage-associated RNA 
polymerases are known to be involved in in the transcription of late-early genes (Willis 
et al., 2002). ΦEa9-2 also carries a DNA-directed methylase which might be involved in 
protecting phage DNA from restriction modification of the bacterial host. E. amylovora 
phage ΦEa9-2 is the only N4-like phage that possesses a gene for a DNA-directed 
methylase (Wittmann et al., 2015). rIIA and rIIB genes are also predicted in ΦEa9-2 
genome just downstream of thymidylate synthase gene. N4-Like phages are also 
known to possess rIIA and rIIB that are involved in host lysis inhibition during phage 
infection.  Delayed in cell lysis during infection can increase total burst size (Paddison et 
al., 1998).  
Some genes that are involved in DNA replication were also identified in ΦEa9-2. 
Genes such as DNA polymerase, DNA primase, ATP-dependent DNA helicase and 5'-
polynucleotide kinase are found just downstream of rIIA and rIIB genes, a common 
feature of some N4-Like phage genomes.  The identified genes that involved in DNA 
replication were located among other genes of unknown function. However, these 
unidentified genes are expected to be involved in DNA replication as well.   
All of the predicted structural proteins in ΦEa9-2 such as major capsid protein, 
EPS depolymerase and phage tail length tape-measure proteins are located on the 
lower strand at the end of the phage genome. Genes encoding for structural proteins 
are interrupted by a putative holin gene that is involved in cell lysis. 
Seven tRNA genes specific for the codons for Asn (GTT), Asp (GTC), Glu (TTC), 
Ile (GAT), Lys (TTT), Ser (GCT), Tyr (GTA) were predicted in the beginning of the 
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second half of the viral genome. Phage tRNAs play a role in phage genes transcription 
to compensate for the compositional differences between the viral and the bacterial host 
genome (Bailly-Bechet et al., 2007). 
 
 
 
Table 8: Genomic and morphological features of ΦEa9-2 and some of N4-like 
phages. 
 
Phage host 
Head 
dimension 
(nm) 
Tail 
dimension 
(nm) 
genome 
size (Kb) 
GC% Proteins tRNA 
GenBank 
accession 
number 
ΦEa9-2 E. amylovora NA NA 75.57 47 94 7 NC_023579.1 
Escherichia 
phage N4 
E. coli 
70 20 70.15 41.3 72 0 NC_008720.1 
Lit1virus P. aeruginosa 70 30 72.3 54.9 87 0 FN422399 
G7C E. coli 70 25 72.92 43.4 80 0 HQ259105 
S6 E. amylovora 66 - 74.7 41.3 115 0 HQ728266 
JWAlpha Achromobacter 59 22 72.3 54.4 92 0 KF787095 
DFL12phi1 
Dinoroseobacter 
shibae 
- - 75 49.3 86 2 KJ621082 
pCB2047-B Sulfitobacter sp. - - 74.5 42.9 77 13 HQ317387 
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Figure 21: Circular representation of ΦEa9-2 genome. 
The outermost circles in purple represent the CDSs on the plus strand (track 1) and the 
minus strand (track 2). Also tRNA (maroon) is shown on track 1. The second circle from 
outside represents the positions of protein-coding genes as determined by BLASTp. 
The third circle shows GC content (black).  Innermost ring indicates the GC skew, 
minus strand (fuchsia) and positive strand (green). 
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Figure 22: Genome comparison (amino acid level) of ΦEa9-2 and related N4-like 
phages. 
Proposed functional clusters are marked by the same colour. Level of amino acid 
identity range is shown via the gradient scale. The figure was reproduced from 
(Wittmann et al., 2015). 
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Chapter 4 
Characterization of depolymerase from a Myoviridae phage  
Abstract 
 Phages are currently being investigated for their potential use as biological 
control agents (BCAs) for the control of E. amylovora, the fire blight pathogen. The 
ability of phages to kill bacteria may be hindered by the presence of a biofilm which is 
mainly composed of exopolysaccharides (EPS).  Phage EPS-depolymerase enzyme 
degrades amylovoran, an essential bacterial pathogenicity factor, and facilitates phage 
access to the target bacterial host membrane. The genome sequence of the E. 
amylovora Myoviridae phage ΦEa35-70 revealed the presence of an EPS-
depolymerase gene. The existence of depolymerase gene in ΦEa35-70 makes this 
phage a potential candidate for phage mixtures (or cocktails) used for the control of E. 
amylovora. The goal of this study was to characterize the novel EPS-depolymerase 
gene from the Myoviridae phage and compare it to the EPS depolymerase of E. 
amylovora Podoviridae phage ΦEa31-3 (this study).  The Podoviridae phages are 
known to produce depolymerase, and on soft agar overlays their plaques are 
characterised by large clear halos.  In this work, the potential EPS-depolymerase gene 
from ΦEa35-70 was cloned and expressed in E. coli DH5α. When E. coli cells 
harbouring the EPS-depolymerase gene plasmid were plated with a soft agar overlay 
containing E. amylovora cells, a halo was produced around each E. coli bacterial 
colony.  In contrast, purified His-tagged EPS depolymerase from ΦEa35-70 did not 
exhibit EPS-depolymerase activity on purified EPS from P. agglomerans and E. 
amylovora.  Depolymerase from Podoviridae phage ΦEa31-3, which was used as a 
control, degraded the EPS from both bacteria. 
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Introduction 
 E. amylovora capsule is composed of exopolysaccharides (EPS) which serve as 
the primary bacterial pathogenicity factors.  The EPS is the main component of the 
bacterial biofilm which in turn provides the bacterium with protection against 
environmental stresses and host plant defense systems (Leigh and Coplin, 1992). E. 
amylovora EPS is composed primarily of levan and amylovoran (Bellemann et al., 1994; 
Bellemann and Geider, 1992; Bennett and Billing, 1978; Durlu-Ozkaya et al., 2007; Kim 
et al., 2002; Koczan et al., 2011; Ramey et al., 2004). Levan is made of chains of 
fructose molecules (Du and Geider, 2002; Du et al., 2004; Geider et al., 1993; Geier 
and Geider, 1993; Gross et al., 1992; Zhang and Geider, 1997) and amylovoran is a 
polymer of repeating units made of galactose and glucuronic acid (Bellemann et al., 
1994; Bereswill and Geider, 1997; Jumel et al., 1997; Nimtz et al., 1996).   
 On soft agar overlays, Podoviridae phages produce clear plaques with halos with 
E. amylovora host cells that are characterized as high-exopolysaccharide-producing 
(HEP), and turbid plaques with the low-exopolysaccharide-producing (LEP) host cells. 
Myoviridae phages, on the other hand, do not produce halos around plaques with the 
LEP or HEP hosts (Roach et al., 2013).  The production of clear plaques with halos by 
the Podoviridae phages on HEP bacterial host cells is attributed to phage EPS-
depolymerase activity which is not present in most Myoviridae phages  (Bayer et al., 
1979; Born et al., 2014; Lagonenko et al., 2015; Müller et al., 2011a).  
 Roach et al. (2013) used lab generated amylovoran and levan deficient mutants 
to study the role of bacterial EPS in phage infection. Erwinia spp. Podoviridae phages 
have an absolute requirement for the presence of amylovoran (Roach et al., 2011; 
Roach et al., 2013; Roach, 2011; Sjaarda, 2012).  Amylovoran-deficient bacterial 
mutants could not be infected by Podoviridae phages. In contrast, Myoviridae phages 
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could infect the amylovoran deficient mutants (Roach et al., 2013). Levan, on the other 
hand,  may act as a receptor for the Myoviridae phages since levan-deficient E. 
amylovora mutants resulted in reduction of Myoviridae phage titers (Sjaarda, 2012). 
Levan-deficient mutants, however,  showed a 29-119% increase in the amylovoran 
production (Sjaarda, 2012).  Therefore, it was not clear if the reduction in Myoviridae 
phage titers using levan-deficient mutants was due to the lack of levan production or the 
increase in amylovoran production.  Amylovoran may create a physical barrier between 
Myoviridae phages and receptors on the cell surface reducing the probability of their 
binding to the bacterial host. In general, the mechanism by which E. amylovora phages 
penetrate the EPS barrier and infect their bacterial hosts is not fully understood. In fact, 
it is unclear whether E. amylovora EPS plays a role in blocking phage infection, by 
providing a physical barrier between the phage and cell surface receptors (Deveau et 
al., 2002), or enhances infection by providing specific receptors for phage attachment.  
 Certain bacteriophages have evolved to specifically bind and, in some cases, 
degrade EPS structures (Cornelissen et al., 2012a; Deveau et al., 2002; Glonti et al., 
2010; Hsu et al., 2013; Scholl et al., 2005; Stummeyer et al., 2006; Sutherland et al., 
2004). Many of these phages, such as phages that belong to Podoviridae families; 
seem to enhance their ability to overcome the EPS by producing virion-associated 
proteins with EPS-depolymerisation activities (Born et al., 2014; Glonti et al., 2010; Hsu 
et al., 2013; Hughes et al., 1998a; Kim and Geider, 2000; Pelkonen et al., 1992). The 
depolymerases function by destroying the EPS physical integrity allowing the phage to 
gain access to receptors on bacterial cells (Cornelissen et al., 2012a; Hsu et al., 2013; 
Hughes et al., 1998a; Yan et al., 2014). The mechanism(s) by which non-depolymerase 
producing phages break down the cell capsule and access the bacterial cell wall is still 
unknown. Erwinia spp. Podoviridae phages are also known to produce EPS 
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depolymerases which may be involved in promoting phage adsorption (Born et al., 
2014; Kim and Geider, 2000; Vandenbergh et al., 1985). DNA and amino acids 
sequences comparison of EPS depolymerases from different Erwinia spp. Podoviridae 
phages shows major sequence variations (this study, unpublished data). It is not clear if 
these variations dictate differences in structure or mode of action of these proteins.  
 Myoviridae phages from the AAFC Vineland Collection infect E. amylovora HEP 
and LEP isolates, and the orchard epiphyte, Pantoea agglomerans.  The P. 
agglomerans EPS is composed of arabinose, glucose, galactose, and glucuronic acid  
(Dong and Fang, 2000). The ability of these phages to penetrate two structurally 
different EPS molecules and reach the bacterial host without depolymerase activity 
suggests that alternate mechanism may be present in this family. Certain E. coli phages 
are able to recognize and bind to a serotype-specific sugar “K antigen” a specific 
component of the bacterium capsular EPS (Scholl et al., 2005; Stirm, 1968). EPS-
deficient E. coli mutants were shown to be resistant to K antigen-specific phages (Stirm, 
1968).  
Proteins that bind to specific sugars in plants and/or animals are generally called 
“lectins”, and in mammalian viruses, they are termed “hemagglutinins”. Hemagglutinins 
are found in viruses such as influenza, a part of the virion structure, and can bind to a 
pacific receptor on the blood cell (Collier et al., 1991; Naim and Roth, 1993; Simpson 
and Lamb, 1992; Zurcher et al., 1994). Lectins, on the other hand, are a heterogeneous 
group of proteins with diverse molecular structures that have the ability to bind to 
carbohydrates. The presence of lectins, as a part of Myoviridae phages structure, may 
enable phages to bind to the receptors on the EPS and allow the penetration to the host 
cell. However, the existence of these structural proteins in Myoviridae phages has yet to 
be confirmed.    
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 Phage ΦEa35-70 has been classified as a member of the Myoviridae family 
(Yagubi et al., 2014). In contrast to other known Myoviridae phages, ΦEa35-70 
produces clear plaques on E. amylovora HEP. E. amylovora Myoviridae phages 
typically produce hazy plaques on HEP (Roach et al., 2013).  Genomic sequence 
analysis of ΦEa35-70 revealed the presence of a gene, Depol35-70, with sequence 
similarity to EPS-depolymerase genes found in Podoviridae phages.  However, phage  
ΦEa35-70 does not produce plaques with halos (Yagubi et al., 2014)   
 In contrast to the Podoviridae, Myoviridae phages showed high efficacies in 
controlling E. amylovora under field, greenhouse and in pear blossom flower bioassay 
trials (Lehman, 2007). Phage ΦEa35-70 may be a superior candidate for inclusion in 
phage mixtures since it is a Myoviridae phage with potential EPS-depolymerase activity. 
Studies have demonstrated that phages capable of degrading the EPS are highly 
effective in targeting pathogenic bacteria that produce biofilms (Hanlon et al., 2001; 
Hughes et al., 1998b; Tait et al., 2002). The EPS depolymerases act by degrading the 
host biofilm by digesting the EPS and subsequently exposing bacterial cells to phage 
infection. In addition, purified phage EPS-depolymerase proteins were found to target 
and eliminate the colonization of E. amylovora in plants (Kim and Geider, 2000). 
Releasing bacterial cells from biofilm exposes the cells to plant host defence system, 
environmental influences and reduces the spread of the pathogen.  Phages that carry 
depolymerases could be a promising tool to target E. amylovora and other pathogens 
that are resistant to antibiotics due to the presence of EPS.  Bacterial EPS is found to 
play an important role in resistance mechanisms  against antibiotics (Gander and 
Gilbert, 1997).  E. amylovora colonies can grow on NA plates supplemented with 
ampicillin and kanamycin antibiotics; in contrast the bacteria cannot survive in liquid 
cultures supplemented with the same concentration of antibiotics (Yagubi, personal 
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observation). Bacterial cells on a solid surface are perhaps surrounded by a thick layer 
of EPS which might protect them from the antibiotic activity.  
 The objective of this study is to further investigate the role of E. amylovora EPS 
by characterizing the EPS depolymerase protein (Depol35-70) found in Myoviridae 
ΦEa35-70 and to compare the activity to EPS depolymerase (Depol31-3) found in 
Podoviridae phage ΦEa31-3. This work will provide important information in 
understanding of the interaction between phages, phage mixtures and the pathogen E. 
amylovora.  
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Materials and Methods 
Bacterial isolates and phages growth conditions  
Conditions and media used for growing bacteria and propagating phages were 
described in Materials and Methods of Chapter 3. Two phages, ΦEa21-4 (Myoviridae) 
and ΦEa31-3 (Podoviridae), and three bacterial hosts, Ea6-4, Ea29-7 and Pa13-5 
(isolated from pear, Vineland Station) were used in this study. 
 
Depolymerase gene cloning, expression and purification 
 Depol35-70 of ΦEa35-70 and Depol31-3 of ΦEa31-3 cloning and expression 
were carried out using Champion™ pET Directional TOPO® Expression Kits 
(Invitrogen). All target genes were cloned in pET200/D-TOPO® vector (Invitrogen). This 
vector contains the IPTG-inducible T7 promoter for high-level expression and N-
terminal 6x His-tag for protein detection and purification (Figure 23). All genes of 
interest were amplified using primers targeting gene sequences including start and stop 
codons. To clone all genes in the right orientation, all PCR products were amplified by 
adding four bases (CACC) to the forward primer to allow base pairing with the overhang 
sequence, GTGG, in pET200/D-TOPO® vector (Figure 23). The forward PCR primers 
were also designed to place the gene of interest in frame with the N-terminal His-tag 
(list of primers can be found in table 7A in Appendix).   
 PCR Reactions were run using 1 μL of 1x108 PFU/mL of phage suspension as a 
template, 5 units of Pfx50TM polymerase (Invitrogen, USA), and final concentration of 1X 
Pfx50 buffer, 0.4 μM of each primer and 10 mM dNTP Mix. Reactions were run using 
the following amplification conditions: 94°C for 2 min, (94°C for 10 sec, 45°C for 20 sec, 
68°C for 60 sec) x 30 cycles, and a final extension at 68°C for 5 min. 
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 Before ligation of PCR products to the vector, all PCR products were treated with 
FastAP Thermosensitive Alkaline Phosphatase (ThermoFisher Scientific) according to 
the supplier recommendations; 5´ phosphate interferes with cloning into the pET200/D-
TOPO® vector using topoisomerase ligation. The ligation reaction of the PCR products 
and pET200/D-TOPO® vector was then transformed into One Shot® TOP10 Chemically 
Competent E. coli (Invitrogen, USA) as described previously in Chapter 3. Transformed 
cells were then plated on NA plates supplemented with kanamycin and incubated at 
37°C for 16 h.  
 To screen for the correct clones, single colonies were picked using a sterile 
toothpick and placed in a sterile test tube containing 2 mL of LB supplemented with 
kanamycin. The tubes were then incubated in a shaker at 37°C for 16 h at 200 rpm. 
Plasmid DNA isolation was carried out using The Norgen Plasmid DNA MiniPrep kit 
(Norgen Biotek Corp., Thorold, ON Canada). Clones were confirmed with the 
appropriate restriction enzymes and digested DNA was run on an agarose gel. The 
agarose gel was placed in electrophoresis chamber, and covered with TAE buffer (40 M 
Tris, 20 mM acetic acid, 1 mM EDTA; pH 8.0) and run at 90V for 60-90 min. To 
visualize the DNA, the gel was stained with GelRed (Biotium, USA).  DNA fragments 
size was estimated using molecular weight ladders (Norgen Biotek Corp., Thorold, ON 
Canada). Constructed plasmids in this study are listed in Table 9.  
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Figure 23: Cloning site of pET200/D-TOPO®. 
Reproduced from Invitrogen, USA website. pET200/D-TOPO® allows expression of 
recombinant proteins with an N-terminal tag containing the Xpress™ epitope and a 
6xHis-tag. The N-terminal tag also includes an enterokinase recognition site to enable 
removal of the tag after protein purification. The “GTGG” overhang for cloning in the 
right orientation is shown.   
 
 
 
 
Plasmid Cloned gene 
pET-depolH31-3 Depolymerase gene of ΦEa31-3 (Podoviridae) 
pET-depolH35-70 Depolymerase gene of ΦEa35-70 (Myoviridae) 
pET-H26 Tail fiber gene of ΦEa21-4 (Myoviridae) 
 
Table 9: List of plasmids constructed to investigate EPS-depolymerase activities 
of Depol35-70 of ΦEa35-70 and Depol31-3 of ΦEa31-3. 
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Protein Expression 
 In order to express the cloned Depol35-70 and Depol31-3 genes, pET-depolH31-
3 and pET-depolH35-70 plasmids were first transformed into BL21 Star™ (DE3) One 
Shot® Chemically Competent E. coli (Invitrogen, USA). These cells carry the T7 RNA 
polymerase gene under the control of the lacUV5 promoter that can be induced with 
isopropylthio-β-galactoside (IPTG).  Briefly, 10 ng of plasmid DNA was added to one 
vial of BL21 Star E. coli competent cells, and the mixture was incubated on ice for 30 
min. The cells were then heat shocked for 30 sec at 42°C in a water bath. Then cells 
were placed on ice for 2 min.  250 μL of SOC medium was added, and cells were 
incubated on a shaker at 300 rpm for 30 min at 37°C for recovery. After incubation, 100 
μL of the transformed cells were added to 10 mL of LB supplemented with kanamycin 
and incubated in shaker at 37°C overnight. To express target proteins, 500 μL of the 
overnight culture were added to a 10 mL of LB containing kanamycin. Then the cultures 
were incubated with shaking at 37°C until OD600 reached 0.5 in approximately 2 h. IPTG 
was added to 0.5 mM, and the cells were further grown for 4 h at 22°C (22°C and 4 h 
incubation were found to give the highest protein yield). Cells were harvested by 
centrifugation at 8000 xg for 5 min at 4°C, and and the supernatant was aspirated. The 
cells pellets were immediately frozen at -20°C. 
 
Purification of His-tagged proteins 
 All His-tagged proteins in this study were purified using Dynabeads® His-Tag 
Isolation & Pulldown (Invitrogen, USA). Protein purification was carried out according to 
the supplier’s recommendations. In general, the cell pellet from a frozen 10 mL IPTG 
induced culture was thawed and resuspended in 5 mL of binding/wash buffer (100 mM 
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Sodium Phosphate, pH 8.0, 600 mM NaCl, 0.02% Tween®-20). DNase I (Roche) was 
added to avoid a sticky bacterial pellet. Cells were freeze-thawed three times at -80°C 
and 42°C, respectively.  Approximately 4 mg of Dynabeads® was added to each 1 mL 
aliquot of protein sample in a microcentrifuge tube and mixed thoroughly. The tubes 
were incubated on a roller for 5 min at room temperature.  The tubes were then placed 
on a magnet until the supernatant was totally separated from the Dynabeads® then 
supernatant was discarded.  The beads were washed four times by resuspension in 2 
mL of binding/wash buffer followed by discarding the supernatant after placing the tube 
on a magnet for at least 2 min.  To elute the His-tagged proteins, 100 μL of His-Elution 
Buffer (300 mM imidazole, 50 mM sodium phosphate pH 8.0, 300 mM NaCl and 0.01% 
Tween®-2) was added, and the suspension was incubated on a roller for 10 min at room 
temperature. The mixture was placed on a magnet for 8 min and the supernatant 
containing the eluted proteins was transferred to a clean tube. Each purified protein was 
dialyzed using dialysis tubing (MWCO of 6-8 kDa) against 2 changes of 3 L of 
phosphate buffer saline (PBS) at 4°C for 1 h and 6 h, respectively.  All proteins were 
then analysed on a protein polyacrylamide gel to ensure their integrity. 
 
Depol35-70 and Depol31-3 depolymerase activities on EPS 
 Two methods were used to analyze the activities of Depol35-70 and Depol31-3 
depolymerases. 
Agar Overlay  
 In this method E. coli DH5α competent cells (Invitrogen, USA) were transformed 
with pET-depolH31-3, pET-depolH35-70 or pET-H26 plasmids.  One hundred 
microliters (102 CFU/mL) of the three E. coli transformants were prepared and mixed 
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with 100 μL of approximately 108 CFU/mL of EaD7 cells in three separate tubes. Then 3 
mL of molten top agar was added to the cells and poured on plates containing 25 mL of 
solidified NA. Plates were then incubated at 27°C for 48 h. After incubation, plates were 
assessed for the presence of a halo around E. coli colonies due to depolymerase 
activity. The negative control was E. coli carrying pET-H26 plasmid with a putative tail 
fiber protein, a viral protein with no depolymerase activities, from ΦEa21-4.  
 
Incubating Depol35-70 and Depol31-3 proteins with isolated EPS 
 To test depolymerase activity of Depol35-70 and Depol31-3 proteins, 
approximately 100 ng of His-tag purified depolymerase proteins were mixed with 200 ng 
of bacterial EPS. Mixtures were incubated at 27 or 37°C and various pHs (4, 6 and 8) 
for 1 h. PB (pH 6.8) was mixed with 200 ng of EPS as a negative control in all 
experiments. After incubation, samples were mixed with protein loading dye and loaded 
on a polyacrylamide gel. The gel was stained with Alcian blue solution (0.1% Alcian 
blue in 5% acetic acid, 40% ethanol) and incubated for 2 h at RT in the dark. Gels were 
de-stained three times in 100 mL of de-stain solution (40% ethanol and 15% acetic 
acid) for 2 h each time. To ensure the removal of the Alcian blue solution, a final wash 
with de-stain solution was carried out overnight. Gels were then were placed on a 
fluorescent light box for visualization.  
 
E. amylovora and P. agglomerans EPS production and purification 
 EaD7 and Pa13-5 cells were streaked on 150 mm plates containing 23 g/L NA 
(Difco Laboratories)  supplemented with 2.5 g/L sucrose to enhance exopolysaccharide 
production. Plates were incubated at 27°C for 72 h. Cells were suspended in 10 mL of 
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0.01 M PB (pH 6.8). EPS and the cells were separated by centrifugation at 6,000 xg for 
15 min at 4°C. The supernatant was filtered with a 0.45 μm Millipore filter. The collected 
EPS was dialyzed extensively against of 0.01 M PB (pH 6.8) for overnight at 4°C.   The 
amount of EPS was estimated calorimetrically using anthrone reagent method (Scott Jr 
and Melvin, 1953). Anthrone reagent was prepared by dissolving 0.2 g of anthrone 
(Thermo Fisher Scientific, NJ, USA) in 100 mL of 72% sulphuric acid. Glucose solutions 
at concentrations of 25, 50, 100, 150 and 200 mg/L were used as a standard. In this 
procedure, 1 mL of each of the standards or the EPS solution was added to a test tube 
and placed in ice for 10 min. Five milliliters of anthrone reagent were added to each 
sample, and placed in 100°C water bath for 15 min. Samples were then placed on ice.  
The absorbance of samples and standards was measured at 600 nm using a 
spectrophotometer. Various concentrations of glucose were used to prepare a standard 
curve. The standard curve was then used to determine the concentration of EPS in 
samples.  
 
Depolymerase labelling and fluorescence microscopy analysis 
 To test the ability of Depol35-70 and Depol31-3 to bind to EPS, purified Depol35-
70 and Depol31-3 were labelled using Alexa Fluor 350 fluorescent dye (Invitrogen, 
USA) and mixed with EaD7 and analyzed using fluorescence microscope. 
 
Depolymerase labelling  
 Proteins were labelled using the Alexa Fluor 350 Protein Labelling Kit according 
to the supplier’s recommendations (Invitrogen, USA). Briefly, purified protein sample 
(approximately 2 mg in PBS) was added to a vial containing a reactive dye resin and 
 
   124 
was stirred at room temperature for 1 h. The resin was pipetted into the column, 
allowing excess buffer to drain away into a waste beaker. The protein/resin reaction 
mixture was carefully loaded into a column. An elution buffer (PBS, pH 7.2, with 0.2 mM 
sodium azide) was slowly added to the column. The column was occasionally 
illuminated with a handheld UV lamp to observe the labeled protein movement.  The 
labelled protein was collected and stored at 4°C for short-term use or at -20°C for long 
time storage. 
 
Fluorescence microscopy  
 An EaD7 cell pellet from a 500 μL culture was washed twice with 1 mL of 0.01 M 
PB, pH 6.8. The pellet was then mixed with 4 μg of labelled Depol35-70 or Depol31-3 
protein in 500 μL PBS, pH 6.8 and incubated on ice for 10 min. The mixture was 
centrifuged and washed three times with 500 μL PBS, pH 6.8 to remove unbound 
proteins.  A fine fixed smear of cells/protein mix was placed on a microscope slide and 
viewed on a Leica DM2000 LED fluorescent microscope equipped with 346 nm 
absorption and 442 nm emission filters and digital camera. 
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Results 
Sequence Analysis of ΦEa35-70 depolymerase gene Depol35-70 
 The Depol35-70 gene is 1920 bp and encodes 640 amino acids. Blasting of 
Depol35-70 amino acid sequences against sequences in GenBank showed 99% 
identity to recently sequenced Erwinia sp. phages vB_EamM_Simmy50, 
vB_EamM_Special G and vB_EamM_RAY (Table 10), and  54% identity (82% similar) 
to EPS depolymerase of Erwiana Siphoviridae phage PhiEaH1 (Meczker et al., 2014) 
and 28% identity with the putative tail fiber subunit of E. amylovora  ΦEa 21-4 (Lehman 
et al., 2009), and 29% identity the tail spike protein in  E. amylovora phage ΦEa9-2 (this 
study). Interestingly, Depol 35-70 showed 42% identity with the amylovoran 
biosynthesis protein AmsF in Pantoea vagans, 41% identity with AmsF in Pantoea 
ananatis, and 41% identity with AmsF in Pantoea stewartii, Pantoea agglomeran and  
39 % identity with AmsF in E. amylovora (Table 10). Sequence aligmnent of EPS 
depolymerases of ΦEa35-70 and Erwiana Siphoviridae phage PhiEaH1 showed ten 
conserved regions. These regions are mainly located at the C-terminus of these 
proteins (Figure 24). 
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Description Max 
score 
Total 
score 
Query 
cover (%) E value 
Identity 
(%) Accession 
Putative EPS-depolymerase [Erwinia 
phage vB_EamM_Simmy50] 
1321 1321 99% 0 99% ANH51541.1 
Putative depolymerase/tail fiber 
protein [Erwinia phage 
vB_EamM_Special G] 
1319 1319 99% 0 99% ANJ64889.1 
Putative EPS-depolymerase [Erwinia 
phage vB_EamM_RAY] 
1319 1319 99% 0 99% ANH51857.1 
Putative EPS-depolymerase [Erwinia 
phage PhiEaH1] 
686 686 99% 0 54% YP_009010167.1 
Amylovoran biosynthesis protein AmsF 
[Pantoea vagans] 
456 456 89% 2E-148 42% WP_048784190.1 
Amylovoran biosynthesis protein AmsF 
[Pantoea ananatis] 
441 441 91% 1E-142 41% WP_019106526.1 
Amylovoran biosynthesis protein AmsF 
[Pantoea dispersa] 
436 436 91% 5E-141 40% WP_058780357.1 
Amylovoran biosynthesis protein AmsF 
[Pantoea stewartii] 
434 434 91% 5E-140 41% WP_054633476.1 
Amylovoran biosynthesis protein AmsF 
[Pantoea agglomerans] 
433 433 89% 1E-139 41% WP_039391519.1 
Amylovoran biosynthesis protein AmsF 
[Erwinia billingiae] 
425 425 89% 2E-136 42% WP_053144111.1 
Amylovoran biosynthesis protein AmsF 
[Erwinia pyrifoliae] 
414 414 89% 2E-132 40% WP_014538792.1 
Amylovoran biosynthesis protein AmsF 
[Erwinia amylovora] 
411 411 89% 4E-131 39% WP_004162445.1 
 
Table 10: A summary of Depol35-70 protein blast results against phage and 
bacterial proteins in GenBank. 
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ΦEa35-70 1    MSTDVLGQADSLSMFGQVESFEALRKLKPQKEGARISLRGWNKGSCLGGGEFIGHLVTKD  60 
              ++ + L   DS +MFG V+SF  LRKLKP     R++LRGWN GS LGGG+FIG +     
PhiEaH1  50   VTLEKLSAVDSTAMFGSVQSFADLRKLKPTANNVRVNLRGWNNGSDLGGGQFIGRIGVAK  109 
 
ΦEa35-70 61   LKARPDDGGMIA-AGSGFFWERVCSDCGQMNVTHFGALPGATAATDCVPAMTAMLNWSNA  119 
                 + DDGG+IA +G+ ++WER   D   ++VTHFGA+  A   TD +PA+ AM  WS A 
PhiEaH1  110  ASMKKDDGGVIATSGTDWYWERAIGDINTLDVTHFGAV--ADGVTDSLPAVLAMFKWSQA  167 
 
ΦEa35-70 120  NAVGLGIQFPAGTFFASSLKFTKEIGYFRIAGNHIN-FGYFANTVLVSDATENFMLDVAA  178 
              +     IQFPAG FF S  ++  EI  FR+ G   N FGYF  T L SD+ EN +  + A 
PhiEaH1  168  SGGFQAIQFPAGKFFLSQFEYLAEIARFRLNGTATNHFGYFNATTLTSDSNENVLFSLNA  227 
 
ΦEa35-70 179  RRVELANIIFRGVSTTEKPNKKGIFNNIVIGGQYFNMTCVRFEKIGGTCVNLIDTLDTKM  238 
              R VE++  +F G +  +  NKKG + NI+ GGQY  ++ +R+ K+GGTCV+++DTLD+K+ 
PhiEaH1  228  RWVEISGFVFEGRTDIDG-NKKGFYKNIIAGGQYTRISMMRWSKVGGTCVDMLDTLDSKI  286 
 
ΦEa35-70 239  TQWYASQCTGDVIVNKWSDRQAGGWNHTTAVEMTNFNIQKCVGGKVFDMQRCAQSFITNG  298 
               QWYAS CTGDVI   WS R AG W+H TAVE++NFN+Q C GGKV ++ RC QSFI NG 
PhiEaH1  287  DQWYASGCTGDVIKGYWSGRAAGVWDHMTAVELSNFNVQNCRGGKVLNLPRCTQSFIWNG  346 
 
ΦEa35-70 299  WIEHCDDPGDLSNGQWTVNGLSIEDCK-KPLKASYARFIEIQRNLQSGSRIDYSIDPELE  357 
              WIEH D+PGDLSNGQW +NGL+IEDCK  PLK ++AR I  Q  LQSGS + Y +      
PhiEaH1  347  WIEHSDNPGDLSNGQWIINGLNIEDCKMSPLKLTFARIINFQLGLQSGSSVSYDVQDGDV  406 
 
ΦEa35-70 358  EWLSEWERGRLDIANHGIFIDGTLEPGTIMSRNKLSNSSDKAKWFRVGTWYSPSEGDSID  417 
              EWLS+WERG +DI NHGI+IDGT++   + SRNKLSNSSDKAKWF +G +++PSEGD ID 
PhiEaH1  407  EWLSQWERGHVDIDNHGIYIDGTIDAAIVGSRNKLSNSSDKAKWFCLGRFFTPSEGDQID  466 
 
ΦEa35-70 418  INLVGTGNFLSVAPKLDDIDGVRQGGGNTLIRVQLKKDSVGATLEPHGSSPLQAAKIAKV  477 
              IN+VGTGNFLS++  + DID  RQGGGNTLIR Q KK + G +L P GSSP++A       
PhiEaH1  467  INMVGTGNFLSISTTMADIDDTRQGGGNTLIRYQAKKGAAGLSLMPMGSSPIKAVAYTST  526 
 
ΦEa35-70 478  GAGKFVIYAQLKPYTRNVIPVIVATGATHYEAGVSYYFRPAIASMSDEEIAAVPDAVVIA  537 
               AG   +Y QLKPYTRNVIP+I ATG TH+EAGVS Y+RP   +++DEE+AA+ D   +  
PhiEaH1  527  SAGNITLYVQLKPYTRNVIPIITATGLTHFEAGVSVYWRPDRKALTDEEMAAIVDVKPVV  586 
 
ΦEa35-70 538  EQWSLGQMAGVGATNEGNLMLKSKIVNDHLQVQVMVSQAQWAKPELRYIELK   589 
              EQWS+GQ+AG+GAT EG L++KSK+ N HL V+V          +++Y++LK 
PhiEaH1  587  EQWSIGQLAGIGATQEGYLLVKSKVENGHLAVKV--------NGKVQYLQLK   630 
 
Figure 24: Amino acid alignment of Depol35-70 protein with EPS depolymerase 
of PhiEaH1. 
The two proteins shared 54% identiy. Highly conserved regions were found 
between the two proteins are underlined. 
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Testing Depol35-70 and Depol31-3 depolymerase activities on EPS  
 
Top agar overlay method 
 Three different plasmids pET-depolH31-3, pET-depolH35-70 and pET-H26 were 
constructed to test depolymerase activities of Depol35-70 and Depol31-3. Incubation of 
the transformed E. coli with EaD7 on NA plates revealed depolymerase activities for 
Depol35-70 and Depol31-3. A clearance (halo) around the E. coli colonies harbouring 
pET-depolH35-70 that carries Depol35-70 was detected as a result of Depol35-70 
depolymerase activity (Figure 25, B).  A similar, but more distinct, halo was observed 
around the E. coli colonies containing pET-depolH31-3 (Figure 25, A). No halo was 
detected around E. coli colonies that carry pET-H26 (negative control, Figure 25, C). 
Some of the bacterial colonies that exhibited halos around them were picked and 
plasmid DNA was isolated and analysed using restriction enzymes to confirm that they 
carried the correct plasmid.  
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Figure 25: EPS degrading activities of Depol35-70 and Depol31-3 using agar 
overlay method. 
(A) Agar overlay of EaD7 cells mixed with E. coli carrying pET-depolH31-3. (B) Agar 
overlay of EaD7 cells mixed with E. coli carrying pET-depolH35-70. (C) Negative 
control: Agar overlay of EaD7 cells mixed with E. coli carrying pET-H26. (D) Spot test of 
ΦEa31-3 and ΦEa35-70 phages over a lawn of EaD7 cells.  Clearances (halos) around 
E. coli colonies due to depolymerase activities are shown by black arrows. No halos are 
detected around E. coli colonies carrying pET-H26 (C). A halo can be seen around 
ΦEa31-3 phage in the spot test (D); however, no halo was observed with ΦEa35-70 
(D).  
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Exploring purified Depol35-70 and Depol31-3 digestion specificity 
 To test Depol35-70 and Depol31-3 digestion specificity, two different EPSs 
purified from E. amylovora and P. agglomerans were exposed to Depol35-70 and 
Depol31-3.  EPS structure of P. agglomerans is slightly different from E. amylovora 
EPS.  Phage ΦEa35-70 is known to infect and replicate in P. agglomerans; however, 
ΦEa31-3 can only replicate in certain P. agglomerans isolates.  EPS was first isolated 
from P. agglomerans and E. amylovora as described previously.  The isolated EPS from 
all bacterial samples were incubated at 27°C for 1 h with Depol35-70 and Depol31-3. 
Samples were then loaded on SDS-PAGE stained with Alcian Blue to visualize EPS 
digestion. Results showed that Depol35-70 did not degrade EPS isolated from E. 
amylovora or P. agglomerans. On the other hand, Depol31-3 digested both types 
(Figure 26).  
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Figure 26: The digestion of EPS from E. amylovora and P. agglomerans with 
Depol35-70 and Depol31-3. 
SDS-PAGE stained with Alcian Blue shows the digestion of EPS from E. amylovora 
(EaD7) and P. agglomerans (Pa13-5) with Depol35-70 and Depol31-3.  Lane 1 contains 
EPS from P. agglomerans (Pa), and Lane 2 contains EPS of E. amylovora (Ea). Both 
lanes contain only EPS without adding depolymerase. Lane 3 and 4 contain EPS from 
both hosts incubated with DepolH31-3. Clearance in the lanes represented EPS 
degradation. Lanes 5 and 6 contain EPS incubated with DepolH35-70. The intensity of 
EPS at the top of the lane indicated no discernable digestion activity.  
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The effect of temperature on Depol35-70 and Depol31-3 activities 
 Two temperatures were used to test the EPS digestion abilities of the Depol35-
70 and Depol31-3. The digestion incubation was carried out at 27°C and 37°C for 1 h.  
Depol31-3 was able to digest the EPS similarly at 27°C and 37°C.  No digestion activity 
was detected using Depol35-70 at both temperatures (Figure 27).  
 
Figure 27: The digestion of EPS from E. amylovora with Depol35-70 and 
Depol31-3 under different temperatures. 
SDS-PAGE stained with Alcian blue visualizing E. amylovora EPS digestion using 
Depol35-70 and Depol31-3 at 27°C and 37°C. (-) control: EPS incubated with PB, pH 
6.8. The depolymerases used for EPS digestion are shown. The digested EPS by 
Depol31-3 appeared as a smear inside the gel. 
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The effect of pH on Depol35-70 and Depol31-3 activities 
 The effects of three different pHs were tested on the EPS-digestion activities of 
Depol35-70 and Depol31-3. Depol35-70 or Depol31-3 was mixed with E. amylovora 
EPS in three buffers with different pH sets: pH 4, 6, and 8; the mixtures were then 
incubated at 27°C for 1 h before loading on SDS-PAGE. Results showed that Depol35-
70 showed no activity and Depol31-3 degraded the EPS at all pHs.  However, pH 6 and 
8 slightly improved EPS-digestion activities of Depol31-3 compared to pH 4 (Figure 28).  
 
Figure 28: The digestion of EPS from E. amylovora with Depol35-70 and 
Depol31-3 using different pH sets . 
Alcian blue stained SDS-PAGE to investigate the effect of pH on depolymerase 
activities of depol35-70 and depol31-3. Very little EPS is seen at any pH when Depol31-
3 is used due to enzymatic degradation. When Depol35-70 was used, EPS staining 
intensity was indistinguishable from the buffer control, indicating no digestion. (-) control 
is only EPS. The pHs of the digestion reactions are shown. 
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Investigating binding properties of Depol35-70 and Depol31-3 
 The ability of the depolymerases of ΦEa35-70 and ΦEa31-3 to bind to the EPS 
of EaD7 cells was characterized by confocal imaging. The binding of fluorescent-
labeled depolymerases to EaD7 EPS is illustrated in Figure 29. EaD7 was incubated 
with Depol35-70 and Depol31-3 labelled with Alexa Fluor™ 350 and examined under a 
Leica DM2000 fluorescent microscope. It is clearly evident that Depol35-70 cannot bind 
to EaD7 EPS while Depol31-3 can (Figure 29). 
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Figure 29: Fluorescent microscope images of EaD7 mixed with Depol35-70 and 
Depol31-3 fluorescently labelled proteins. 
Images taken from Leica DM2000 Fluorescent Microscope at 40X magnification. (1 and 
2)  Depol35-70 protein mixed with EaD7 cells.  (3 and 4) Depol31-3 mixed with EaD7 
cells. Images 1 and 3 were taking with regular light. Images 2 and 4 (fluorescence). In 
image 4, it seems that Depol31-3 is binding and decorating EaD7 (red arrows). No 
similar observation was detected with Depol35-70 mixed with EaD7. The EPS appears 
like a halo around cells, and is indicated by yellow arrows.  
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Discussion  
 The sequence analyses of Myoviridae ΦEa35-70 genome revealed the existence 
of a potential EPS-depolymerase gene with similar sequences to other EPS 
depolymerases found in Podoviridae phages  (Yagubi et al., 2014). The existence of an 
EPS depolymerase in E. amylovora phages is novel in that there is a single report of an 
E. amylovora Myoviridae phage in GenBank with potential EPS depolymerase is 
phiEa2809 (Lagonenko et al., 2015). In this study, the EPS depolymerases of ΦEa35-
70 (Yagubi et al., 2014), a Myoviridae phage with a genome size of 271 kbp, was 
characterized in comparison to EPS depolymerase of ΦEa31-3 (Podoviridae), genome 
size of 45 kbp (this study). The size of the potential depolymerase gene (Depol35-70) in 
ΦEa35-70 is 1961 bp. Depol35-70 showed a 52% identity to Erwinia Siphoviridae 
phage ΦPhiEaH1 EPS depolymerase (Meczker et al., 2014) (Figure 24). Amino acid 
sequences alignment of Depol35-70 and EPS depolymerase found in ΦPhiEaH1 
showed conserved sequences at the C-terminus (Figure 24). It has been shown that the 
C-terminus of some Podoviridae phages EPS depolymerase is responsible for 
degrading EPS (Born et al., 2014). This suggests that the C-terminus of Depol35-70 
may also be responsible for EPS depolymerase activity. Depol35-70 might also have 
sugar binding abiltiy since this protein showed a 42% and 41% identity with the 
amylovoran biosynthesis protein AmsF in P. vegans, P. ananasis, P. agglomeran and  
E. amylovora, respectively.  AmsF is known to be involved in building up repeating units 
of the amylovoran and having significant homology to viral EPS depoymerases (Geider, 
2000). Langlotz et al. (2011) showed that Ams F protein is involved in processing the 
newly formed EPS repating units and/or polymerization of the new amylovoran chain 
(Langlotz et al., 2011). 
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 Phage EPS depolymerases may be structural viral proteins or soluble proteins 
expressed during phage infection (Drulis-Kawa et al., 2015; Pires et al., 2016; 
Stummeyer et al., 2006). This study confirmed that the Depol35-70 is expressed as part 
of the viral particle structural proteins since it was associated with other phage ΦEa35-
70 structural proteins (Yagubi, unpublished data). Also, sequences analyses of ΦEa35-
70 genome revealed that Depol35-70 is positioned in the vicinity of other phage 
structural proteins. The location of Depol35-70 protein on the phage particle was not 
explored in this study. The sequence  similarity of Depol35-70 to the tail fiber subunit 
found in ΦEa 21-4 and the tail spike protein in ΦEa9-2 might indicate that Depol35-70 is 
a part of tail structure of ΦEa35-70. In other Podoviridae phages, EPS depolymerases 
were found on the phage tail (Born et al., 2014; Luna et al., 2013; Ritz et al., 2013).  
 The depolymerase activity of Depol35-70 was further confirmed when E. coli 
DH5α harbouring a plasmid carried Depol35-70 gene produced a halo when plated with 
EaD7 cells (Figure 25). A similar halo was produced by in the control when E. coli DH5α 
harbouring a plasmid carried Depol31-3. No halo was observed in the negative control 
which consisted of E. coli DH5α sheltering a plasmid with a phage protein with no 
depolymerase activity (Figure 25).  
 To further investigate both Depol31-3 and Depol35-70 proteins, the coding genes 
of these proteins were cloned in plasmids next to His-tag sequences near the protein N-
terminus.  The fusion of these genes to a His-tag facilitated purification of the proteins. 
The EPS-depolymerase activities of His-tagged proteins were investigated using 
different EPS digestion conditions such as temperature and pH to determine the optimal 
conditions for EPS digestion.  Depol35-70 did not exhibit any EPS-digestion activities 
with EPS isolated from E. amylovora and P. agglomerans regardless of using various 
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pHs and incubation temperatures (Figures 26, 27, 28). The lack of depolymerase 
activity of the His-tagged Depol35-70 may be attributed to the His-tag interference with 
the overall folding of the protein. Adding the tag to C-terminus instead of N-terminus of 
Depol35-70 was not an option since the C-terminus is expected to be responsible for 
depolymerase activity according to Born et al. (2014). Depol31-3, on the other hand, 
was shown to be a versatile enzyme since it digested both EPSs from E. amylovora and 
P. agglomerans.  The ability of Depol31-3 to digest E. amylovora and P. agglomerans 
EPS is interesting. Usually EPS degrading enzymes are made specifically to recognize 
certain EPS structures (Pires et al., 2016). These EPS degrading enzymes might not 
recognise the diversity of EPS structures that are made by different bacteria (Azeredo 
and Sutherland, 2008). Depol31-3 was also able to digest EPS at 37°C and 27°C, and 
at different pH sets (Figures 26, 27, 28). However, pH 8 seemed to be optimum for 
Depol31-3 depolymerase activities.  Maximal activity of the purified protein from E. 
amylovora bacteriophage ΦEa1h, a Podoviridae,  was observed between pH 4 and 5 at 
52°C (Kim and Geider, 2000). Depolymerase protein found in E. amylovora Podoviridae 
phage L1 has been demonstrated to have optimal activity at 50°C, and at a pH 6.0 
(Born et al., 2014). The temperature of 50°C was not investigated in this study since it is 
irrelevant in using phages in biological control.  
 Since Depol35-70 did not show depolymerase activity, EPS-binding abilities of 
Depol35-70 and depol31-3 proteins, as a control, were investigated.  The His-tagged 
purified Depol31-3 and Depol35-70 proteins were labeled using Alexa Fluor 350 
fluorescent dye (Invitrogen, USA). The labeled depolymerases were mixed with EaD7 
cells and viewed under a fluorescent microscope. In case of Depol31-3, EaD7 cells 
were found to be decorated with fluorescence an indication of protein binding to the 
EPS. No fluorescent cells were observed with Depol35-70 (Figure 29). Instead, the 
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Depol35-70 formed aggregations which were observed under the fluorescent 
microscope. It is not clear that the aggregation of Depol35-70 was a result of proteins 
interaction or improper folding of Depol35-70.  Increasing salt (NaCl or MgCl2) 
concentration or adding glycerol and EtOH might help prevent aggregation. However, 
this was not tested in this experiment. 
 A host range study of selected E. amylovora phages was carried out against a 
total of 30 P. agglomerans and 100 E. amylovora bacterial isolates from worldwide (S. 
Gayder, PhD thesis). Phages included in that study: ΦEa10-1, ΦEa10-2, ΦEa21-4, 
ΦEa45-1b and ΦEa35-70, which belong to Myoviridae family, and ΦEa10-7, ΦEa31-3, 
ΦEa46-1-A-1, ΦEa46-1-A-2, and ΦEa9-2, which belong to Podoviridae family. The 
genome sequence of these phages was determined in this study. The data from the 
host range study was used to investigate the effect of Depol35-70 on ΦEa35-70 
infectivity in comparing to other phages including ΦEa31-3 that carries Depol31-3. 
When E. amylovora was used as a host, ΦEa35-70 generally didn’t grow well in all 
hosts. However, it preferred HEP over LEP by producing higher titers of up to 2 logs 
units on the HEP.  Myoviridae phages, which do not carrying EPS depolymerase, 
replicated more efficiently than ΦEa35-70 by 3 to 4 logs in all host including HEP and 
LEP. Podoviridae phages, carry EPS depolymerase, did extremely well in HEP and 
much less by up to 3 logs in LEP due to EPS depolymerase activates. These results 
may indicate that Depol35-70 is enhancing ΦEa35-70 infectivity in E. amylovora 
isolates that produce high levels of EPS. 
 The host range pattern for the same phages in P. agglomerans was very 
different from E. amylovora. ΦEa35-70 replicated more efficiently in all P. agglomerans 
isolates when compared to other phages, especially Podoviridae phages which 
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replicated very poorly in all isolates. The ability of ΦEa35-70 to achieve a higher titre in 
P. agglomerans compared to other phages may indicate that ΦEa35-70 is a Pantoea 
phage. As a result, using ΦEa35-70 as a biological control agent against E. amylovora 
might not be effective since it prefers P. agglomerans over the pathogen E. amylovora. 
This would mean that when the phage is delivered inside P. agglomerans (carrier) as 
part of a BCA for fire blight control, the phage would kill the epiphyte rather than the 
pathogen on the flower stigma resulting in failed efficacy under field conditions. 
 In conclusion, the sequence analysis of EPS-depolymerase gene Depol35-70 
from ΦEa35-70 showed high similarity to genes in three phages, low similarity to other 
EPS depolymerases found in other E. amylovora Podoviridae phages and to the Ams F 
protein from P. vegans, P. ananatis and E. amylovora. When this protein was cloned in 
a plasmid and expressed in E. coli, it exhibited depolymerase activities by degrading 
EPS of E. amylovora. However, when this protein was expressed using an expression 
vector and purified using His-tag column, no depolymerase activities were detected 
under various EPS digestion conditions. It is not understood why Depo35-70 protein 
was not biologically active after His-tag purification despite it being purified under native 
conditions and eluted using a mild buffer. Also it is not clear if the His-tag of the protein 
might have had a negative effect on the protein folding and activity. Depol3-31 of the 
Podoviridae phage ΦEa31-3, which was used as a control, is found to be a versatile 
protein that can efficiently degrade EPS isolated from P. agglomerans and E. amylovora 
at 27°C at 37°C and a range of pH. 
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General Discussion 
 Lytic phages are currently being developed as biopesticides for the control of the 
fire blight pathogen. In order to develop an effective phage-based biopesticide against 
E. amylovora, the resistance mechanisms of the bacterial host against phages need to 
be explored and understood.  The role of CRISPR/Cas systems, an acquired resistance 
mechanism, of E. amylovora in phage resistance has not been investigated. All the 
previous studies on E. amylovora CRISPR/Cas system have concentrated on the 
exploration of CRISPR/Cas system structure and diversity and CRISPR array spacers 
origin (McGhee and Sundin, 2012; Rezzonico et al., 2011). To date, resistance 
mechanism(s) to phages have not been identified in this pathogen.  
 The role of E. amylovora CRISPR/Cas system in response to phage invasion 
and plasmids transformation were explored in this thesis.   Previous research 
demonstrated  that the level of expression of Cas genes was increased during viral 
infection in S. thermophilus (Young et al., 2012) and Thermus thermophilus (Agari et al., 
2010).  The CRISPR/Cas system of E. amylovora was anticipated to respond in a 
similar manner to phage invasion. In this study, the level of expression of innate Cas 
genes of E. amylovora did not react to phage infection when challenged with phages 
from the Myoviridae and Podoviridae families. This is an indication that E. amylovora 
CRISPR/Cas system may not be effective in the recognition of invading phages. Only a 
minor increase was observed in the expression level of Cas genes in the beginning of 
Podoviridae phages infection with EaD7, an isolate that produces high levels of EPS. 
The genomes of Podoviridae phages sequenced in this study showed no protospacers 
match spacers in CRISPR arrays of bacterial isolates used in this project. Therefore, 
the initial response of bacterial isolate EaD7 CRISPR/Cas system in the start of 
Podoviridae phages infection could be attributed to the ability of phages form the 
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Podoviridae family to degrade the EPS structure. Dissolving the EPS capsule, in turn, 
might create a stress on the bacterial host stimulating the bacteria defence 
mechanisms.   
 The tactic used by of E. amylovora phages to avoid the host CRISPR/Cas 
system might be credited to an unidentified anti-CRISPR function used by the Erwinia 
spp. phages. Anti-CRISPR genes have been identified in P. aeruginosa phages (Bondy-
Denomy et al., 2013; Pawluk et al., 2014).  The anti-CRISPR proteins of P. aeruginosa 
phages did not affect the expression level of Cas genes during infection, but prevented 
CRIPSR/Cas system of the host from recognizing phages during CRISPR interference 
step (Bondy-Denomy et al., 2013; Pawluk et al., 2014). It is possible that E. amylovora 
phages are equipped with similar anti-CRISPR genes. To investigate this further, 17 
Erwinia spp. phages belonging to Myoviridae and Podoviridae families were sequenced 
and analyzed.  None of the phages were found to carry comparable anti-CRISPR 
genes. None the less, Erwinia phages might harbour anti-CRISPR genes with 
distinctive sequences that differ from the anti-CRISPR genes of P. aeruginosa phages. 
Alternative, E. amylovora phages may lack anti-CRISPR genes and use different 
mechanisms to avoid CRISPR/Cas system recognition. 
 The alternative mode of action of the CRISPR/Cas system was explored based 
on the infection of E. coli K12 by phages.  In this system, CRISPR/Cas provided 
resistance against λ phage when Cas genes were overexpressed using a plasmid that 
carried Cas genes (Brouns et al., 2008). Increasing in Cas level of expression also led 
to adding new phage derived spacers to CRISPR  arrays of E. coli K12 (Datsenko et al., 
2012). In this study, a  plasmid which carried an artificial CRISPR/Cas system and three 
spaces targeting sequences in phage ΦEa21-4 was introduced into E. amylovora 
isolate Ea6-4. In contrast to the E. coli K12 results, this study showed that improving 
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Cas genes level of expression in E. amylovora did not prevent normal phage infection 
and replication, and did not enhance the gaining of new spacers from invading phages.  
 The CRISPR/Cas system of E. amylovora did not prevent phage infection; 
however, it appears to be functional.  The existence of intact CRISPR/Cas system, 
conservation of Cas gene sequences, and existence of various spacers indicate that 
this system is evolutionarily selected to serve specific functions.   This study 
demonstrated that E. amylovora CRISPR/Cas system was capable in blocking plasmid 
DNA transformation especially with plasmids carried protospacers targeting CRR1 and 
CRR2. The apparent increase in the accumulation of crRNA in the isolates transformed 
with plasmids carried an artificial CRISPR/Cas system comparing to wild type isolate. 
The increase of crRNA accumulation may be a result of the increase in the intercellular 
concentration of Cas proteins expressed by the artificial CRISPR/Cas system.  The 
overexpression of CasE (Cse3) in E. coli was shown to increase in the accumulation of 
crRNA (Pougach et al., 2010). 
 Spacer sequences in E. amylovora CRISPR arrays have been examined in 
bacterial isolates in this study and other worldwide isolates (McGhee and Sundin, 2012; 
Rezzonico et al., 2011). No protospacers were found in already sequenced E. 
amylovora phages that match spacers detected in the CRISPR arrays of all bacterial 
isolates. However, a limited number of fully sequenced phages are available in 
GenBank.  Availability of larger number of phage genomes will significantly contribute to 
the further understanding of the CRISPR/Cas system and other bacterial phage 
resistance mechanisms.  In this thesis, the genomes of 17 E. amylovora phages from 
the Podoviridae and Myoviridae families were sequenced and annotated. None of the 
sequenced phages were found to harbour protospacers with a perfect match to spacers 
detected in E. amylovora CRISPR/Cas system. It is important to note, that all of these 
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phages were originally isolated and enriched on 6 wild type isolates of E. amylovora 
obtained from southern Ontario. Therefore, phages carried protospacers match existing 
spacers in E. amylovora may be excluded during the isolation step from environmental 
samples due to CRISPR/Cas system. 
  This thesis progressed the understanding of the CRISPR/Cas system in E. 
amylovora; however, more questions needed to be answered. For example, how the 
existing spacers in E. amylovora CRISPR arrays were gained, and what motivates the 
gaining of new spacers. Future work on anti-CRISPR genes in E. amylovora may 
explain what the mechanisms allow the phages to escape CRISPR/Cas systems of E. 
amylovora.  
   The 17 phages studied in this project demonstrated distinct host range and 
replication efficiency (Steven Gayder unpublished data). Genomic analyses of 15 of 
these phages revealed that they share 99.9% similarity with existing phages in 
GenBank.  E. amylovora phages ΦEa10-1, ΦEa10-2, ΦEa10-4, ΦEa10-16, ΦEa21-2, 
ΦEa35-2, ΦEa45-1b, and ΦEa51-7 belong to Myoviridae family, and are similar to E. 
amylovora ΦEa21-4 (Lehman et al., 2009). Phages ΦEa10-6, ΦEa10-7, ΦEa31-3, 
ΦEa35-3, ΦEa35-10 ΦEa46-1-A-1, and ΦEa46-1-A-2 were found to be similar to 
Podoviridae phage ΦEa1h (Müller et al., 2011a). It is interesting to note that phage 
ΦEa1h was originally isolated in Michigan, US (Ritchie, 1978; Ritchie and Klos, 1977).  
The reason that phages belonging to the same family share 99.9% sequence similarity 
despite their apparent host range difference is not clear.  A closer look at the phage 
genomes revealed rearrangement in the location of some genes. However, this 
rearrangement could be due errors in the assembly process of phage genomes. The 
actuality of genes rearrangement has to be confirmed further using different molecular 
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biological techniques. The construction of phage genomic library and sequencing 
analysis of the cloned fragments could be useful in the validation of genes location in 
the genome.  
 Among all sequenced phages, only the Podoviridae phage ΦEa9-2 and the 
Myoviridae phage ΦEa35-70 genomes were found to be different when compared to 
other phages in GenBank.  ΦEa9-2 genome is 75,568 bp, and found to be is related to 
coliphage N4 since they share 50 protein homologs (69% identity). ΦEa9-2 can infect 
E. amylovora (pathogen) and P. agglomerans (phage carrier), unpublished data. The 
distinctive sequence of ΦEa9-2 and its ability to infect both the pathogen and carrier 
potentially makes this phage a good biopesticide candidate. Phages with unique 
sequences are easier to be detected and monitored in the field when they applied.  
 ΦEa35-70 genome, on the other hand, is 271,084 bp and it encodes 318 
putative proteins and one tRNA. ΦEa35-70 shares 26% protein homologs with 
Pseudomonas phage ΦKZ, and is related to the Phikzlikevirus genus within the 
Myoviridae family. An EPS-depolymerase gene was detected in the genome of the 
Myoviridae phage ΦEa35-70. The EPS-depolymerase gene of the ΦEa35-70 was 
characterized in comparison to the EPS depolymerase of E. amylovora Podoviridae 
phage ΦEa31-3 (this study). ΦEa35-70 EPS depolymerase degraded the EPS structure 
of EaD7 when it was cloned and expressed form E. coli cells.  However, when the EPS-
depolymerase protein was His-tag purified, no EPS depolymerase activity was 
detected.  In a host range study carried by Steven Gayder (PhD Candidate, Brock 
University), ΦEa35-70 infectivity in E. amylovora producing high EPS is higher than in 
low EPS producers. An indication that the EPS depolymerase might play a role in 
helping the phage to penetrate the EPS capsule of the host. Myoviridae phages were 
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shown to do well in field trails to control E. amylovora (Lehman, 2007). Myoviridae 
phages that carry EPS-depolymerase gene could be a promising tool in eliminating E. 
amylovora. The EPS depolymerases degrades the host biofilm by digesting the EPS 
exposing of the pathogen allowing phage infection and plant host defence system 
recognition.  Despite the characterization of the EPS depolymerase of ΦEa35-70, 
further confirmation of its ability to degrade EPS structure and enhance phage infectivity 
have to be explored. Furthermore, ΦEa35-70 efficacy to control E. amylovora has to be 
investigated.  
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Appendix 
Table 1A: Primers used to amplify and sequence CRR1, CRR2 and CRR3 of E. 
amylovora isolates in this study.   
Primer Sequence Function 
CR11Fr 
CR12Rev 
5' ACCGGAGTGCGTAATATGAG 3' 
5' GAATAGCAGGGCCATTAACC 3' 
Amplify CRISPR region 2 of Ea110R, 
Ea6-4, Ea17-1-1, EaG5, EaD7, 
BC1280, BC29 and Ea4-96 
CR21Fr 
CR22Rev 
5’AAACTGACGTGCCGTATCTG 3’ 
5’ TCCTGACGTAACGTGGATAG 3’ 
Amplify CRISPR region 1 of Ea110R, 
Ea6-4, Ea17-1-1 and  EaD7 
CR1Ea110F 
CR1 Ea110R 
5’ GCAGCGTGACAGTTATGGAG 3’ 
5’ ACACCCGTAAGCAGCCTACC 3’ 
Amplify CRISPR region 1 of Ea110R 
CR1-480 
CR1-850   
CR1-1201 
CR1-1953 
CR1 EA110R   
5’ CGGAGATGCACTGGATATAC 3’ 
5’ ACCATCGCCGCGATAAATCC 3’ 
5’ GGGATAAACCGCAGATGAGG 3’ 
5’ AAATCAGTGGCGGCGAAACC 3’  
5’ ACACCCGTAAGCAGCCTACC 3’ 
Sequence CRISPR region 2 of Ea110R, 
Ea6-4, Ea17-1-1 and  EaD7 
CR1-609 
CR1-973 
CR1-1351 
CR1-1842 
CR1-2155 
CR1 EA110F 
5’ CGAGCATCTCGGGAACTGTG 3’  
5’ ACCGCAGGTATTTCGGATAG 3’ 
5’ CGGAAATGTCGGCGGAGATG 3’ 
5’ GGCTTTGCGTTGTTACTCAG 3’ 
5’ ATTGCCACCAGATGTGTTCC 3’ 
5’ GCAGCGTGACAGTTATGGAG 3’ 
Sequence CRISPR region 1 of Ea110R, 
Ea6-4, Ea17-1-1 and  EaD7 
CR1-1700 
CR1 Ea110R   
CR1-1201 
CR1-850   
CR1-1201 
CR1-1953 
CR1 Ea110R 
CR1EAG5FR 
CR1EAG5REV 
5’ GTTCGCATACGACAATCTCC 3’ 
5’ ACACCCGTAAGCAGCCTACC 3’ 
5’ GGGATAAACCGCAGATGAGG 3’ 
5’ ACCATCGCCGCGATAAATCC 3’ 
5’ GGGATAAACCGCAGATGAGG 3’ 
5’ AAATCAGTGGCGGCGAAACC 3’  
5’ ACACCCGTAAGCAGCCTACC 3’ 
5’ AGTCGAGAACGTGCCTTATG 3’ 
5’ TTCGGCTGAGGCTTGCTTTG 3’ 
Sequence CRISPR region 2 of EaG5 
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G5LaRev 
G5LaFr 
5’ CCGGTCGGAGTTTGTTGTTG 3’ 
5’ AACCGCAACTGAGCAACTCC 3’ 
BC292Fr 
BC292Rev 
BC293Fr 
CR1-1700 
CR1-1953 
CR1-1201 
5’ GATAAACCGCCATTCCCGAG 3’ 
5’ TCGCCGCCACTGATTTGAGC 3’ 
5’ AAACCGTAACCGCAACCATC 3 
5’ GTTCGCATACGACAATCTCC 3’ 
5’ AAATCAGTGGCGGCGAAACC 3’ 
5’ GGGATAAACCGCAGATGAGG 3’ 
Sequence CRISPR region 2 of BC29 
and BC1280 
Ea4-962Fr 
Ea4-962Rev 
5’ TCGCCAAGGTAGTCATCGTG 3’ 
5’ TAACGGGTGTCGTAGTGATG 3’ 
 Sequence CRISPR region 2 Ea4-96 
CR3F 
CR3R 
5' AGACTGGCGTTATAGGATGG 3' 
5' AGCCCGTGAAGCAAAGTATG 3' 
Amplify and sequence RISPR region 3 
 
 
Table 2A:  Primers used to amplify and clone Cas genes of EaD7 isolate.   
Bolded-underlined letters indicate overhangs to introduce specific restriction sites for 
cloning purposes. 
 
 
 
 
 
 
 
 
Primer Sequence Function 
Cas1Cas2F 
Cas1Cas2R 
5’ CCGGAGGCTTTATGTCGTTTG 3’ 
5’ GGTTTGCATGTCAGACGGGA 3’ 
Sequence 
Cas1 and 
Cas2 
Cas12ekxF 
 
Cas12bR 
5’ GGGCGGCCGCGTGGTACCGACATCTCGAGCCGGAGGC 
TTTATGTCGTTTG 3’ 
5’ GGCGTCTCAAACGCGGTTTGCATGTCAGACGGGA 3’ 
Amplify and 
clone Cas1 
and Cas2  
Cas3kaaF 
 
Cas3xR 
5’CGTGGTACCGGGCCCGTACGGGCGCGCCCGTAAAGGGA 
GCTTATGAATTCGC 3’ 
5’ CGGCTCGAGCCAGTCATCGGTCAATAAATTCATC  3’ 
Amplify and 
clone  Cas3 
CasgF2 
CasgR 
5’ GATGGTACCTGGATGGTCAGCAGCTGG 3’  
5’ ATCTTGGGCCCCCATCCAGCACATCGATTTGC 3’ 
Amplify and 
clone Cas 
genes 
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Table 3A:  Primers used to sequence a Cas genes of EaD7 and Ea6-4 isolates.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer Sequence (5’-3’) Function 
Casg1 
Casg2 
Casg3 
Casg4 
Casg5 
Casg6 
Casg7 
Casg8 
Casg9 
Casg10 
Casg11 
Casg12 
Casg13 
Casg14 
Casg15 
Casg16 
Cas1 
Cas2 
Cas3 
Cas4 
Cas5 
Cas6 
Cas7 
TTTGACAGCGAACACGGCAGGG 
CGCATGCCAGCAAATCACCT 
AGCTGCTGGTCGGGTTAACC 
AGG AAGAGGTGATTGCCGGC 
GCA ACAGGTCAATAAACAGCAG 
GAA AAGGTTGATGCCCCGTA 
TTACAGCTGGATCCGGGGAGCAAG 
AGGTGTACTGGCCCGGTTTC 
AGCATGCGCACCATCCATCT 
AATCCCCGGTGCCAAACAGC 
CGAGGGATAACAATGACCGA 
TGACACGATCCTCACCTGGC 
CCGTTAATCCACCTACCACG 
TAACGCAGTTTGCCCTGTCGCC 
CTGGTTAACGGTATCGGACC 
ATAATGCGGTGGATGTGGCG 
CGCTGCCGCTAAAAGATCGC 
GATGGTGAGAAGATCTCAGGCAGA 
TGGAGCAGTGAGGAGACCTTCTG 
CGCGCTTTAATCCGGCTTTT 
TTATCCGCTGGTCACCTGGC 
GGATGTCGATTTCGACTGGCTG 
AACGATCATGCCGTACGCGC 
Sequence Cas 
genes  
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Table 4A:  Primers and probes used in this study to monitor the level of expression of 
Cas1, Cas3, CrRNA and house-keeping genes in E. amylovora. Probes are in bold. 
Fluorophores are attached to the 5' end of the probe and a quencher to the 3' end. 
Primer/Probe Sequence Function 
Cas1ExF2  
Cas1ExP3 
 
Cas1ExR 
5’ GATATGCACCCGCTATTGGT 3’  
/ROXN/TAAACAAATGACAGCGGCTTGC 
CAC/IABRQSp/ 
5’ GCTTGCCCAGTATTCTTCCA 3’ 
Monitor Cas1 
expression 
groELExF 
groELExP 
groELExR 
5’ ATGAACCCAATGGACCTGAA 3’ 
/HEX/CGGTATCGACAAAGCAGTCA/IABkFQ/  
5’ CACACCTTCTTTGCCCACTT 3’ 
Monitor 
groEL 
expression 
recA FWD 
recA PRB  
recA REV  
5’ GGGACGCTGCTGATCTTTAT 3’ 
/FAM/TGATGTTCG/ZEN/GTAACCCGGAAACCA/IABkFQ/ 
5’ CGATACGGCGAATATCCAGAC 3’ 
Monitor 
RecA 
expression 
CrRNA R1 FWD  
CrRNA R1 PRB 
CrRNA R1 REV 
5’ GGGATAAACCGTGAAG 3’  
/ROXN/ AGCCAGAATCCCATCCG/IBHQ_2/ 
5’ GGGAACACGATAAAGG 3’ 
Monitor 
region 1 
CrRNA  
expression 
CrRNA R2 FWD  
CrRNA R2 PRB 
CrRNA R2 REV 
 5’ GGGATAAACCGGATGG 3’ 
/ROXN/CGTACCGATGTTTGCGAA/IBHQ_2/ 
5’ GGAACACGCGAATCT 3’ 
Monitor 
region 2 
CrRNA 
expression 
Cas3GD FWD  
Cas3GD PRB 
Cas3GD REV  
5’ CCGTGGGATCACGGTAAAG 3’ 
/ROXN/CCGTTTGCTATGCGGTGGTTCATC/IBHQ_2/ 
5’ ATACTCACGCACCACATAGC 3’ 
Monitor Cas3 
expression 
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Table 5A:  Primers used to detect spacer acquisition in CRR1, CRR2 and CRR3 of E. 
amylovora.   
Primer Sequence Function 
CR1AcqF 
CR1AcqR 
5’ CGTGCGTGCTTTAAAGTGGAAA 3’ 
5’ AACACAGTTCCCGAGATGCTCG 3’ 
Detect spacer acquisition in 
CRISPR region 1 
CR2AcqF 
CR2AcqR 
5’ CGCGGCTTTTGACAGCAAA 3’ 
5’ CGGGGAACACGCTGTTTTGT 3’ 
Detect spacer acquisition in 
CRISPR region 2 
CR3F 
CR3R 
5' AGACTGGCGTTATAGGATGG 3' 
5' AGCCCGTGAAGCAAAGTATG 3' 
Detect spacer acquisition in 
CRISPR region 3 
CR2AcqF 
M13 Reverse 
5’ CGCGGCTTTTGACAGCAAA 3’ 
5´ CAGGAAACAGCTATGAC 3´ 
Detect spacer acquisition in 
pSp21-4, pSpCas123 and 
pSpCasg plasmids 
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Table 6A:   Primers and probes used to monitor phage replication in E. amylovora. 
Probes are in bold. Fluorophores are attached to the 5' end of the probe and a 
quencher to the 3' end. 
Primer Sequence Function 
Phage 9-2 F 
Phage 9-2 P 
Phage 9-2 R  
5’ CATGGGTAATCCCTTTGAG 3’ 
/FAM/TCTGGTGGA/ZEN/CAGAGACGATGTAAT/IABkFQ/ 
5’ GATAGACTGGTTCCCCTGTG 3’ 
Monitor 
ΦEa9-2 
replication 
Phage 35-70 F  
Phage 35-70 P 
Phage 35-70 R  
5’ TGGAAGGTCTTCTTCGAGAC 3’ 
/ROXN/GACGGAAAAGATCACGGTACCTT/IABRQSP/ 
5’ GACTACCTGGGGATGTTCAG 3’ 
Monitor 
ΦEa35-70 
replication 
Pun45-F 
Pun45-P 
Pun45-R 
5’ TTCAGCTTTAGCGGCTTCGAGA 3’ 
/ROX/AGTCGGTACACCTGCAACGTCAAGAT/IABRQ/ 
5’ AGCAAGCCCTTGAGGTAATGGA 3’ 
Monitor 
ΦEa21-4 
replication 
 dpo1-F 
dpo1-P 
dpo1-R 
AGGTGTGGATTGACGTAGGC 
/FAM/TGGTGGTAAGACGACCATCA/BHQ/ 
CCTTCGCATCAGAGTCCTTC 
Monitor 
ΦEa31-3 
replication 
Ea-lscF 
Ea-lscP 
Ea-lscR 
5’ CGCTAACAGCAGATCGCA 3’ 
/CY5/CTGATAATCCGCAATTCCAGGATG/IABRQ/ 
5’ AAATACGCGCACGACCAT 3’ 
Monitor E. 
amylovora 
replication 
 
Table 7A : Primers used to amplify and clone  depolymerase genes of  ΦEa35-70 and 
ΦEa31-3 in pET200/D-TOPO® vector. 
Primer Sequence (5’-3’) Function 
HdepolFr 
depolRev 
CACCATGACAGATAGCACTACA 
GAATCCCCTCCTCCAGTTAGC G 
Amplify and clone  ΦEa35-
70 depolymerase  protein  
(with a His-tag) 
Hdepol31-3Fr 
depol31-3Rev 
CACCATGCCGGAAACTAAGATTAAG 
TTACGTGTTAGATACTGTACCA 
Amplify and clone  ΦEa31-
3 depolymerase  protein  
(with a His-tag) 
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Figure 1A: Sequences of the leader and protospacers and repeats inserted in the 
plasmid carried the artificial CRISPR system. The leader sequence is in bold. The 
protospacers are underlined. The three protospacers are made to target ΦEa21-4 gene 
66 (putative baseplate component), gene 69 (putative tail fiber protein) and gene 83 
(conserved hypothetical protein). 
 
ACGCATGCAAACCGCGGCTTTTGACAGCAAAAAATCCGGTAGATTTTGACGGGT
AAAAAAAGCCGTTATGGTTCAATGGTTTGTATCTAGAGTGTTCCCCGCGTGAGCG
GGGATAAACCGATTTGGGACACAAAACCTGCTGGTATTCGTGCGTGTTCCCCGCG
TGAGCGGGGATAAACCGAAGTATGTTACAGCGAAAGTTGTAAACGACCTGTGTTC
CCCGCGTGAGCGGGGATAAACCGCGTCTTAACTCGTTGATTGATAACGCAACTTT
GTGTTCCCCGCGTGAGCGGGGATAAACCGTGT 
 
 
Figure 2A: the map of pTotalStdA plasmid used to create standard curves titer phages 
and E. amylovora using real-time PCR in this study.  This plasmid was constructed by 
cloning the PCR target sequence in phages and E. amylovora in plasmid vector. Coned 
sequences are shown in colors. 
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